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This work investigates neuroimaging as applied to movement disorders by the 
use of radionuclide imaging techniques.  There are two focuses in this work:  
 The optimisation of the SPECT imaging process including acquisition and 
image reconstruction.  
 The development and optimisation of automated analysis techniques 
The first part has included practical measurements of camera performance using 
a range of phantoms.  Filtered back projection and iterative methods of image 
reconstruction were compared and optimised.  Compensation methods for 
attenuation and scatter are assessed.   
Iterative methods are shown to improve image quality over filtered back 
projection for a range of image quality indexes.  Quantitative improvements are 
shown when attenuation and scatter compensation techniques are applied, but 
at the expense of increased noise.  
The clinical acquisition and processing procedures were adjusted accordingly.  
A large database of clinical studies was used to compare commercially available 
DaTSCAN quantification software programs.   
A novel automatic analysis technique was then developed by combining 
Principal Component Analysis (PCA) and machine learning techniques (including 
Support Vector Machines, and Naive Bayes).  
The accuracy of the various classification methods under different conditions is 
investigated and discussed.  
The thesis concludes that the described method can allow automatic 
classification of clinical images with equal or greater accuracy to that of 
commercially available systems.   
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 Definition 
 123I-FP-β-CIT Radiopharmaceutical used for imaging Dopamine 
 transporters (DAT), replaced 123I-β-CIT
 123I-β-CIT Radiopharmaceutical used for imaging Dopamine 
transporters (DAT), replaced by 123I-FP-β-CIT due to 
 improved imaging characteristics
 AD  Alzheimer's Disease, a common degenerative dementia
 Caudate  Small curved structure near centre of brain, part of Striatum
 CT Computed Tomography, clinical imaging technique which 
utilizes a rotating x-ray source and detectors to acquire 
transmission projection data which can be combined to give 
 transverse slices (see also FBP)
 D2 Dopamine receptor type 2, expressed on post-synaptic 
 neuron
 DA  Dopamine, a neurotransmitter
 DAT  Dopamine Transporter, expressed on pre-synaptic neuron
 DaTSCAN Trade name for kits for the preparation of ioflupane/FP-β-
 CIT
 DDRR  Depth Dependent Resolution Recovery
 DLB  Dementia with Lewy Bodies, a degenerative dementia
 EANM  European Association of Nuclear Medicine
 ET  Essential Tremor, benign movement disorder
 FA Factor Analysis, A range of processing techniques applied to 
 principal components
 FBP Filtered Back Projection, a reconstruction method that 
 creates transverse slices from a series of projection images
 FDG FluoroDeoxyGlucose, glucose analogue used in PET imaging, 
 labelled with 18F  
 FDOPA Fluorodopa, a PET radiopharmaceutical used to image the 
 Dopamine synthesis and storage, labelled with 18F
 FP-β-CIT Ligand used for imaging of Dopamine Transporters (DAT), 
 normally labelled with 123I
 FRR  Fixed Resolution Recovery
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 FT / IFT  Fourier Transform / Inverse Fourier Transform
 FWHM / FWTM Full Width at Half Maximum, Full Width at Tenth Maximum, 
ways of defining the width of a peak, often used in 
 resolution measurement
 IBZM IodoBenZaMide, radiopharmaceutical used in SPECT 
 imaging of the D2 Receptors, labelled with 123I
 ioflupane  Chemical name for 123I-FP-β-CIT
 IPD Idiopathic Parkinson's disease, the most common form of 
 Parkinsonism
 LEHR / VXGP Two collimators designed used for low energy high 
 resolution gamma camera imaging
 MLEM Maximum Likelihood - Expectation Maximisation - an 
iterative reconstruction method that creates transverse 
 slices from a series of projection images
 MRI Magnetic Resonance Imaging, clinical imaging technique 
which utilises the magnetic properties of tissues to form 
 images
 MSA  Multiple System Atrophy
 MSA-P  Parkinsonian variant of MSA
 NEMA  National Electrical Manufacturers Association
 NMSE Normalised Mean Square Error, method of comparing two 
 sets of data
 NPS Non-Parkinsonian Syndrome, classification group used in 
 this work to distinguish from PS
 OSEM Ordered Subset Expectation Maximisation, an accelerated 
 form of ML-EM reconstruction
 PCA  Principal Component Analysis
 PD  Parkinson's Disease, a movement disorder
 PET Positron Emission Tomography, clinical imaging technique 
allowing imaging of positron emitters labelled to various 
 pharmaceuticals/molecules. 
 PS Parkinsonian syndromes, the group of Parkinson's like 
 diseases including IPD, PSP and MSA and others
 PSP  Progressive Supranuclear  Palsy, a Parkinsonian syndrome
 Putamen  Small curved structure near centre of brain, part of Striatum
14 
 
 PVE Partial Volume Effect, image artefact seen in all digital 
 imaging modalities
 rCBF  regional Cerebral Blood Flow
 ROI  Region of Interest, cluster of pixels analysed as a group
 ROR Radius of Rotation, the distance from the gamma camera to 
 the centre of rotation during SPECT acquisition
 SNR  Signal to Noise Ratio
 SPECT Single Photon Emission Computed Tomography, a mode of 
operation for gamma cameras which allows 3D volume data 
 to be acquired
 SPET  See SPECT
 SPM Statistical Parametric Mapping, set of computational 
 algorithms developed for analysis of groups of brain images
 SSM / CSSM Step and Shoot Mode, Continuous Step and Shoot Mode, 
 different gantry motions in SPECT imaging
 Striatum Small structure near centre of brain, formed of the Caudate 
 and Putamen, part of Basal Ganglia
 SVCD  Small Vessel Cerebrovascular Disease
 SVD Singular Value Decomposition, computational technique for 
 calculating eigenvalues, eigenvectors and singular values
 SVM Support Vector Machine, an example of a supervised 
learning technique to classify data points in 2 or more 
 dimensions
 TEW Triple Energy Window, a scatter compensation technique 
 used in gamma camera imaging
 VOI  Volume of Interest, cluster of voxels analysed as a group
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1.  
This work investigates neuroimaging as applied to movement disorders by the 
use of radionuclide imaging techniques.  There are two focuses in this work:  
 The optimisation of the SPECT imaging process 
 The development and optimisation of automated analysis techniques 
Before discussing these ideas, the nature of the clinical conditions being 
investigated will be described.   
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1.1 Parkinsonian syndromes, clinical presentations and 
neurophysiological basis 
Parkinson’s Disease was first described by James Parkinson in 1817 and 
originally named the shaking palsy 7.  It is the second most common neurological 
disorder after Alzheimer’s disease, and the most common movement disorder 8.  
The term Parkinsonian syndromes (PS) encompass a range of related diseases 
including amongst others Parkinson’s Disease, Progressive Supranuclear Palsy 
and Multiple System Atrophy.  Idiopathic Parkinson’s disease (IPD) accounts for 
around 80% of cases.   
1.1.1 IPD – presentation, clinical features, neurophysiological 
basis 
Idiopathic Parkinson’s Disease normally presents in the form of motor effects, 
most commonly a tremor, but also rigidity, involuntary movements, abnormal 
posture and Bradykinesia (slowness of movement) 9.  Non-motor dysfunction is 
also widely seen in Parkinson’s Disease, with a range of Neuropsychiatric 
(depression, anxiety, apathy and cognitive impairment), anosmia, sleep 
dysfunctions (insomnia, limb movement, restless leg syndrome) and autonomic 
symptoms (Urinary Bladder, Nocturia, Sexual dysfunction)10-13.  In advanced 
disease around 80% of patients will display cognitive impairment, e.g. memory 
loss, and almost half will show signs of depression 12.   
Post-mortem investigations find damage and loss of pigmented cells in the 
substantia nigra, including cytoplasmic inclusions, known as Lewy bodies.  The 
cells in the substantia nigra extend to the striatum and supply it with Dopamine 
17 
 
(DA).  The overall effect is a depletion of DA in the striatum, globus pallidus and 
substantia nigra.  Within the striatum, the posterior of the putamen is normally 
affected first followed by the caudate.  The loss of DA from the basal ganglia 
causes them to become overactive leading to the clinical motor features 14.   
Diagnosis from clinical examination has around 80% sensitivity, but only 30% 
specificity when compared to post-mortem examination 15.   
1.2 Parkinson’s – Plus syndromes – presentation, clinical 
features and neurophysiological basis 
Within the Parkinsonian syndromes there exists a range of so-called Parkinson’s-
plus syndromes 16.  These typically present with similar motor features to IPD, 
but can vary.    
1.2.1 Progressive Supranuclear Palsy 
This disease shares some of the problems with movement seen in IPD, including 
a shuffling gait and accounts for around 6-10% of movement disorder cases 16,17.  
The main differences that are seen are problems with eye movement.  Typically, 
this begins with impairment of the down gaze and progresses to general 
ophthalmoparesis.  Patients with PSP will tend to have an increased number of 
falls, which can be due to a combination of gait and eye-movement problems.  
However, these effects may not be seen at first presentation.   
As with IPD, post-mortem examination shows damage and loss to the substantia 
nigra 17 that gives rise to the Parkinsonian motor changes.  Neurofibrillary 
tangles are seen in many areas of the brain including the brain stem.  The 
brainstem changes give rise to the eye movement effects.   
18 
 
Neurofibrillary tangles are also seen in other diseases, most notably Alzheimer’s 
Disease  (AD).  However, the characteristic amyloid plaques of AD are absent.   
1.2.2 Multiple System Atrophy 
Multiple System Atrophy (MSA) combines three previously separate disorders of 
Shy-Drager syndrome, olivopontocerebellar atrophy and striato-nigral 
degeneration 16,18-20.  Clinically the Parkinsonian symptoms are accompanied by 
autonomic failures.  Two subcategories exist depending on which symptoms 
predominate, MSA-P where the symptoms are predominantly Parkinsonian, and 
MSA-C in the case of cerebellar ataxia.  The former is more common in western 
populations, but considerable overlap between the two groups exist 20.   
The physiological basis is glial cytoplasmic inclusions.  Neuronal loss is seen in 
the basal ganglia along with loss in the cerebellum, pons, inferior olivary nuclei, 
and spinal cord.   
1.2.3 Dementia with Lewy Bodies  
Dementia with Lewy Bodies (DLB) is a specific condition first defined in the late 
1970s 16,21,22.  The main clinical presentation is dementia.   
Lewy bodies are cytoplasmic inclusions common in many neurological 
conditions (including PD and AD) and exist in two forms: Cortical Lewy Bodies, 
and Brain stem Lewy Bodies.  DLB is characterised by the presence of diffuse 
cortical Lewy bodies.  Cortical changes give rise to the neurological symptoms.  
As the disease progresses these bodies may be seen in the substantia nigra.  
Damage and loss of cells here leads to Parkinsonian movement features.  More 
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recently, DLB and the dementia variant of PD (PDD) have been viewed as 
different presentations of the same disease 23,24.   
The three conditions, IPD, MSA and DLB belong to a group of diseases known as 
-synucleinopathies as the characteristic Lewy Bodies are formed from 
aggregated -synuclein.   
1.3 Other neurological disorders 
1.3.1 Alzheimer’s disease 
Alzheimer’s Disease (AD) us the most common neurological disorder and 
accounts for around half of all dementias.  It was originally described as “A 
unique illness involving the cerebral cortex” by Alois Alzheimer 25 who detailed 
the characteristic neurofibrillary tangles and amyloid plaques.   
Clinical symptoms at presentation are mainly related to short-term memory 
problems and other neurological symptoms.  However, differentiating this from 
other dementias such as DLB can be problematic.  Such differentiation is 
important as patients with DLB can be highly sensitive to the neuroleptic (or 
antipsychotic) treatments often given in AD 22.   
1.3.2 Tremors 
The term tremor is associated with many movements of the body, as well as 
diseases and disease groups.  A consensus statement of the movement disorders 
society 26 set out to define and standardise the descriptions of movements so 
that better comparisons could be made between diagnostic and research groups.  
Defining the tremors by frequency, and activation cause (i.e. rest, posture or 
intentional movement), can direct the definition of some of the tremor 
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syndromes.  The following descriptions of tremor groups are based on the 
disease definitions given there.   
1.3.2.1 Essential Tremor  
Essential Tremor (ET) is an involuntary tremor or shaking of the limbs or head 
for which no specific cause can be identified.  It is not linked to any 
neurodegenerative processes such as Lewy bodies.  It is the main differential 
diagnosis with Parkinsonian Syndromes as the disorders of movement can be 
difficult to separate.  ET can have a genetic link as it can occur in families, known 
as Familial Essential Tremor (FET), but will often occur with no obvious familial 
history – known as Sporadic Essential Tremor (SET).   
1.3.2.2 Psychogenic Tremor 
These tremors occur in patients suffering from psychological problems.  The 
physical symptoms do not originate from physiological changes, but are a 
manifestation of the psychological problems.  A common example being a stress 
induced tremor.   
1.3.2.3 Holmes Tremor 
This tremor is generally related to brainstem/cerebellum or thalamic lesions.  It 
presents clinically with a slow frequency tremor in both resting and intention 
movement 27.   
1.3.3 Vascular diseases  
Disturbances in the blood supply to the brain are collectively known as 
cerebrovascular diseases.  The disturbances can be transient or permanent, 
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reductions or occlusions and can vary in size and number.  A number of subtypes 
are recognised including Multi-infarct dementia (MID) and Small Vessel 
Cerebrovascular Disease (SVCD).  The area of brain affected can be permanently 
damaged and treatment is targeted on preventing further problems by limiting 
vascular risk factors.  The area of brain affected will obviously determine the 
clinical manifestation.  Vascular Dementia is the second most common form of 
dementia, and is difficult to distinguish clinically from AD 28.  A related condition 
is Cerebro-Vascular Parkinson’s Syndrome (CVPS) 29 where the vascular disease 
affects the striata producing Parkinsonian features.   
1.3.4 Drug Induced Parkinsonism 
There are a number of prescription drugs that can affect the action of dopamine 
in the brain.  In particular, some neuroleptic drugs, often prescribed to control 
dementia and schizophrenia, can cause severe parkinsonian symptoms.  In 
general, withdrawing these drugs will lead, in time, to a reversal of the 
Parkinsonian symptoms 30.  However, patient specific risk-benefit analyses have 
to be performed to ensure the best clinical outcome.   
1.3.5 Other Neurological conditions 
Because of the nature of neurological symptoms, there exist many overlaps 
between normal variants and the clinical features of many diseases.  Other 
diseases types that can present as movement disorders include, but are not 
limited to, Multiple sclerosis, Huntington’s disease, Fragile-X syndrome and 
Wilson’s disease.   
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1.4 Neurotransmitters 
Neurotransmitters are a group of chemicals utilised in the path of signals 
between neurons in the central nervous system.  Signals pass along neurons as 
waves of polarisation.  The passage of 
these signals across synapses – the 
joins between individual neurons - is 
facilitated by neurotransmitters.   
 
The neurotransmitters are stored 
within a great number of vesicles 
within the terminal of the pre-
synaptic neuron.  When the action 
potential reaches the synapse, these 
vesicles eject their transmitters into 
to the synaptic cleft.  The transmitters 
will bind to and activate some of the 
receptors on the post-synaptic 
neuron.  Activated receptors act as 
open ion channels, changing the 
potential on the post-synaptic 
membrane.  Once sufficiently 
polarised, this produces an action 
potential in the post-synaptic neuron 
and the signal is passed on.   
Figure 1-1. Schematic diagram of synapse 
between two neurons.  Vesicles in pre-
synaptic neuron release a neurotransmitter 
(in this case Dopamine) into the cleft.  
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The transmitters only act on the post-synaptic receptors for a brief time as they 
are quickly broken down by enzymes.  Unbound transmitters in the cleft are 
reabsorbed by transporters in the pre-synaptic neuron.   
1.4.1 Dopamine 
Dopamine (DA) is a neurotransmitter that plays a role in many neurological 
processes including movement, cognition and mood.  It is also important in 
reward and pleasure 14.   
 
Figure 1-2. Synthesis of Dopamine from Tyrosine 
Dopamine is synthesised as part of a series of enzyme mediated actions starting 
with Tyrosine.  This is oxidised by tyrosine hydroxylase to give L-Dopa, which is 
then converted to DA by dopamine B-hydroxylase.  In some cell types, DA is 
further processed to give Norepinephrine and Epinephrine.  Tyrosine and L-
Dopa can pass through the blood-brain-barrier, whereas dopamine cannot.  
Dopamine production occurs within the pre-synaptic neuron where it is stored 
within the vesicles ready for release into the synapse.   
To date, at least five DA receptor subtypes have been identified 31.  They can be 
split into two sub groups, D1-like receptors (D1 and D5) and D2-like receptors 
(D2, D3 and D4).  D1 and D2 dopamine receptors are the more common forms 
and are found in particularly high concentrations in the striatum.  The D2 
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subtype is seen predominantly in the post-synaptic membrane of the nigro-
striatal synapses.  
The DA Transporter (DAT) is the site on the pre-synaptic neurons where DA is 
re-absorbed for storage ready for the next excitation.   
Both the D2 receptor and the DA Transporter are important targets for imaging 
studies of Parkinsonian syndromes.   
1.5 Imaging of movement disorders and associated conditions 
Functional imaging with radiopharmaceuticals for movement disorders can be 
divided into two groups depending on whether they target the pre-synaptic or 
post-synaptic neurons.  Further divisions can be made on process or feature 
being imaged and with which modality it can be imaged, either single Photon 
Emission Computed Tomography (SPECT) or Positron Emission Tomography 
(PET).  An overview of these tracers is given in Table 1-1, which also includes 
some of the main references on their use.   
In general, PET imaging is superior to SPECT imaging in humans due to the 
improved resolution and accuracy of quantification.  As PET involves imaging 
from 360 degrees simultaneously, kinetic measurements can be made on tracers 
with faster biokinetics than for SPECT.  For these reasons PET is normally the 
preferred choice in the research setting.  However, due to cost, availability and 
practical considerations, SPECT imaging is the more widely used clinical 
investigative imaging tool.  An introduction to SPECT imaging is given in section 
1.7.   
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Table 1-1 Summary of radiopharmaceuticals that can be used for imaging the 
dopaminergic pathway 
  SPECT PET 
Pre-synaptic 
imaging 
DA synthesis 
/storage 
 18F-DOPA 23 
    
Pre-synaptic 
imaging 
DA 
Transporter 
123I- -CIT 32-34 35 
11C / 18F - -
CIT 
  
123I-FP- -CIT 34 
36,37 
11C / 18F -FP-
CIT 
  99mTc-TRODAT 38  
  123I-PE2I 39 
11C / 18F -
PE2I 
    
Post-synaptic 
imaging 
D2 receptor 123I-IBZM 40,41 
11C-
raclopride 41 
  123I-Epidepride42 
11C / 18F - 
Fallypride 
 
1.5.1 Imaging Dopamine synthesis and storage 
The design of radiopharmaceuticals for brain imaging is hampered by the blood-
brain barrier (BBB).  This membrane protects the brain by preventing larger 
molecules and objects such as bacteria from entering the brains extracellular 
fluid.  DA cannot cross the BBB and so cannot be used as an imaging tracer.  
However, 18F-DOPA mimics the action of L-DOPA and can cross the blood-brain 
barrier.  Its uptake will reflect the locations of DA production and storage.  The 
uptake of 18F-DOPA will be dependent on a number of factors including the rate 
of transfer across the BBB, the rate of synthesis within the neuron and its 
retention within the neuron 31,43.  
1.5.2 Imaging the Dopamine Transporter 
The radiopharmaceuticals used to image the dopamine transporter (DAT) are 
based on analogues of cocaine.  Cocaine binds to the DAT blocking the re-uptake 
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of DA, subsequently increasing DA levels within the synapses producing the 
‘high’.  The most common pharmaceuticals that have been used to study DAT 
using SPECT are 123I- -CIT 32,33,44 and 123I-FP- -CIT 44-48.  An example transverse 
slice from a 123I-FP- -CIT scan is shown in Figure 1-3.  The image shows high 
uptake in the caudate and putamen.  The corresponding slice from a T2 weighted 
MRI scan is shown for anatomical localisation.  This patient shows normal uptake 
of 123I-FP- -CIT.   
 
Figure 1-3 Example transverse slice from 123I-FP-beta-CIT SPECT scan with corresponding 
slice from T2weighted MRI 
 
The biokinetics of 123I- -CIT in the brain and its binding to the dopamine and 
serotonin transporters was described by Brucke et al. 32.  Further work by Innis 
et al. 33 showed that loss of striatal dopamine transporters could be detected 
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using 123I- -CIT imaging.  They suggested that it could be used for both 
monitoring disease, and distinguishing between idiopathic Parkinson’s and other 
disorders.   
The binding of -CIT based ligands (including 123I- -CIT, 123I-FE- -CIT and 123I-
FP- -CIT) to dopamine, serotonin and norepinephrin transporters were 
compared by Okada 44.  This work and others lead to the use of 123I-FP- -CIT for 
DAT imaging.  
Booij et al. 45 described the bio-kinetics of 123I-FP- -CIT, showing a pronounced 
decrease in uptake in Parkinson’s disease compared to age matched healthy 
volunteers.  The bio-distribution and kinetics have also been described 
elsewhere 47.  The faster kinetics of 123I-FP- -CIT compared to 123I- -CIT, allow 
imaging at 3-6hrs as opposed to 24hrs, with higher specific to non-specific 
binding ratios.  However, the relative changes in uptakes between normal and 
Parkinson’s patients for the two tracers are equivalent 46.   
In retrospective analyses, the use of 123I-FP- -CIT has been shown to have a large 
impact on diagnosis and clinical management in clinically uncertain 
Parkinsonian syndromes 49, dementia and DLB 50.  Another retrospective study 
showed a normal 123I-FP- -CIT image to give a high negative predictive value 51.  
A study of 123I-FP- -CIT and 18F-FDOPA 52 showed that 123I-FP- -CIT gave similar 
accuracy for discrimination between Parkinsonian and non-Parkinson’s patients.  
The authors also described an age dependency of the uptake of 123I-FP- -CIT.   
Comparisons between 18F-FP- -CIT and 11C- FP- -CIT suggest the former is 
superior due to the lower production of metabolites 53.  The increased half-life is 
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also beneficial, as it allows better imaging of the biokinetics.  No direct 
comparisons of 18F and 123I labelled FP- -CIT have been published.   
More recently, 123I labelled PE21 has been proposed as an alternative due to its 
lower affinity with Seratonin Transporters (SERT) 39.   
99mTc TRODAT-1 is a relatively new agent that can be used to image DAT 38.  The 
use of 99mTc as the radioisotope as opposed to the cyclotron-produced 123I may 
allow more widespread use.   
1.5.3 Imaging the Dopamine receptors 
Dopamine receptors are found in both pre- and post-synapse neurons, but the 
vast majority of D2 receptors are seen in the post-synaptic neurons.  Hence, the 
D2 receptor has been used as post-synaptic imaging target.  Most routine clinical 
imaging of D2 has been done with 123I-IBZM 54.  11C -raclopride and 11C / 18F -
fallypride are important PET research probes, but due to cost, availability and 
practicalities they have not found their way to clinical use.   
Koch et al. 55 demonstrated that combining pre- and post- synaptic imaging could 
improve diagnostic power.  Financial and logistical issues have prevented this 
becoming the clinical routine.   
1.5.4 Differentiation of parkinsonian syndromes using SPECT 
1.5.4.1 MSA and PD 
Nocker et al. 56 investigated the progression of MSA-P and IPD.  They found 
significant reductions of DAT in the brainstem of MSA-P patients compared to 
IPD at baseline.  The reduction of uptake was greater in MSA-P patients 
compared to IPD.  The brainstem uptake in the MSA-P patients did not decline 
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further after baseline.  Their work showed distinct differences in the rate of 
progression of disease between MSA-P and IPD.  Their results also suggest 
differences in the pattern of uptake between the two disease groups.  In another 
publication by some of the same authors 57, similar differences between MSA-P 
and IPD were highlighted.  Changes in glucose metabolism in MSA have also been 
shown 58.   
1.5.4.2 PSP and PD 
The clinical differences between PSP and IPD are hard to distinguish at early 
stages of disease. However, some work 59 has suggested that the rapid 
progression of PSP, along with its more symmetrical progression, allows 
differentiation of these diseases using 123I-FP- -CIT imaging.   
1.5.4.3 DLB and PD 
Using both rCBF and DAT images, Rossi et al. 60 showed no statistically 
significant differences between DLB and Parkinson’s Disease -dementia.  Others 
have reported on regional cerebral blood flow differences in PS 61 and DLB 62 
when compared to healthy volunteers.   
1.5.4.4 Holmes Tremor 
In the case of Holmes tremor reported changes in ioflupane imaging have been 
inconsistent with some workers reporting marked dopaminergic loss 63 and 
others minimal changes 64.   
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1.5.4.5 Wilsons disease 
In Wilson’s disease (a copper deposition disorder) effects to both the pre- and 
post- synaptic neurons have been shown using 123I- -CIT and 123I-IBZM 
respectively 65.   
1.6 Imaging with other modalities and non-imaging 
techniques 
CT imaging is widely used to identify areas of vascular disease, trauma and 
malignancies, however its use in movement disorders is limited.  Likewise, MR 
imaging has found little use so far.  Ultrasound, though difficult in the brain due 
to the fact it is enveloped in bone, has been used with some success, however it 
could not be used to define severity of disease 66.   
Due to the early onset of anosmia in many patients, olfactory testing has been 
suggested as a useful adjunct to DAT imaging in early Parkinson’s Disease 67.  
However, the low positive predictive value would rule out its use in population 
screening on its own.   
1.7 SPECT imaging 
Single Photon Emission Computed Tomography (SPECT) imaging utilises 
radiopharmaceuticals to allow visualisation and quantification of physiological 
processes.  After injection, the radiopharmaceutical circulates around the body 
and localises according to its biochemistry.  A gamma camera is then used to 
detect the gamma emissions coming from the radioactive isotope.  To perform 
tomographic imaging, the gamma camera is rotated around the patient acquiring 
images at equidistant projection angles.  These projection images must then be 
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reconstructed to produce the transverse slices that represent the activity 
distribution in the patient.   
In this section, the operation of a gamma camera is described, followed by the 
acquisition and reconstruction of SPECT images.   
 
1.7.1 Gamma camera design and operation 
The basic gamma camera design was first demonstrated by Anger 68 as a method 
of imaging single photon emissions and replaced the rectilinear scanner.  A 
schematic diagram is given in Figure 1-4.   
 
Figure 1-4 Schematic diagram of gamma camera 
Gamma photons emitted from within the patient travelling in the direction of the 
gamma camera first encounter the collimator.  These are normally constructed 
from folded sheets of lead, to form a series of parallel holes or tubes.  They have 
also been made by drilling into blocks and are sometimes made of tungsten 
(Figure 1-5).   
 
32 
 
 
Figure 1-5 Schematic diagram of collimator 
The walls between these holes, known as septa, absorb photons that are not 
travelling perpendicular to the face of the detector (or within a certain 
acceptance angle).  The ratio of the width (d) and depth (l) of these holes define 
the acceptance angle, the range of angles of photon paths that can still reach the 
detector (Figure 1-5).  A reduced acceptance angle will improve the geometric 
resolution of the collimator, but will also reduce the sensitivity.  Conversely, a 
wider acceptance angle will improve the sensitivity, but degrade the resolution.  
The septa of the collimator will also affect the sensitivity as they cover an area of 
the detector proportional to their thickness.  The required thickness of the septa 
will be related to the range of energy of the photons being imaged.  As the 
number of gamma rays passing through a material falls exponentially with 
thickness, no amount of material would attenuate all the photons; hence, 
collimator designs are defined for energy ranges that allow less than 5% 
transmission.  This situation can be complicated where isotopes have multiple 
higher energy emissions.   
The detector is a scintillation crystal (NaI doped with Tl), coupled with an array 
of Photo-Multiplier Tubes (PMTs).  Gamma rays incident on the crystal will be 
absorbed by photoelectric absorption or undergo Compton scattering.  After a 
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short delay, the energy absorbed by the crystal is re-emitted as a group of visible 
light photons.  The number of photons emitted is proportional to the energy 
deposited in the crystal.   
Some of the emitted photons will hit the photocathodes of the PMTs.  This 
interaction causes the emission of electrons from the photocathode.  The 
electrical potential between the dynodes cause an acceleration of the electrons 
and results in a cascade of electrons along the dynodes, resulting in an electrical 
signal.  The signals from all the PMTs can be combined to give the position of the 
original crystal interaction.  The sum of the signals is relative to the energy 
deposited.  An energy acceptance window (the photopeak window) can then be 
used to discriminate between scattered and non-scattered photons, since 
scattered photons will be of lower energy.  The energy of the scattered photon 
(h ’) is related to the scattering angle ( ) and the initial energy (h ) by the 
constant mec2 (Equation 1-1).   
 
Equation 1-1 
The energy resolution of a modern gamma camera is around 10% (Full Width at 
Half Maximum - FWHM).  Hence, non-scattered photons will be detected at a 
range of energies, and so compromise must be made between widening the 
photopeak window to accept sufficient non-scattered photons, but not to include 
too many scattered photons.  Scatter compensation methods are discussed 
further in Chapter 2.   
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1.7.2 Resolution with distance 
The resolution of a gamma camera is the error in the positioning of an emission.  
It is formed of two components; the first is the intrinsic resolution of the detector 
Ri.  This is positioning error of the interaction within the detector.  It is 
dependent on a number of factors including the crystal thickness, the light 
output of the crystal, and PMT size and arrangement.  The second component, Rc 
is a geometric uncertainty of the origin of the emission relating to the acceptance 
angle of the collimator.   
As the geometric resolution of the collimator is based on an acceptance angle, its 
width will be dependent on the collimator-source distance.  For a circular holed 
collimator, Rc can be approximated as shown in Equation 1-2. 
 
Equation 1-2 
 
Where d is the diameter or width of the hole, b is the distance from the source to 
the collimator and leff the effective length of the holes.  The effective length of the 
holes leff is slightly shorter than the physical holes (l) due to septal penetration.  
The effective length is given by Equation 1-3 69 where  is the linear attenuation 
coefficient for the collimator material at the energy being imaged.   
 
Equation 1-3 
For a hexagonal collimator the resolution will have an angular dependency that 
follows the width of the hole.   
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The intrinsic and collimator resolution effects combine in quadrature to give the 
total system resolution RTot (Equation 1-4).   
 
Equation 1-4 
1.7.3 Septal penetration  
The collimator design is optimised for a particular energy ranges.  Typically, this 
will involve ‘Low’ (<160-180keV), ‘Medium’ (160-280keV) and ‘High’ (>280keV) 
energy ranges.  The isotope of interest here is Iodine-123, which has main 
photon emission at 158.99keV (emission probability 0.9922), which would imply 
low energy collimators.  However, the emission spectrum from 123I is complex 70 
and contains a number of higher energy emissions (see Figure 1-6).  The 
probability of emissions above 159keV is 3%, with emission above 500keV at 2% 
probability.  These higher energy photons will not be attenuated as much by the 
collimator septa.  This septal penetration can lead to reduced contrast and 
increased noise 71.  Some level of septal penetration is always present in gamma 
camera imaging, however, when higher energy emissions are present, as is the 
case for 123-Iodine, a greater level of septal penetration will be present.  Thus, 
the choice of collimators is not straightforward 71.   
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Figure 1-6. Emission probabilities of 123-Iodine.  Principal gamma energy 158.99keV 
omitted for clarity.  Uncertainties in the published data too small to be displayed. 
1.7.4 SPECT mode acquisition 
Single Photon Emission (Computed) Tomography (SPECT or SPET) is an 
acquisition mode in which the gamma camera is rotated around the object, 
acquiring a series of static images from a number of discrete, uniformly spaced 
angles.  To allow quicker scans modern scanners will have multiple detectors 
acquiring at different angles at the same time.  Often this is with two detectors 
but three and four detector systems have also been used.  These static images are 
known as projections or projection images.  The projection images can be 
combined using reconstruction algorithms to produce transverse slices or 3D 
volume data.   
Figure 1-7 and Figure 1-8 show the positioning of a patient for a SPECT brain 
scan using a dual headed gamma camera.  The patients’ head is held in a special 
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cradle to allow the detectors to be positioned as close as possible, avoiding the 
shoulders and couch.  Forehead and chin straps are used to minimise patient 
movement.   
 
 Figure 1-7 A subject positioned ready for a 
brain SPECT acquisition 
 
 Figure 1-8 The patient positioning as seen 
through the gantry 
1.8 Image reconstruction 
The two categories of algorithm are analytical and iterative reconstruction.  A 
brief description of these models is given here, but a more complete description 
can be found in the literature 72,73.   
1.8.1 Analytical reconstruction 
The most common form of analytical reconstruction program, and the one still 
widely used in nuclear medicine, is Filtered Back Projection (FBP).  Here the 
projection data are convolved with a windowed ramp filter.  The ramp filter is 
required to limit the star artefact.  The windowing filter will normally be a low-
pass filter (such as a Butterworth filter).  Such windowing is required to prevent 
the amplification of high frequency data in the images since high frequency data 
is made purely of noise.  Once convolved with a suitable filter, the projection data 
can be back projected across the image space.   
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1.8.2 Iterative reconstruction 
Iterative reconstruction models generally work by estimating the activity 
distribution, calculating the projection data that would arise from this estimate 
and then comparing the estimated projection data with the measured projection 
data.  This comparison then allows the distribution estimate to be updated.  
Thus, there are three main parts of the iterative algorithm: 
 The system model (which is used to calculate the projections from the 
distribution estimate) 
 How the differences between the measured and calculated projections are 
defined 
 How these differences are used to update the distribution estimate 
A common implementation of iterative reconstruction is Maximum likelihood – 
Expectation Maximisation (ML-EM) 74.  
1.9 Image analysis and classification 
When trying to classify a medical image the aim is to combine all the information 
in an image into some meaningful description.  For example the images in this 
work, the starting point is a patients’ scan of around 500,000 voxels, and the 
finish point we hope to reach is a meaningful diagnosis (Parkinson’s disease or 
tremor) or some level of disease progression (early – late disease).  The normal 
process is to first identify the salient features of the image.  The second stage is 
to use these features to classify the image by comparing them to known features 
or patterns.   
This combination of feature extraction followed by classification occurs in all the 
assessment techniques discussed here.   
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1.9.1 Visual assessment 
The main assessment technique used for the majority of medical imaging tasks is 
visual assessment by an experienced reporter.  They look for features in the 
images that are typical of the healthy or diseased states.  Allowances are made 
for known image artefacts and limitations of the modality being used.  The 
evaluation of SPECT images is performed using specialised nuclear medicine 
reporting software that allows some basic manipulation of the images.   
The reporting clinician is presented with images that have been through a series 
of preparatory steps:  
 Image reconstruction (which may include a range of image correction 
factors – see Chapter 3)  
 Image alignment (often performed manually but can also be automatic 
registration to a template) 
 Display colour table windowing – there are three general techniques to 
this, scaling to some predetermined absolute figure (e.g. an SUV of 7 in 
PET imaging), scaling to the highest pixel, or scaling based on the non-
specific binding (e.g. with the maximum being some multiple of the 
background region).  The first two options are the simplest to implement, 
however, the third may be easier to interpret for some image types.   
Each clinician will have their own way of visually analysing the images - the 
consensus involves looking for two properties: firstly, the image quality (was 
there patient movement?  Have the images been re-aligned correctly?).  The 
second stage is to examine the images for signs of disease.  Such steps are 
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obviously pharmaceutical specific.  The normal variants with which they 
compare may be also be age and sex specific.   
 
Figure 1-9 A series of transverse slices from a normal 123I-FP-B-CIT SPECT scan 
Using 123I-FP-β-CIT SPECT imaging as an example, and with reference to the 
example transverse slices shown in Figure 1-9, the following characteristics 
would be looked for:   
 Symmetry – assuming there are no technical problems with the 
acquisition and the images have been aligned properly, non-symmetrical 
images would suggest disease   
 Shape of the uptake – the classic shape of striatal uptake if the ‘dot-and-
comma’.  Disease progression is typically seen as loss of signal from the 
putamen so a change in shape towards a dot rather than commas would 
be suggestive of disease   
 Over-all uptake – a uniformly reduced uptake is suggestive of disease, this 
can be assessed visually by comparing to background/non-specific 
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binding areas, but this is not easy see without some form of quantisation 
or a normalised way of applying the colour table  
 Comparison with previous scans, including previous 123I-FP-β-CIT 
imaging, CT and MR where available   
 Comparison with clinical History.  If symptoms are unilateral, 
concordance with uptake patterns may add confidence to a particular 
report.  However, image and symptomatic concordance is not guaranteed 
5.   
Good sensitivity and specificity have been found when using visual assessment to 
differentiate between groups of subjects with parkinsonism and either essential 
tremor or healthy volunteer 75,76.   
1.9.2 Regions and Volumes of Interest (ROI/VOI) 
Regions and Volumes of Interest are widely used in most imaging modalities.  
The VOI is used to define a group of voxels (and/or partial voxels) and the 
average or total signal within the volume gives some measure of the tissue or 
organ contained within it.  These figures need to be processed further, either by 
comparing to a normal range/cut-off or by combining it with data from another 
volume.   
VOI sizes typically range from individual voxels up to sub-organ or organ sized 
volumes.  The shapes can be defined manually or automatically using some form 
of edge detection/region growing algorithm.  Often standard sized VOIs will be 
defined based on templates or structural images.   
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VOI can be placed manually by an operator or automatically.  Automatic 
positioning can be based on image registration, edge detection or image 
maximums/minimum values.   
One advantage of using VOI data is that (assuming appropriate corrections can 
be applied) the counts/signal in the VOI will often directly represent a clinically 
relevant physical value, or can be used to create such a figure.  For example, the 
counts within a VOI on 123I-FP-β-CIT images will be proportional to the number 
of transporter sites within that volume.   
123I-FP-β-CIT imaging lends itself nicely to quantification techniques as it is 
based on measuring uptake in known structural components rather than trying 
to identify increased or decreased uptake across the whole body, as is often the 
case in tumour imaging.  Overviews and comparisons of various techniques have 
been published 77,78 along with calls for the widespread implementation of semi-
quantitative analysis 79.  The European guidelines for dopamine transporter 
imaging 80 state that semi-quantitative analysis may be useful, and where 
performed should include standardised ROIs and have a normal range preferably 
based on age-matched controls.  They recommend the use of either occipital or 
cerebral regions for count normalisation.   
A number of VOI based methods have been suggested for quantification in 
dopamine receptor and transporter imaging.  These methods can be split into 
two subgroups depending on whether the placement of the VOIs is manual or 
automatic.  Three of the techniques using manually based VOIs have been 
combined into a software package (QuantiPSECT, Mirada solutions / GE-medical 
Oxford UK).   
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1.10 Aims of this work 
The main aim of this work is to investigate the use of classification techniques in 
movement disorders.  However to ensure the best performance of the process 
each step must be optimised and hence there are a number of aims:  
 Investigate the gamma camera performance characteristics when using 
123-Iodine  
 Optimise the acquisition settings taking into account scanner 
performance, patients’ needs and pharmaceutical characteristics 
 Investigate and optimise the image reconstruction and image correction 
techniques for use with 123I-FP- -CIT SPECT imaging 
 Develop an automatic classification technique 
 Compare the new automatic technique with other published techniques  
 Using a database of clinical scans, test the following hypothesis: 
 
“An automatic classification tool based on machine learning techniques will give 
better performance than currently available techniques.”   
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2  
The performance of gamma cameras for imaging 123-Iodine SPECT varies 
greatly and the exact characteristics will affect the quality of the images 
produced, and potentially the likelihood of an accurate diagnosis.  In this chapter, 
a range of scanner performance characteristics will be measured.  These results 
will be used to define image acquisition parameters most suitable for clinical 
dopamine transporter imaging.   
The following parameters will affect the imaging performance: 
 Gamma camera manufacturer / model 
 Collimator 
 Pixel size and Field of view/zoom setting  
 Number of projections 
 Orbit shape (circular/non-circular) 
 Orbit type (continuous / step and shoot) 
 Time per projection 
 Energy window selection 
The original EANM procedure guidelines for imaging of dopamine transporters 
published in 2002 81 were updated following developments and comments and 
were published in updated form in 2010 80.  They were produced by the EANM 
Neuroimaging committee and summarize the recommendations for the imaging 
of Dopamine Transporters using both 123I- -CIT and 123I-FP- -CIT.  As the 
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recommendations are designed to cover a wide range of equipment and 
institutional clinical practices they are necessarily broad.   
The manufacturer of 123I-FP- -CIT (under the tradename ‘DaTSCAN’) has also 
produced basic guidelines covering recommended acquisition and processing 
procedures.  Unlike the EANM guidelines, the manufacturer’s recommendations 
give specific camera settings for individual scanners; the data quoted here refer 
to the gamma cameras used in this research.  The three sets of guidelines are 
summarised in Table 2-1.   
Table 2-1 Published recommendations for acquisition settings 
Parameter EANM 2002 EANM 2010 
123I-FP-β-CIT 
manufacturer (GE) 
Delay to imaging 3-6hours 3-6hours 3-6hours 
Imaging device 
Minimum 2 
detectors 
Minimum 2 
detectors 
2 detectors 
Collimators 
LEHR or LEUHR 
Fan beam preferred 
LEHR or LEUHR 
Fan beam preferred 
VXGP / LEHR 
Orbit style Not stated Not stated Circular 
Orbit mode 
Step and shoot, (but 
continuous may 
reduce time and 
reduce mechanical 
wear) 
Step and shoot, (but 
continuous may 
reduce time and 
reduce mechanical 
wear) 
Not specified 
Radius of rotation Smallest possible Smallest possible 
Smallest possible, 
11-13cm 
Matrix 128*128 128*128 128*128 
Angular sampling 3degrees 3degrees 3degrees 
Pixel size / Zoom 
Between ½ and 1/3 
expected resolution 
Between ½ and 1/3 
expected resolution 
No zoom, 4.6mm 
Total counts >3million >3million >1.5million 
Total time 
40-50mins typical 
for triple headed 
30mins typical for 
triple headed system 
30sec/projection 
(30mins total) 
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2.1 Gamma camera manufacturer/model 
There are currently three main manufactures producing gamma cameras for 
clinical use and a number of smaller companies producing specialist equipment.  
However all the patients used in this work were scanned at one hospital, using 
one of two cameras.  The cameras are identical (Forte, ADAC Laboratories, 
California, USA) except for the collimators used on them.  Due to time 
constraints, and the nature of this project, only these two cameras were 
investigated.   
2.2 Energy windows  
The equipment available in our institution limits the number of energy windows 
that can be acquired simultaneously.  Up to three non-overlapping windows can 
be acquired per detector at the same time.  The width of the photopeak window 
will affect the resolution and sensitivity of the scanner.  Increasing the width of 
the window will mean more counts will be included in the image.  However, the 
wider window will take in a greater proportion of scatted photons.  Scattered 
photons are imaged in erroneous positions, degrading the resolution of the 
image.  The energy resolution of the detector determines its ability to distinguish 
between scattered and non-scattered photons.  The energy resolution is 
dependent on the crystal (material, doping levels, quality and thickness), the 
optical coupling of the crystal to PMTs, and the PMTs and associated electronics.  
The sensitivity-resolution trade off within the collimator will have to be taken 
into account when optimising the photopeak widths.  Detector uniformity and 
energy maps will be affected by the choice of photopeak width and changes to it 
will require further corrections maps.   
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The main photopeak window was fixed at 20% symmetrical window, centred on 
the main photopeak, as per the manufacturers recommended procedure.  This 
was done to ensure the system correction files were appropriate.   
2.2.1  Energy window simulation 
A series of Monte Carlo simulations were performed to investigate the 
contributions of scattering events and collimator interactions.  The SIMIND 
package 82 was configured to model the scanners used in this work.  A range of 
basic phantoms were used and tested against real-life measurements and found 
to match real scanner performance to within experimental error 6.  
Figure 2-1 shows the energy spectra output from a simple head sized cylinder 
(15cm diameter, 20cm length, uniform activity distribution, uniform material) 
for direct photons, and photons that have been scattered when imaging with a 
LEHR collimator on the ADAC forte gamma camera.  Only a single projection was 
simulated.   
The results of the simulation show that a large number of the photons detected 
within the photopeak window will have undergone at least one scattering 
interaction.  A number of scatter correction methods have been proposed, some 
of which use secondary energy windows as estimates of the scatter fraction 
within the photopeak.  Smaller windows, positioned very close to the main 
photopeak are likely to give a better estimate, however, the photon flux away 
from the main peak is much lower, so the use of very thin scatter windows will 
result in noisy estimates.   
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Figure 2-1Results of a Monte Carlo simulation.  Showing the number of detected photons 
as a function of energy 
A number of window widths have been used in published data.  In triple energy 
window corrections both 3%83,84 and 7%85 have been used.  For dual energy 
window corrections, with the scatter window below the photopeak these widths 
may be increased to 20% Dobbeleir et al. 71,86 or 40%87.  A slightly different 
approach was taken by Small et al. 88, who focused on the down scatter from 
higher energy emissions and used a 20% window above the photopeak.   
A very simple test was performed using the spectra output from this Monte Carlo 
model.  Using the energy windows proposed by Iida et al.  85 the number of direct 
(non-scattered) photons, and total photons (scattered, non-scattered, and 
collimator penetration and scatter) were calculated for the three energy 
windows.  These are shown in Figure 2-2 as direct photons, scattered photons, 
and total photons detected.  Three energy windows are also shown representing 
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a 20% photopeak, and two 7% scatter windows.  These counts are shown in 
Table 2-2.   
 
Figure 2-2 The energy acceptance windows compared to the energy of direct and scattered 
photons 
 
Table 2-2 Results of scatter correction using Monte Carlo simulations 
Window 
Direct 
(Non-scattered) 
Total 
(Direct and 
scattered) 
TEW corrected Error 
Low scatter 7 517   
Photopeak 1250 2333 1272 2% 
High scatter 36 168   
 
In this very simple test of the TEW scatter correction, the windows proposed by 
Iida gave very reasonable results, with an error of 2%.  However, the application 
of this technique will need to be further investigated using more realistic data.   
The optimum scatter window width will be dependent on the scatter correction 
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technique used, the scattering conditions of the clinical procedure being 
undertaken, and the scanner design including energy resolution of the detectors 
and scattering properties of the collimators.  Only three energy windows could 
be applied simultaneously using the equipment available in this work, so a 
retrospective analysis of all techniques would not be possible.  A full 
investigation into the optimum widths and positioning of these windows was 
considered to be beyond the scope of this work so a choice was made on based 
on the published data.  The windows were chosen to match those in Iida et al. 85 
with two 7% scatter windows positioned either side of the photopeak.  These 
widths were using the following collimator comparison tests.  Scatter correction 
is discussed further in chapter 3.   
2.3 Comparison of LEHR, VXGP and MEGP Collimators 
The design of collimators is a compromise between resolution and sensitivity, 
with sufficient thickness of septa to prevent excessive penetration.  Their design 
is optimised based on the energy of photon being imaged.  Until recently, 123I was 
not a regularly used isotope, and hence it is rare for collimators to be optimized 
for it.  The main emission energy of 123I is 159keV, but it also emits a number of 
higher energy photons (Figure 1-6).  These factors complicate the choice of 
collimator 71.   
The presence of higher energy photons will degrade the image in two ways.  The 
higher energy photons may not be attenuated by the septa of the collimator.  A 
second effect occurs when higher energy photons undergo Compton scattering.  
The energy loss means they fall within the photopeak acceptance window.  For 
both these effects, the resulting scintillation event in the detector will give 
51 
 
erroneous positional information.  They both add a background “fog” to the 
image, increasing the noise, reducing the contrast and affecting the quantisation.   
Macey et al. 89 investigated collimator choice for whole body imaging.  Improved 
resolution was found with the low energy high-resolution collimators, but 
medium energy collimators gave better quantitative accuracy.  They concluded 
that the MEGP collimators were superior for whole body imaging.  However, no 
attempts to correct for the septal penetration or scatter were included in that 
work.   
Gillard et al 90 investigated measurement of size and activity in SPECT when 
using low and medium energy collimators.  As well as the characteristic 
dependency of recovery coefficient on object size, they found that septal 
penetration in low energy collimators could lead to reduced contrast, and image 
artefacts.  The most obvious artefact is activity being positioned outside of the 
emitting body, seen as a hot ring around the reconstructed volume.  This “hot 
ring” artefact was also described by Macey et al. 89.   
More recently, corrections for down scatter and septal penetration have been 
investigated when using LEHR collimators 82,86,88,91.  They have been shown to 
significantly improve the image quality by compensating for the image 
degradation caused by scatter and septal penetration.  Allowing imaging to be 
performed using LEHR collimators taking full advantage of the superior 
resolution.   
An investigation was performed to describe the resolution performance of the 
various collimators available for clinical use.  Three types of collimator are 
available at this institution, two low energy high-resolution collimators (LEHR, 
VXGP) and medium energy general-purpose collimators (MEGP).  The resolution 
52 
 
and sensitivity for 123I can be measured directly using techniques described by 
National Electrical Manufacturers Association (NEMA) 92 and can be further 
investigated by changing the source to collimator distances. 
2.3.1 Collimator comparison - Method 
Two capillary tubes were filled with 123I and placed in parallel with 8cm 
separation.  The tubes were suspended between the two camera heads parallel 
to the long axis of the camera.  As the internal diameter of the capillary tubes is 
very small compared the resolution of the camera, the resulting images are good 
approximations to the line spread function of the camera.   
A 256x256 matrix was used with a detector mask of 25.4cm (i.e. 2.19 zoom) to 
produce a pixel size of 1.1mm.  A series images was acquired with a range of 
collimator to source distances ranging from 5cm to 15cm.  The acquisitions were 
performed on each of the three collimator styles available and profiles drawn 
across the images.  The timing was adjusted to ensure a minimum of 1000 counts 
in the highest pixel of the profile.  Repeat measurements were taken over two 
years.   
A second series of images were acquired using Perspex sheets to act as a 
scattering medium.  A total thickness of Perspex of 18cm was placed gently on 
the collimator face.  The capillary tubes were positioned between the Perspex 
sheets at different depths into the Perspex.   
The relative sensitivity of the collimators was measured as a function of distance 
from the collimator.  This was performed using the total counts in-air resolution 
images after correcting for radioactive decay and differences in acquisition 
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length.   
2.3.2 Collimator comparison - Results 
The resolution measured in air are shown in Figure 2-3 and Figure 2-4 as a 
function of collimator to source distance in terms of full width at half maximum 
(FWHM) and Full Width at Tenth Maximum (FWTM) respectively.  The 
manufacturers’ specifications for 99mTc imaging are also shown along with 
distance of interest for SPECT imaging of the striatum.  No specification for 123I 
imaging is quoted by the manufacturer.   
 
Figure 2-3 Resolution as a function of distance from the collimator for three collimators 
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Figure 2-4 FWTM Resolution as a function of distance from the collimator for three 
collimators 
 
 
Figure 2-5 Resolution as a function of distance from collimator in scattering material.  The 
FWHM and FWTM are shown with and without TEW scatter correction. 
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Figure 2-6 Line profiles across line sources at various depths in scattering material 
Figure 2-6 shows the profiles of the line sources acquired in a scattering 
material.  Counts per second per pixel vs x position (mm).  Y-error given as +/- 
square root of counts/pixel. The x-error is +/-half pixel.  The counts per pixel 
have been rescaled according to the length of acquisition.  As the line sources are 
positioned deeper into the material, further away from the detector, the signal is 
spread out and attenuated.   
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Figure 2-7 Relative sensitivity with distance for photopeak window and TEW corrected 
photopeak window 
Figure 2-7 shows the relative sensitivity as a function of distance from the 
collimator.  The data has been decay corrected and then normalised to the 
sensitivity at 25cm with scatter correction.   
In SPECT imaging for average sized patients with no positioning difficulties, the 
striatum occupies a distance of up-to 4.5cm from the centre of rotation.  This 
equates to between 6.5 – 10.5cm from the nearest collimator.  This distance has 
been shown on Figure 2-3 and Figure 2-7.  
All collimator performance measurements were within manufacturers’ 
specifications.   
2.3.3 Collimator comparisons - Discussion: 
As can be clearly seen in these graphs, improved resolution is seen with the two 
low energy collimators compared with the medium energy.  There is a small 
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improvement in resolution when imaging with LEHR collimators rather than 
VXGP.   
The FWTM results also show an improvement when moving from medium to low 
energy collimators, however, the relative improvement is lower.   
Comparing the resolution results with the distances seen in clinical imaging, the 
expected planar resolution for the organ of interest will range from 6.5mm to 
10mm FWHM.   
Normally the compromise in collimator choice is between resolution and 
sensitivity, however, the sensitivity is increased when using low energy 
collimators than compared to MEGP as less of the camera face is covered with 
lead.  These results show a clear improvement with low energy collimators, with 
little difference between the LEHR and VXGP styles.  A possible problem that has 
shown here is the varying sensitivity with distance that is seen with the two low 
energy collimators (Figure 2-7).  This effect should not be present in parallel-
hole collimators, but appears here because of septal penetration.  Figure 2-7 also 
shows how scatter correction can reduce this effect.  Scatter correction is 
discussed further in chapter 3.  The effect of scatter correction is also seen in 
Figure 2-5 where the FWTM shows a decrease when scatter correction is used.  
This relates to a reduction in the broad tails of the line-spread function and 
suggests improved image contrast.  This is in contrast to some results published 
using a different correction method 88 where the improvement in FWTM was not 
found to be significant.  In that work only a down scatter correction was being 
applied, rather than full scatter correction method shown here.  
The resolution performance defined here can be further used when investigating 
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the reconstruction techniques, where the depth dependence characteristics are 
modelled in the reconstruction.  This will be further discussed in chapter 3.   
2.3.4 Collimator comparisons – Conclusions 
The two low energy collimator designs should give improved image quality in 
terms of reduced blurring.  The LEHR is marginally superior to the VXGP 
collimator but both will be used for clinical imaging.  The measured line spread 
functions can be used in the reconstruction process to try to improve 
reconstructed resolution (see chapter 3).  The expected FWHM for the striatum, 
varying between 6.5mm 10mm can be used to guide the acquisition pixel sizes 
(see section 2.4).   
2.4 Pixel size / Image Matrix  
Sampling theory dictates that the highest spatial frequency data that can be 
defined by an imaging system will be half of the spatial sampling frequency.  In 
the absence of noise considerations, the spatial sampling (i.e. the pixel size) 
should be defined based on the FWHM at either the centre of rotation or the 
depth of interest.  In section 2.3 the limits to the imaging system were defined in 
terms of blurring factors at distances from the collimator.  The EANM guidelines 
80 suggest a pixel size between one third and half of the expected FWHM.   
2.4.1 Pixel and matrix size – Results 
From the resolution measurements, (section 2.3) and from examining typical 
orbits used clinically, the following calculation can be made: 
FWHM at depth of object of interest covers the range 6.5mm to 9.0mm  
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FWHM at centre of rotation = 9mm 
Using the EANM guidelines for the FWHM at the depth of the organ of interest - 
the maximum pixel size should be between 2.1 and 3.2mm.  When the resolution 
at centre of rotation is used the maximum pixel size should be between 3.0 and 
4.5mm.   
The image matrix sizes available for the departmental scanners are limited to 
pre-defined ranges (see Table 2-3).  In SPECT mode only128*128 and 64*64 
matrices are allowed.  Also, the range of zoom settings is restricted to 48, 38, 30 
and 25.4 cm. (zoom factors 1, 1.46, 1.85 and 2.19 respectively).   
Table 2-3 Pixel Sizes for SPECT mode acquisition 
 Field of View 
 48cm 38 cm 30 cm 25.4 cm 
64*64 matrix 9.3mm 6.4mm 5.1mm 4.3mm 
128*128 matrix 4.7mm 3.2mm 2.5mm 2.1mm 
 
2.4.2 Pixel and Matrix size - Discussion 
From the resolution measurements, a pixel size of 2.1mm is suggested.  This 
figure is significantly smaller than the “~4.6mm” recommended by the 
pharmaceutical manufacturer.  This discrepancy can be understood once the 
effects of noise are considered.  By halving the length of a pixels edge, the 
scanning area it represents will decrease to ¼, with a corresponding drop in 
counts to ¼.  The lowered counts may lead to noise problems in the clinical data.  
As a compromise, data could be acquired in 128matrix form, with a zoomed field 
of view.  This will allow the high spatial frequency data to be acquired, but will 
60 
 
still allow the pixels to be combined to give 4.3mm voxels.   
2.4.3 Conclusions:  
The recommended matrix size should be 128*128 using a 25.4cm field of view, 
with the option to combine data into 64*64data.  
2.5  SPECT gantry orbits 
A previous section (section 2.3) showed how the distance from the camera 
affects the resolution of the images.  When performing SPECT acquisition, the 
detectors are rotated around the object of interest, maintaining the minimum 
distance to ensure the best resolution.  There are two shapes of orbit, circular 
and non-circular.  A circular orbit uses a fixed radius of rotation for each head, 
which when equal, produce a circular orbit.  When images are acquired using a 
non-circular orbit, the camera heads will change radius of rotation as the gantry 
rotates.  The idea of the non-circular orbit is to allow the camera movement to 
better reflect the shape of the object being scanned.  Theoretically the non-
circular orbit has the potential to give better images, as it should be able to 
maintain a smaller object to camera distance, however there are problems in the 
implementation.  The non-circular orbit is defined by marking the radii to be 
used at 0, 90, 180 and 270 degrees.  The gantry computer then uses these values 
to define the ellipse.  It had been noted anecdotally that the resulting radii were 
significantly bigger than the set values.  This was investigated.   
2.5.1 Gantry Orbit measurements - Method 
To investigate how the camera orbits are defined a series of dummy acquisitions 
were performed.  This entailed setting up the camera for a series of acquisitions, 
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at different starting radii, and then monitoring the radii used in the acquisition.  
The starting radii were chosen based on the starting radii taken from clinical 
acquisitions within the department.  The radii were recorded from the gantry 
display during the acquisition.   
2.5.2 Gantry Orbit measurements - Results 
Figure 2-8 shows the radii of the camera heads whilst acquiring a circular or 
non-circular orbit.  For clarity, only one representative orbit set-up is shown.  
The original gantry definitions were for a 13cmx10cm radii elliptical orbit and 
13cm circular orbit.   
 
Figure 2-8. The radius of rotation as measured for a phantom experiment.  The scaled 
phantom image is also included 
Figure 2-8 shows the gamma camera detector radii as the system rotates around 
the phantom.  A suitably scaled transverse slice from the phantom has been 
added to show the extent of the radius. 
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2.5.3 Gantry Orbit - Discussion 
Figure 2-8 clearly shows a significant increase in radius of rotation when non-
circular orbits are used.  The gantry software automatically adjusts the orbit 
definition to avoid the patient couch, even when the couch is retracted away 
from the detectors, as is the case with brain imaging.  The same phenomenon is 
shown on both scanners.   
The increase in rotation radius when non-circular orbits are used will clearly 
lead to a decrease in image quality, and hence circular orbits should be used for 
all brain imaging until updated software has been provided and tested.   
One advantage of using circular orbits occurs when the data is reconstructed.  
With the software available, a depth dependent resolution recovery calculation 
can be performed.   
The camera manufacturer was contacted regarding this issue.  To date no 
changes to the gantry control software have been made.  
2.6 SPECT Gantry movement 
The gamma camera is capable of acquiring data in two modes, step-and-shoot 
mode (SSM) and continuous step and shoot mode (CSSM).  The first option only 
records counts when the detectors are inline with the predetermined projection 
angles.  At this point, they are held stationary for the full time of the "time-per-
azimuth" setting.  In the second option, CSSM will record the counts during the 
movement between the projection angles together with the counts when the 
detectors are in position.  The advantage of CSSM is a decrease in unused 
imaging time, at the expense of a theoretical blurring effect.   
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The advantages of using CSSM over SSM when fast SPECT acquisitions were 
performed have been described 93.  The increased count statistics within the 
same total imaging time lead to improved image quality.  However, this 
increased imaging time is of reduced importance when the time per azimuth is 
much greater than the gantry rotation time.  The theoretical blurring was shown 
in noiseless images, but was masked in realistic images when 64 views were 
used.  They also note that the blurring effect will decrease further with 
increasing number of azimuths.  The theoretical blurring introduced in CSSM is a 
function of distance from the COR.   
In 123I-FP- -CIT imaging 128 views are used, and the main structure of interest 
lies near the COR, it is unlikely to be significantly affected.  The "deadtime" 
associated with step and shoot acquisition is 1.5% of the imaging time.  Since the 
exact choice was unlikely to have a significant effect on the resulting images, the 
continuous step-and-shoot mode was chosen as it has been suggested that it may 
cause less damage to the gantry.   
2.7 The number of projections 
A parameter related to the gantry movement is the number of projections (or 
azimuths) that are acquired.  When too few azimuths are acquired, some 
artefacts are seen in the reconstructed slices.  The effect gets progressively 
worse as the distance from the COR increases.  A number of different approaches 
have been used to define the ideal number of azimuths94.  The spacing between 
line integrals should be substantially less than the resolution of the final image.  
Values of 0.4 to 0.7 times the resolution have been quoted.  For the geometry 
used here this gives an arc of 0.54cm and hence a minimum of 128 azimuths.   
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The choice of number of projections will also have an effect on reconstruction 
speed, particularly if iterative methods are employed.  An increase in the number 
of azimuths will cause an increase in reconstruction time.  However, most 
reconstruction algorithms, including the ones available for this work, are 
performed using ordered subsets methods that will limit this effect.  A further 
practical implication of the number of azimuths is the associated increase in 
imaging acquisition time.   
2.8 Time per projection 
Noise has a large effect in nuclear medicine imaging.  The random nature of 
radioactive decay, and interactions of photons with matter, coupled with the low 
sensitivity of a gamma camera, means noisy images.  The maximum activity that 
can be used is given in national guidelines 95 so the only way to increase the 
number of counts is to increase the acquisition time.  Unfortunately, it is 
impossible to ensure patients will not move for long periods of time.  Even when 
patients are held still using immobilisation devices such as chin and head straps, 
and leg supports, there is a limit to the length of time they can be expected to be 
scanned for.  This limit is normally set at around 45 minutes.  Movement can be a 
particular problem when a patient has movement disorders and/or dementias.   
2.9 Conclusions 
In our department the imaging is now performed with the following parameters.  
LEHR or VXGP collimators, 128x128 matrix with a 25.4cm field of view.  Circular 
CSSM orbits of 128 azimuths.  Radius of rotation should be set as small as 
possible, and should be less than 13cm.  This measurement should be recorded 
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on the patient notes for use in image reconstruction.  Energy windows should be 
defined as:  Photo-peak - 158 ±10% Low scatter - 137 ±3.5%, High scatter - 178 
±3.5%.  
Table 2-4 Comparisons of local settings with published guidelines 
Parameter Local setting EANM 2010 GE 
Delay to imaging min 3 hours 3-6hours 3-6hours 
Imaging device 2 detectors 
Minimum 2 
detectors 
2 detectors 
Collimators LEHR or VXGP 
LEHR or LEUHR 
Fan beam preferred 
VXGP / LEHR 
Orbit style Circular Not stated Circular 
Orbit mode 
Continuous step and 
shoot 
Step and shoot, (but 
continuous may 
reduce time and 
reduce mechanical 
wear) 
Not specified 
Radius of rotation 
Smallest possible 
<13cm 
Smallest possible 
Smallest possible, 
11-13cm 
Matrix 128*128 128*128 128*128 
Angular sampling 2.8degrees 3degrees 3degrees 
Pixel size / Zoom 2.1mm 
Between ½ and 1/3 
expected resolution 
No zoom, 4.6mm 
Total counts As acquired >3million >1.5million 
Total time 45mins 
30mins typical for 
triple headed system 
30sec/projection 
(30mins total) 
 
Table 2-4 shows a comparison of the new local acquisition settings to published 
recommendations.  These settings are similar to those used elsewhere and in the 
European guidelines 80 but with slightly reduced pixel sizes and the addition of 
scatter correction.  Summing the pixels to give 64*64 matrix data will give 
similar data to the manufacturers guidelines.   
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3  
The previous chapter described the various parameters and options available for 
the acquisition of images from a patient undergoing brain-SPECT imaging.  The 
resulting images are known as projection images.  These projection images 
cannot be analysed in this form and must be combined to produce images that 
are suitable for clinical reporting and analysis.  This process is known as 
tomographic reconstruction, the output of which is a series of transverse slices.  
Reconstruction can be performed using a number of algorithms, most commonly 
Filtered Back Projection (FBP) or some form of iterative algorithm, (e.g. Ordered-
Subset Expectation-Maximization, O.S.E.M.).  For both techniques, corrections 
can be applied for attenuation, scatter and partial volume effect.  Some post 
reconstruction filtering can also be applied to remove excess noise.   
Although acquired as a series of 2D projection images, the reconstruction models 
described below work on smaller groups of this data described using sinograms.  
Sinograms are simply the projection data re-binned into a different form.  Figure 
3-1 shows the projection and sinogram data from a scan of a brain phantom.  The 
images on the left show four projections at (from top to bottom) 270, 180, 90 
and 0 degrees, relating to views from the left, posterior, right and anterior of the 
phantom.  Each projection has the same central row of pixels highlighted.  Each 
projection image is orientated so the horizontal axis is ‘x’ and the vertical axis ‘z’.  
The right hand image shows the sinogram for the row of pixels highlighted in the 
projections.  The sinogram is produced by stacking the same row of pixels from 
each of the projection angles, so the horizontal axis is also ‘x’, but the vertical axis 
is the projection number/angle.  In this example, there are 128 projections of 
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128x60 pixels, which can also be viewed as 60 sinograms each measuring 128 
x128.   
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Figure 3-1 Projection images and sinogram data 
Each transverse slice is therefore described by a single sinogram.  The following 
descriptions of reconstruction models describe how this sinogram data is used to 
produce a transverse slice.   
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3.1 Filtered Back Projection 
All gamma camera systems are capable of using FBP, and as such it is often the 
default reconstruction to use.  Because of its linear form, it should give consistent 
performance with regard to quantitation.   
There are two filters used in the FBP reconstruction process.  The ramp filter is 
required to counteract the smoothing function inherent in the back projection 
process.  For a description of this effect the reader is directed to text books on 
this subject 96 a full proof of this can also be found 72.  The amplification power of 
the ramp filter is proportional to the frequency and hence the ramp filter 
amplifies high frequency data.  In theory, the ramp filter will apply exactly the 
right level of filtering for the reconstruction process.  In practice the high 
frequency data that the ramp filter amplifies the most will mainly be noise.  To 
prevent the amplification of noise the behaviour at higher frequencies needs to 
be modified.  A sharp cut-off in the frequency response will lead to ringing 
artefacts in the image, so a range of filters have been implemented that act as 
low-pass filters with smoothly changing frequency responses.  These filters are 
often known as windowing filters, as their action is described as a modification 
of the normal ramp filter.  In practice, these two filters are normally applied 
separately during the reconstruction process.   
The Butterworth filter is commonly used for clinical SPECT processing.  This 
filter has two variables, the cut-off frequency and the order or power.  The 
equation used to describe this filter has a number of different forms, with slight 
variations between software companies.  The FBP software used in this work 
uses the form shown in Equation 3-1.   
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Equation 3-1 
The cut-off frequency fco defines at which frequency the signal is attenuated to 
50%.  The filter order defines how steeply the filter rolls off with increasing 
frequency.  Figure 3-2 shows the frequency response for four Butterworth filters.  
Three filters are shown with filter order 10, and fco = 0.8, 1.5 and 2.0 cycles/cm.  
A forth filter is shown using fco =1.5cycles/cm and order 5.  The Nyquist 
frequency (2.4cycles/cm) and the frequencies related to 6.5mm and 9.0mm 
features are also shown.   
 
Figure 3-2 Example Butterworth filters 
The Butterworth filter is also used for post-reconstruction smoothing where is 
can be applied to images from both FBP and iterative reconstructions.   
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3.2 Iterative reconstruction 
Iterative reconstruction involves starting with an estimate of the activity 
distribution.  The projection images that would be acquired from such a 
distribution are then calculated.  A comparison of the measured and predicted 
projection data is made, which can be back-projected onto the distribution 
estimate and used to improve the estimate.  Iterative reconstruction has a 
number of features that may give it advantages over filtered back projection.   
The forward projection step, where estimated projections are calculated from 
the activity distribution estimate, allows mathematical models of the imaging 
process to be incorporated into the algorithm (see section 3.3).  In the ML-EM 
iterative model, the measured sinogram is divided by the predicted sinograms to 
give the error estimate.  As the noise in the projection data can be included 
explicitly in the reconstruction algorithm, iterative techniques tend to deal with 
low count data better than FBP.   
As further iterations are performed, the estimate should converge towards the 
measured projection data.  The convergence of the image with the true activity 
distribution is not uniform.  The local convergence will be dependent on size, 
location and surroundings of an object.  In addition, the convergence is towards 
the measured projection data, rather than the true activity distribution.  Large 
numbers of iterations will eventually lead to excessive noise levels in the 
reconstructed image.  Figure 3-3 shows a transverse slice through a phantom, 
reconstructed using a range of numbers of iterations.  In practice, a pre-defined 
number of iterations are performed.  This can be followed by the application of 
some form of post-reconstruction filtering.   
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Figure 3-3. Example central transverse slice reconstructed using OSEM with depth 
dependent resolution recovery and a range of iterations and subsets.  The numbers of 
equivalent iterations (iterations*subsets) are 10, 16, 20, 24, 40, 64, 96, 128 and 200 from 
left to right. 
An accelerated form of ML-EM, known as Ordered Subset Expectation 
Maximisation (OSEM) 97 is used in most commercially available software.  
Instead of calculating all the projections for every iteration, only a subset of the 
projections is calculated.  The next sub-iteration calculates another subset of the 
projections and so forth until all the subsets have been used once.  In this way, 
the convergence of the model is speeded up dramatically.  The increase in speed 
is approximately equal to the number of subsets used.  The number of iterations 
multiplied by the number of subsets gives the number of image refreshes or 
equivalent iterations.  A reconstruction using four iterations and four subsets is 
almost identical to a reconstruction produced using two iterations of eight 
subsets, or 16 iterations of ML-EM72,97.   
For both iterative and FBP reconstructions there are a wide range of parameters 
that will affect the quality of the images produced.  For most of these parameters, 
their effect on the end result will be dependent on other parameter choices.  For 
example, the optimum number of iterations and post reconstruction filter are 
heavily interdependent, and related to the use of resolution modelling.  With this 
in mind, the obvious solution is to compare all combinations of parameters; 
however, this would lead to so many permutations as to be impossible.  As such, 
a step–by-step approach must be made comparing ranges of groups of 
parameters that are known to heavily influence each other.   
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3.3 Image corrections 
A number of physical interactions can occur between the emission of the gamma 
ray and the formation of the image.  These interactions, along with the properties 
of the imaging device, will affect the quality and quantitative accuracy of the 
image produced.  By examining these limitations some corrections can be made 
to compensate for them.   
In general, gamma rays can undergo four types of interaction in tissue, Rayleigh 
Scattering (RS), Compton Scattering (CS), photoelectric absorption (PE) and pair 
production (PP).  Rayleigh scattering is only of importance at energies below 
50keV, and pair production can only occur at energies above the rest mass 
energy of the particle pair (2x511keV).  Hence, for most SPECT imaging including 
that performed with 123-Iodine, the Compton and Photoelectric interactions are 
of most importance.  These interactions are dependent on the energy of the 
photon, the density of the material and the atomic number of the atoms in the 
material.   
 
Figure 3-4 Four possible photon paths 
PE interactions involve the complete absorption of the photon energy and 
creation of a photoelectrons and Auger electrons.  Compton Scattering results in 
a photon being deflected with some of its energy being transferred to a scattered 
electron.  Figure 3-4 shows four example photons paths that can occur.  From left 
to right:  
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 A non-scattered photon hits the detector.  It is imaged in the correct 
position 
 The photon undergoes PE in the body and is not detected 
 The photon undergoes CS inside the body and is scattered out of the 
collimator acceptance angle – the photon is not detected 
 A photon undergoes CS inside the body and is then imaged in the 
incorrect position 
3.3.1 Attenuation 
Attenuation of the signal occurs when photons with the correct trajectory are 
scattered away from normal incidence with the detector or undergo PE 
absorption.  The effect of attenuation is to decrease the number of photons 
reaching the detector.  The effect is non-stationary and depends on the density 
and composition of the material.  In general, the signal from areas deep within 
the body will be attenuated more than the signal from superficial structures.   
The amount of attenuation in different parts of the object, that is the attenuation 
map, can be either measured or estimated.  Measured attenuation maps can be 
acquired using transmission-CT with either x-ray or isotope sources, and a 
suitable detector.  Estimated attenuation maps can be produced by defining the 
object outline and then making assumptions about the attenuation distribution, 
(e.g. uniform attenuation) within this outline 98.   
This attenuation map can be used to correct the reconstructed image either post-
reconstruction, or in some iterative models, as part of the system model in the 
forward projector.   
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For patient data, a separate CT acquisition is rarely performed and even in 
departments that have combined SPECT-CT systems, the extra radiation 
exposure from the CT is generally not justified.  Within this work, even for the 
few patients where CT data has been acquired, the software available does not 
allow the use of CT based attenuation corrections to be included in the 
reconstruction.   
The correction techniques available use a uniform attenuation factor, which can 
be specified by the user.  For FBP based reconstructions a basic uniform 98 
correction is available.  For the OSEM iterative model two implementations of 
the uniform correction is applied.  The first method, (labelled as ‘fast correction’) 
follows the FBP implementation, applying the scaling factor after the 
reconstruction has finished.  The second method uses the uniform attenuation 
map as part of the forward projector within the reconstruction model.   
3.3.2 Scatter 
Compton scattering has the effect of adding misplaced counts into the image.  
This leads to a decrease in contrast and the addition of noise.  The effect is non-
stationary depending on both the density and composition of material in the 
scattering medium.   
In general, the effect of scattering will be to slightly increase the number of 
counts imaged near the centre of the object.  The simplest scatter compensation 
is to use a reduced attenuation coefficient for the attenuation correction.   
Other scatter compensation methods use a measured estimate of the scattered 
photons.  These include Dual and Triple Energy Window techniques (DEW and 
TEW 99,100).  The number of scattered photons being recorded in the photopeak 
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window is estimated using one or two scatter windows adjacent to the 
photopeak window.  The estimated scatter component can then be subtracted 
from the projection data prior to reconstruction, or be introduced within the 
iterative calculation.  The latter is preferable in iterative methods, as the 
subtraction prior to reconstruction will affect the noise properties of the 
projection data and hence the Poisson noise assumption in ML-EM will be 
incorrect.   
DEW and TEW compensations can lead to an increase in the noise of the 
reconstructed data depending on their implementation.   
The software available in this work allows pre-reconstruction scatter correction 
in the form of Dual or Triple Energy Window (DEW or TEW) methods.  In this 
form, the scaled counts in the scatter windows are used to estimate the scatter in 
the photopeak window, which are then subtracted to produce a new set of 
projection data.   
3.3.3 Septal penetration 
Some level of septal penetration is always present in gamma camera imaging, 
however, when higher energy emissions are present, as is the case for 123-
Iodine, a greater level of septal penetration will be present.  Thus, the choice of 
collimators is not straightforward 71.  Estimates of septal penetration can be 
calculated following similar models to the scatter correction estimates.  The TEW 
scatter correction method measures the number of higher energy photons 
reaching the detector, and as such will include some septal penetration within its 
correction.   
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3.3.4 Collimator blurring  
The spatial resolution of a gamma camera image is dependent on the collimator 
properties, and the distance of the object from the collimator.  In section 2.3 
these depth dependent resolution effects were described and measured.  Since 
these effects are known and predictable, it is possible to incorporate a 
description of these blurring effects into the reconstruction program.   
In the software used in this work, the Gaussian curve is described by (Equation 
3-2) where σ is the standard deviation of the curve in direction x.   
 
Equation 3-2 
This blurring effect increases linearly with distance from the crystal surface (z) 
(Equation 3-3).   
 
Equation 3-3 
0 and Z are the Point spread functions at the collimator surface and at distance 
z from the collimator surface respectively.  scale describes the rate at which the 
blurring increases with distance, z.  Default values for these factors are 0 
=1.5mm, and scale =0.015.   
In practical terms, the blurring function is normally described at specific 
distances by the Full Width Half Maximum (FWHM), which is linearly related to σ 
(Equation 3-4).  
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Equation 3-4 
Thus, two or more FWHM measurements can be used to describe the blurring 
effect for the reconstruction program.   
The reconstruction program uses either distance from collimator or crystal 
surface – this has to match the radius of rotation (ROR) measurement given in 
the projection image parameter details, or entered manually during 
reconstruction.   
The FWHM data described in section 2.3 was scaled by 2.35 to convert to  and 
then fitted with a straight line using a least squares fit, to give values for the 
collimator constant and the scale (Table 3-1).  These numbers are all related - the 
offset for with and without collimator is linear, and the conversation from  to 
FWHM is just a scaling factor.   
Table 3-1 Resolution characteristics for reconstruction software 
  FWHM  
Measured from 
crystal 
VXGP 0.0441x+0.9612 0.0187x+0.4082 
LEHR 0.0407x+1.3196 0.0173x+0.5604 
Measured from 
collimator 
VXGP 0.0441x+3.5174 0.0187x+1.4937 
LEHR 0.0407+3.0709 0.0173x+1.3041 
The values for 0 and scale for these collimators are very similar to the 
suggested typical values given in the software manufacturer’s User Manual.   
With a depth dependent resolution model, in the absence of noise and with high 
spatial sampling rates, the resulting images should produce images with uniform 
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resolution.  It is also possible to use a fixed blurring function that is not depth 
dependent.  By using a fixed blurring function, this uniform resolution is not 
ensured.  At a practical level, when noise is included, and discrete sampling is 
used, this compromise may not be important.   
The inclusion of resolution modelling (either fixed or depth dependent), 
introduces a level of smoothing to the reconstructed images.  This smoothing 
causes the reconstructed image slice estimates to converge more slowly, but can 
potentially improve the resulting image quality.   
In both the fixed and depth dependent resolution recovery models, the forward 
projection step from activity distribution estimate to calculated projection 
involves a convolution with a Gaussian blurring profile.  Although a 1D Gaussian 
profile extends infinitely in each direction, for the blurring functions seen in 
medical imaging the bulk of the counts are seen in the first few pixels.  The 
contribution of counts from a central pixel to neighbouring pixels trails off over a 
few voxels and becomes small over a short distance.  It can therefore be 
proposed that including just the first few pixels of a blurring function may give 
similar results to a convolution with the full curve.  In the software used in this 
work, the width to which the blur is calculated is defined in terms of pixels in the 
X and Z-axis, with Z defining the number of transverse slices the blurring 
function extends over.   
3.3.5 Partial Volume Effect 
The Partial Volume Effect (PVE) is present in all discrete imaging modalities, but 
is particularly prominent when the resolution of the imaging system is of a 
similar magnitude to the object being imaged.  Since the imaging process 
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involves a certain level of blurring (the system resolution) the counts from a 
single point source will be spread out over a region.  Thus, a region of interest 
focused on the object will not include some of the counts originating from the 
object as they will have been imaged outside of the object.  This geometric effect 
is dependent on the resolution of the imaging system and the size of the object 
being imaged.  As the size of an object decreases, the apparent activity 
concentration will reduce.   
Since it is a predictable geometric effect, there are corrections that can be 
applied to image data.  Unfortunately, these corrections require an estimate of 
the object size.  Some work has been done using CT and MRI data to correct 
SPECT data, however there is an assumption that the MRI or CT volumes are the 
same as the receptor imaging studies.  In dopamine transporter imaging studies, 
CT and MR data is not generally available.  In cases of Parkinsonsonian 
syndromes, not all of the striatum will actually take up the tracer.  In such 
circumstances, a CT or MR could over estimate the size of the functioning 
volume, and hence under estimate the correction for some patients.   
PVE has been applied in some work to SPECT imaging data, where MRI scans 
were also available.  Soret et al. 84 found that not including PVE could lead to a 
bias in uptake ratios of up to 50%.  MRI based PVE was also used in a study 
comparing AD and DLB patients, along with the application of scatter and 
attenuation correction 101.  Due to the patient group used, perfect separation 
between the two groups was seen both with and without PVE.  A second set of 
data that had been simulated using MRI data did suggest that this form of PVE 
might be of use for diagnostic classification.  However, this modelling was based 
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on the various uptake levels in the simulated data being the same size and 
distribution as the MRI data that was used to correct it.    
A similar implementation of this form of PVE correction was used as part of the 
BasGan software102.  In this work, the patient data is automatically aligned to a 
template.  The PVE correction factor is calculated for this template and the 
applied to the patient data set.  Although such a technique has been shown to 
produce more accurate uptake values when used with phantom data, an 
improvement of clinical diagnostic power was not tested.   
The scale of the PV effect is dependent on size of object and relative count 
density in the two objects.  The relative density of counts will affect how many 
counts “bleed” across the boundary.  For high contrast data the “bleeding” will 
appear more severe, as less counts will be bleeding into the caudate region from 
the background.  However, this effect is a straightforward function of the relative 
ratios, and hence an uptake figure would be multiplied by some factor to give the 
true uptake.  This is just a linear transformation of the results – a universal 
scaling factor.   
For most forms of Parkinsonism, the disease progression shows both a reduction 
in the number of DAT sites as well as a reduction in the volume of brain in which 
these sites are prevalent – relating to the loss of neurons in the putamen prior to 
the caudate loss.  The partial volume effect will actually work to amplify these 
two effects - with a loss in size of active uptake volume resulting in an apparent 
loss of uptake counts.   
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3.4 Image quality metrics 
What makes a ‘good’ clinical image?  Which parameters should be optimised?  A 
large number of image quality metrics have been used for assessing the quality 
of medical images.  The choice of metric will determine the image characteristic 
that is optimised.  They range in specificity from absolute image qualities, such as 
measurements of pixels values and noise, through to applied measurements such 
as the ability of a particular image group to allow clinical disease differentiation.  
In much of the work in developing reconstruction algorithms, reconstructed 
slices are often assessed for noise, resolution and contrast.  A good algorithm is 
able to reproduce the contrast in the object, by improving resolution, but still 
controlling noise.  In phantom based studies the reconstructed slices can also be 
compared to the known activity distribution.  A number of intermediate end-
points are also commonly used, such as the striatal uptake measurements.  In the 
following descriptions, the image metrics are listed in order of specificity to the 
imaging task.   
3.4.1 Pixel by pixel similarity measurements 
When using phantom data, the exact activity distribution is known, and hence 
the reconstructed images can be compared directly with this distribution.  A 
common measure used in image optimisation is the Normalised Mean Square 
Error (NMSE) 103.  A number of definitions for this metric are used using different 
normalisation factors, but all take the same general form (Equation 3-5).   
 
Equation 3-5 
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The difference between the measured pixel values (Meas) and expected values 
(True) are squared and summed over the range of voxels, N.  The range of voxels 
for which this error is defined can affect this optimisation.  One choice of voxel 
range is to include all voxels within the image.  However, this may lead to the 
optimisation procedure being biased by voxels values outside the body.  A 
common choice is to use all voxels that fall within the body outline, although it 
would be possible to define a subgroup of voxels.  One such method uses just the 
pixels lying along a line profile through the image.  This will bias the optimisation 
towards the exact area contained within the line profile.  Such a bias may be 
desirable, or even be necessary, if the optimisation is to be moved away from 
unimportant features, but must of course be used carefully.   
When comparing reconstruction algorithms, the parameters that produce the 
minimum NMSE are looked for, so the differences between the normalisation 
factors used are unimportant.   
3.4.2 Noise levels 
Noise in reconstructed images has the effect of masking real changes in pixel 
count density.  In general, a lower noise level will mean improved image quality, 
but this cannot be used as a metric in isolation, since noise suppression 
techniques can affect image contrast.  In phantom studies, it is possible to define 
regions/volumes where the true activity concentration is uniform.  In such 
circumstances the coefficient of variation in counts for that region can be used as 
a measure of image noise (Equation 3-6), and will be directly related to the 
image count statistics and reconstruction performance.  For patient studies, this 
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measurement is confounded by variations in the true activity distribution, which 
will increase the measured count variation.   
 
Equation 3-6 
3.4.3 Region of interest measurements 
Moving to larger scales, a calculation in the same form as NMSE can be 
performed on the measured and expected values of groups of voxels, in Volumes 
of Interest (VOI) or, in 2D, regions of interest (ROI).   
This technique has been applied using a variable group sizes 104.  By changing the 
size of the VOI, the image optimisation process can be customised to the imaging 
classification problem being studied.  By definition, this approach involves 
averaging of voxel values, and therefore removes some dependency on noise 
levels within the image.   
The logical progression of this is to apply a VOI which exactly match phantom 
volumes and compare the reconstructed regional counts with known phantom 
regional activities.   
A simplified version of this is to look at the ratio of region count densities rather 
than the absolute values (Equation 3-7).  
 
Equation 3-7 
This comparison of target to background ratios with known target to background 
ratios removes absolute scaling effects and when expressed as a fraction is 
known as the recovery coefficient (Equation 3-8).   
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Equation 3-8 
The recovery coefficient is often used when describing the size dependency of 
partial volume effects in image reconstruction 72.   
These VOI based measurements have often been used in characterising image 
quality in neurotransmitter studies as the activity distributions often follow 
specific anatomical uptake patterns.   
These figures were used as a measure of test-retest variability in 123I-FP- -CIT 
imaging 40.  This paper quotes the variability for different uptake times (injection 
to scan) for 123I-IBZM imaging.  They also measured this variability as a function 
of reconstruction settings to suggest optimized model and parameters.   
3.4.4 Signal to Noise Ratio 
Since noise suppression methods often result in the reduction of image contrast, 
this trade-off is often measured directly as the signal to noise ratio.  The SNR will 
depend on regions of voxels used to define it.  The noise measurement can be 
problematic in clinical images as for a true measure of image noise an area of 
uniform uptake is needed.   
3.4.5 Visual interpretation, scoring and confidence 
In the vast majority of clinical imaging applications, the main image classification 
technique is a visual interpretation.  Human observers are naturally equipped to 
assess and grade clinical images on a range of parameters.  Visual scoring is 
generally performed in a qualitative way giving scores on an arbitrary scale (e.g. 
1-5) or relative in nature (i.e. selecting preferred option from a presented group 
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of images).  These are used either as an overall classification or for a set range of 
image quality parameters, such as noise and contrast, as well as overall indices 
such as image quality.  Further qualitative measures can be gained by recording 
the diagnostic confidence given for an image set.   
In practice such measures often show surprisingly good correlations with more 
quantitative measurements such as signal to noise ratios.   
3.4.6 Correlation of uptake measures with clinical disease 
progression and disease group 
Moving to more task specific measures, correlations between these intermediate 
measurements (e.g. visual scoring, or uptake ratios) and disease progression or 
disease group are sought.  Various clinical disease indices are available which 
can act as surrogates for disease progression, such as the DSM scoring 105.  An 
alternative is to use long-term follow up of patients, and retrospectively analyse 
the images once the clinical diagnosis is defined.  Better correlations between 
these image metrics and disease measurements would imply that the image 
quality is improved.   
The logical conclusion to these progressions is that the images that allow the 
best differentiation between disease groups are the ‘best’ images.  That is, they 
are most fit for purpose.  However, since the optimisation of the images requires 
some diagnostic measurement (e.g. VOI ratios) then it is possible that there will 
be a different optimisation for each particular diagnostic image analysis 
technique.  Image analysis and classification techniques are discussed and 
investigated in chapters 5 and 6.   
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3.5 The choice of images for clinical visual reporting 
All the patient data used in this project was based on clinical work that was 
analysed retrospectively.  It needed to be reported using visual assessment as 
part of the normal clinical process.  To select the preferred reconstructions for 
visual reporting three consultant radiologists with specialist nuclear medicine 
training were asked to score a series of reconstructions.   
3.5.1 The Choice of images for clinical visual reporting- Methods 
Each radiologist was investigated separately with no knowledge of the others 
preferences or results.  The images were presented in groups of three 
representing a broad range of noise/contrast compromises.  The readers were 
asked to select their favourite or joint favourite images, using their own criteria 
for optimum image quality for reporting.  They were given no guidance on what 
they should be optimizing.  Based on their choice a further three images were 
presented covering the range specified.  In this way through a succession of 
levels of choices, their preferred image choice was discovered.   
This sequence was repeated for three patients chosen to be representative of the 
image quality seen clinically.   
Using this process optimum OSEM settings were identified using no attenuation 
or scatter corrections.  The process was repeated for FBP images.  Their 
preferred FBP and OSEM images were then compared. 
Attenuation corrected images were then produced for this preferred setting and 
compared with the non-attenuation corrected images.   
87 
 
The process was repeated after the changes were made to the acquisition 
parameters, as described in chapter 2.  With this second set of data a further test 
was applied to assess scatter correction.   
3.5.2 The choice of images for clinical visual reporting - results 
The preferred OSEM settings for are to use between 8-12 iterations (with 8 
subsets), with little preference between them.  A post reconstruction filter with a 
cut-off frequency in the range 1.2-1.5 cycles/cm was judged to be the visually 
preferred setting.  FBP settings were chosen to include a pre reconstruction filter 
of 1.3 cycles/cm.   
The OSEM images were preferred visually to the FBP images.  No preferences 
between with or without attenuation correction.  The scatter correction images 
were deemed too noisy for visual reporting.   
Following these preferences the reconstruction parameters for visual reporting 
involve the iterative settings without scatter correction.  The data for clinical 
reporting was reconstructed using 12 iterations of 8 subsets, and a post-
reconstruction smoothing filter Butterworth order10, cut-off 1.4 cycles/cm.   
3.6 Practical investigations of the properties of reconstruction 
models using phantom data 
This chapter focuses on two groups of experiments; the first uses images of 
phantoms to show the differences between reconstruction models settings and 
corrections techniques.  The second group of experiments investigates the 
application of correction and compensation methods to these reconstructions.   
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A number of acquisitions were performed using an anthropomorphic phantom 
under a range of conditions and settings, chosen to mimic the range of conditions 
seen in clinical imaging.  A large number of reconstructions were then performed 
on this data using different settings, processing options and correction 
techniques.  The resulting reconstructed data were analysed using the range of 
image quality metrics described in section 3.4.  
3.6.1 Methods – Acquisition of phantom data 
An anthropomorphic brain phantom (ECT Striatal phantom, RSD-Alderson, CA, 
USA) containing five fillable volumes (left/right caudate and putamen and brain 
background) was used to simulate clinical dopamine transporter imaging.  All 
data were acquired using the VXGP collimator.  A series of acquisitions at varying 
Radius of Rotation (ROR) were acquired using circular orbits of 13, 14, 16, 20 
and 25cm.  Each series was repeated with different activity concentrations.  The 
time per acquisition was adjusted to achieve total counts close to 2million (Table 
3-2).  
Table 3-2 Summary of phantom filling parameters and acquisition times for 
anthropomorphic phantom investigations 
Phantom 
run 
number 
Ratio 
(target: 
background) 
Activity 
concentrations 
(first 
acquisition) 
(kBq/ml) 
Time per 
azimuth 
Radius of 
rotation 
Total 
counts 
acquired 
(first 
acquisition) 
Run-1 6.9:1 58.6 : 8.5 40s 13,14,16,20 2.25x106 
Run-2 3.91:1 103 : 34.4 15s 13,14,16,20,25 2.47x106 
Run-3 2.6:1 93.4 : 35.9 10s 13,14,16,20,25 2.17x106 
Run-4 1.84:1 87.2 : 47.4 7s 13,14,16,20,25 2.00x106 
Run-5 1.28:1 82.5 : 64.5 5s 13,14,16,20,25 1.91x106 
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In total, the phantom was filled to five clinically appropriate contrasts, each 
scanned at five ROR distances using the clinical acquisition parameters as 
defined in chapter 2 (except the time per projection and ROR).  Phantom 
parameters are detailed in Table 3-2.   
After scanning, 1ml samples were taken from the phantom and counted in a well 
type gamma counter (Wizard 1470 automatic gamma counter, Wallac Oy, Turku 
Finland).  The well counter was calibrated, and normalised using 123I emitters.  
The count results were corrected for dead time using the counter inbuilt 
correction models and manually adjusted for background radiation.  Results of 
the gamma counter measurements were used as the true activity ratios within 
the phantom as shown in Table 3-2. 
At a later date, the phantom was imaging using a CT scanner (Biograph64, 
Siemens Knoxville USA).  For this acquisition the four striatal volumes were left 
empty and the brain background filled with water.  CT data were reconstructed 
with a Bone kernel using a 512*512 matrix and a slice thickness matching the 
SPECT acquisition.   
After reconstruction, the CT data of the phantom was spatially normalised to 
each of the five SPECT reconstruction data sets manually using a rigid body 
transform.   
3.6.2 Methods – Reconstruction parameters investigated 
3.6.2.1 Filtered Back Projection 
The simplest algorithm in clinical use is Filtered Back Projection (FBP), for which 
the algorithms only inherent free parameter is the choice of filter.  Some 
correction factors can also be applied before or after reconstruction but they are 
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separate from the actual reconstruction.  As such, it should be possible to assess 
the majority of the possible range of images that can be produced by FBP by 
reconstructing with a selection of filters.  Published work generally concludes 
that iterative models perform better than FBP once the correct parameters have 
been chosen.  Since the range of free parameters available in iterative 
reconstructions far outnumber those of FBP, the simplest approach will be to 
find an iterative reconstruction that is better than the best FBP image.  If this can 
be found then FBP data need not be considered further.  However, what 
constitutes the best image will depend on the intended use of the image.  For 
example, Figure 3-5 shows that by varying the filter used the reconstructed slices 
can vary from very smooth to very sharp, with corresponding changes in noise, 
contrast and fine detail.  Hence the approach taken here is to define the 
properties of the FBP reconstructions using the methods described in section 
3.6.3 and use them as baseline figures with which to compare the iterative 
models.   
Filtered Back Projection reconstructions were performed using commercial 
reconstruction software (FBP software, version 3.7, Hermes medical, Stockholm, 
Sweden).   
Projection data was convolved with 2D Butterworth smoothing filter, before 
being reconstructed with FBP and a ramp filter.  The Butterworth filter cut-off 
(fco) was varied from 0.5 to 2.0 cycles/cm, with a fixed order of 10.  Figure 3-5 
shows a central transverse slice of the reconstructed data from a phantom 
acquisition with a range of filters.   
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Figure 3-5 A central slice from a number of reconstructions using FBP and a range of 
Butterworth filters of order 10.  From left to right, fco =0.5, 0.7, 0.8, 1.0, 1.2, 1.4, 1.6, 1.8 and 
2.0 cycles /cm.  Data from Phantom run number 2, at 13cm ROR. 
This range was chosen to extend beyond the range usually used; going from a 
very smooth filter, to one that approaches the Nyquist frequency of the data.  
Image reconstruction for visual reporting of ioflupane SPECT imaging is 
generally performed with fco = 1.2-1.5cycles/cm.  The Nyquist frequency for the 
projection pixel size (0.21cm) is 2.38cycle/cm.   
The manufacturer of ioflupane suggests a filter of 0.6 of the Nyquist frequency 
should be applied, i.e. 1.43 cycles/cm.  However, these suggestions are coupled 
with projection data imaged with pixel size 0.42 cm as opposed to 0.21cm used 
here.   
This set of FBP reconstructions was then used as baselines for comparing the 
various implementations of the OSEM algorithm under different acquisition 
parameters.  
3.6.2.2 OSEM reconstructions – Resolution modelling 
Acquisition data were reconstructed using an implementation of the OSEM 
algorithm (HOSEM, version 3.7, Hermes Medical, Stockholm, Sweden) with 
different resolution recovery techniques.  Baseline results are produced using 
OSEM with no resolution modelling.  A second series of iterative reconstructions 
were produced using a fixed blurring function (PSF= 4.0mm, FWHM = 9.4mm).  
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The third series used a depth dependent blurring function based on resolution 
measurements in section 2.3.    
3.6.2.3 Extent of resolution model in OSEM reconstruction 
The default extent of the resolution model employed for these reconstructions 
was two pixels in x-plane and one in z plane.  For one acquisition data set (run1, 
13cm ROR) the reconstructions were repeated using a range of x and z blurring 
sizes.  Due to differences in the levels of smoothing inherent in these 
reconstructions, the number of equivalent iterations was extended up to 750 
equivalent iterations.   
3.6.3 Methods - Image quality measurements 
3.6.3.1 Specific Uptake Ratio and Noise measurement 
Volumes of interest (VOI) were drawn on the spatially aligned CT data to cover 
the known structures in the phantom.  A VOI was also placed in the posterior 
section of the brain.  These volumes were then applied to the various SPECT 
data.   
Count densities in the target (Strcnts) and background (Bkdcnts) VOIs were used to 
define the Striatal Uptake Ratios (SUR) for the various reconstruction 
parameters using Equation 3-9.   
 
Equation 3-9 
The noise in the image was calculated as the standard deviation of pixel values in 
the background region divided by the mean average counts in the same region.   
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3.6.3.2 Calculating NMSE, Noise and contrast 
To calculate the NMSE of the reconstructed image, the actual activity distribution 
must be known on a pixel-by-pixel basis.  To calculate this distribution the CT 
images of the phantom were used.  
The realigned CT data of the phantom was imported into the MRIcro program 106.  
Automatic VOI drawing tools were used to define the extent of the four striatal 
volumes and the whole brain background.  The whole brain VOI includes the 
regions defined in the striatal volumes.  These VOIs were exported as binary 
image data sets, where voxel values equal to one inside the volume and zero 
elsewhere.  Although the putamen and caudate compartments within the 
phantom are physically separate objects within the phantom, they touch on each 
side.  The walls of these compartments are made of very thin plastic.  When the 
automatic growing tools are used the Caudate and Putamen regions on each side 
are formed as single volumes.  The phantom scans had been performed using 
equal activity concentrations in the four striatal chambers, so the striatal VOIs 
were combined to give one single VOI.  The striatal VOI was subtracted from the 
whole brain VOI to produce a mask that represents the background activity.   
The background mask was scaled to the known activity concentration in the 
phantom and multiplied by a sensitivity factor.  Likewise, the striatal VOI was 
also scaled up, but with an addition scaling factor of the known target to 
background ratio.  The striatal and background activity distributions were 
summed to give the known activity distribution.  Figure 3-6 shows a transverse 
slice through the calculated activity distribution and a corresponding slice from 
one of the test reconstructions.   
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For some phantom acquisitions, the phantom had to be removed and re-fitted 
between scans.  For this data the CT images were re-aligned to the new position 
following the method above.   
All reconstructed phantom data were exported in native format (interfile) 
converted using ImageJ 107 into analyse format and then imported into Matlab.  
The following processing steps were then performed using Matlab functions.   
For each test reconstruction the whole brain VOI was used as a mask to set all 
voxels outside the brain equal to zero.  The known activity distribution and the 
test reconstruction were used to calculate NMSE (as per Equation 3-5).   
A measure of noise was recorded using the brain background VOI following 
Equation 3-6.  The striatal uptake ratio was also measured using the average 
count densities in the striatal and background VOIs (Equation 3-7).   
 
Figure 3-6 Transverse slice through the ideal count distribution (left) and an example 
reconstruction (right) 
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3.6.3.3 Calculating Profile-NMSE, noise and contrast 
A line profile was drawn across the phantom data on a central transverse slice, 
from left to right crossing both putamen tails.  This line profile was applied to 
both the reconstructed SPECT data and the CT data.  Figure 3-7 shows this 
profile drawn across a transverse slice.  These profiles were exported to a 
spreadsheet program for further analysis (Excel 2003, Microsoft).  Changes in 
the CT number (measured in Hounsfield Units) across the profile allowed 
delineation of the separate brain volumes.  The CT numbers were then 
substituted for the expected count value for those regions (defined as per section 
3.6.3.2) to give the expected line profile counts.  The expected and measured line 
profiles were used as inputs for the NMSE measurement (Equation 3-4).   
As the line profile covered both striatum and background regions another 
measure of contrast could be made, using the region boundaries given by the CT 
line profile.   
In this phantom study the central region of the brain between the two putamen 
tails should give a uniform count level.  In practice, the variation in counts in this 
region will be a combination of noise and counts blurring in from the two 
putamen regions on either side.  The coefficient of variation in this region was 
recorded as further image quality metric.   
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Figure 3-7 Two line profiles drawn across a transverse slice with corresponding profile 
chart displaying counts per pixel as a function of pixel number 
3.7 Results:  Phantom experiments with FBP 
3.7.1 Contrast and noise - results 
The first set of results is from the filtered back projection data.  The contrast and 
noise were measured using method described in section 3.6.3.1 using VOIs 
defined on the CT image and transferred to the SPECT data.   
Figure 3-8 shows the contrast measured as a function of fco of the filter used in 
the reconstruction.  The four contrast curves relate to the first four of the 
phantom acquisition runs, all acquired at 14cm Radius of rotation.  For details of 
phantom acquisitions see section 3.6.1.  The data from phantom run five could 
not be reliably aligned with the CT template and was therefore left out of this 
analysis.  No corrections for attenuation or scatter were used.   
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Figure 3-8 Contrast as a function of the cut-off frequency for FBP reconstructed phantom 
data 
The general form of the curves seen in Figure 3-8 is an increase in contrast as fco 
is increased, before levelling off to a plateau.  The same data was rescaled as a 
fraction of the known contrast in the phantom.  This is known as the recovery 
coefficient.  The recovery coefficient is shown as a function of fco in Figure 3-9.  In 
these recovery coefficient graphs, the increase in recovery coefficient with fco is 
more clearly shown for the lower contrast acquisitions.  The highest recovery 
coefficient for all but one of the phantom runs is seen at the highest frequency 
cut-off.  The maximum recovery coefficient for each run, averaged across the four 
runs is 0.58.   
Using the coefficient of variation across the different phantom runs, the recovery 
coefficients are most similar at high frequency cut-offs.   
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Figure 3-9 Recovery coefficient as a function of cut-off frequency.  The variation between 
recovery coefficients is shown on the secondary axis 
Figure 3-10 shows the noise levels recorded in the uniform background region.  
The reconstructions shown are same as those used to create Figure 3-8 and 
Figure 3-9.   
 
Figure 3-10 Noise in the background uniform section of the phantom, as a function of the 
filter cut-off frequency 
The noise- to cut-off relationship is close to linear for the range 0.8 cycles/cm up 
to the maximum frequency.  At low cut-off frequencies (fco <0.8cycls/cm) the 
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noise levels show a weak negative relationship with the cut-off frequency.  Very 
similar noise levels are seen across the different phantom acquisitions.   
The contrast and noise properties are combined in Figure 3-11.  Figure 3-12 
shows the same data but with the contrast rescaled to give recovery coefficient.   
 
Figure 3-11 Contrast as a function of noise for FBP reconstructions 
 
Figure 3-12 Recovery coefficient as a function of noise 
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The same data expressed as Signal-Noise Ratio (SNR) values as a function of fco is 
shown in Figure 3-13.  The peak in SNR relates to the range fco = 0.7-0.8 
cycles/cm.  This frequency is the point of minimum noise in the noise-frequency 
graphs.   
 
Figure 3-13 Signal to noise ratio as a function of cut-off frequency for FBP reconstructed 
data 
3.7.2 Contrast and noise - discussion 
The contrast and noise results from the FBP reconstruction show responses in 
fitting with a visual description of the images.  With reference to the images 
shown in Figure 3-5 and Figure 3-14, the low frequency cut-off is seen to be 
smoothing out some of the detail of the size and shape of the striatal volumes.  
Increasing frequency cut-off allows finer details to be included in the 
reconstruction.  This is seen in the results (Figure 3-8 and Figure 3-9) as a sharp 
101 
 
rise in contrast at low cut-off frequencies.  A difference between the visual 
assessment and the VOI contrast measurement is at which point the contrast is 
fully recovered.  In the contrast curves (Figure 3-8 and Figure 3-9) most of the 
contrast has been recovered once the filter is above 1.2 cycles/cm.  A visual 
assessment of the images shows that raising this filter to over 1.6 cycles/cm 
results in better delineation between the caudate and putamen.  This is a result 
of the relatively large VOI used to define the contrast.   
  
Figure 3-14 A central transverse slice reconstruction using FBP and a range of frequency 
cut-offs (from left to right, 0.5, 0.8, 1.2, 1.6 and 2.0 cycles /cm).   
The recovery coefficient is a function of the size and shape of the object as well as 
the resolution of the imaging system.  Since in these tests the size and shape of 
the object are fixed, the point at which the variation in recovery coefficient is 
minimal may be of importance.  This minimum appears at high cut-off 
frequencies.  There is no dependency in these results on the actual contrast seen 
in the phantom.  This is perhaps surprising, as PVE would tend to affect low 
contrast data less than high contrast data.  It is postulated that the differences 
seen in these maximum contrasts is due to the differences in positioning of the 
VOIs between each set of reconstructions.   
The trends in the background noise are interesting as they appear to show a 
drop in noise over these same low frequencies – examining the transverse 
images (left most slice in Figure 3-14) it can be seen that the higher count 
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variation in the 0.5cycles/cm image is not noise but some form of structured 
pattern.  Since the activity concentration is uniform this pattern must be some 
form of interference pattern.   
3.7.3 NMSE - results 
A series of NMSE calculations were performed on the data from the filtered back 
projection reconstructions following the method described in section 3.6.3.2.  
The use of NMSE as an image quality metric relies on the definition of the 
expected pixel counts.  The expected counts were calculated using the known 
activity concentrations and sensitivity of the scanner.  A large discrepancy was 
found between the expected counts and measured counts for all reconstructions 
using FBP.  For example, using phantom run number 2 the background counts 
should average 28.6 counts/voxel.  For the range of filtered back projection 
reconstructions (without attenuation or scatter correction) the average counts in 
the background region covers the range 8.66 to 8.91 counts/voxel depending on 
filter.  When attenuation and scatter correction are applied this range increases 
to between 14.07 to 14.15 counts per voxel.   
It has been reported that different reconstruction models can give different 
scaling factors for the image data 108,109.  The absolute scaling of these images 
cannot therefore be used on its own.  The relatively small range of voxel 
intensities seen in the background regions does suggest that some universal 
scaling factor may be being included in the reconstruction algorithm.   
The NMSE analysis was then performed using a base count concentration equal 
to the background count concentration.  Figure 3-15 shows the NMSE score, 
Signal to Noise Ratio (SNR) and noise for the FBP reconstruction data.   
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Figure 3-15 NMSE, SNR and Noise as a function of filter cut-off frequency for FBP 
reconstructed data 
In these calculations the noise and SNR levels are measured using the whole 
brain volume as the background region.  The noise levels are at a minimum at a 
cut-off frequency of 0.8 cycles/cm.  The minimum NMSE score occurs at 1.1-1.2 
cycles/cm and the maximum SNR occurs between 1.2 and 1.4 cycles/cm.   
3.7.4 NMSE - discussion 
The use of a scaling factor with the NMSE reduces confidence in its use as an 
absolute comparison tool.  By adjusting the scaling factor the optimum 
reconstruction parameters will change.  A second problem can occur with 
application of the NMSE score to the phantom data described here.  The NMSE 
score is similar to standard deviation, but it is the variation from an expected 
value, rather than mean value.  Since the vast majority of voxels in this study are 
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uniform brain background areas (97.7% of active volume), the NMSE score is 
heavily based on noise in background.  This can be seen in Figure 3-15 where the 
curves for NMSE and background noise are highly correlated.  The background in 
the phantom is a uniform volume, so a reconstruction method that optimises this 
feature (i.e. a uniform spread of pixel intensities) may not actually be the most 
appropriate.   
3.7.5 Line profile NMSE  - results 
A line profile was drawn across a series of FBP reconstructions as described in 
section 3.6.3.3.  To overcome the problems with the scaling factors encountered 
in the whole brain NMSE calculations, the expected background count was set to 
match the average background pixel count.   
The line profiles from the reconstruction using Butterworth filters with fco = 0.5 
to 2.0 cycles/cm and order 10, are shown in Figure 3-16.  The expected profile, 
based on the CT data and scaled to average background count, is shown as the 
solid black line.   
As the filter cut-off frequency is increased the counts in the centre part of the 
profile become smaller.  At the same time, the two high count regions increase.  
The positions of the two peaks are also seen to widen slightly with increasing 
cut-off frequency.  The profile for the 2.0 cycles/cm reconstruction shows large 
fluctuations in the central part of the image.  Large fluctuations are also seen 
outside of the brain volume.   
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Figure 3-16 Line profiles of FBP reconstructed data using a range of filter cut-off 
frequencies. 
These line profiles were used to define NMSE, contrast and noise as described in 
section 3.6.3.3.  The noise was measured as the coefficient of variation for the 
central section of the image between the two peaks.   
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Figure 3-17 NMSE calculated for the line profiles as a function of the cut-off frequency 
Figure 3-17 shows the NMSE score as a function of the cut-off frequency for the 
two line profiles.  The NMSE score for the line profile through the putamen 
region shows a sharp drop for filters from 0.5 to 1.0 cycle/cm.  The minimum is 
reached for a filter with fco =1.6 cycles/cm, but it is a board minimum.  The NMSE 
for the profile drawn across the cerebral region shows an increase between 1.2 
and 1.6 cycles/cm.   
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Figure 3-18 Line profile metrics as a function of reconstruction filter 
Figure 3-18 shows the Noise, Signal, SNR and NMSE scores as a function of the 
reconstruction filter.  The contrast is seen as a rapidly rising curve up to 
1cycle/cm, after which it flattens out.  The noise initially decreases as the image 
sharpens – this relates to the steepening of the boundary between the putamen 
and background regions.  The NMSE score is the same data as depicted in Figure 
3-17.   
3.7.6 Line profile NMSE - discussion 
The progression of line profile curves shown in Figure 3-16 shows the two 
related effects of increasing reconstruction filter cut-off frequency.  The low 
frequency reconstructions show smooth transitions from putamen to 
background, with smooth near-uniform background regions.  The curves 
showing the higher frequency data show a much-improved contrast between the 
108 
 
putamen and background regions at the expense of increased noise.  The 
expected background region counts were taken from the average counts in this 
region, so the noise measurement is simply a measure of variation from this 
mean.  
Comparing the trends in these figures with those from the whole brain NMSE 
results, similar trends are seen.  The SNR and noise measurements show larger 
variations in the line profile data than in the whole brain data, most likely due to 
the reduced number of voxel samples being used to create the figure, and the 
more complicated interplay between the sharp boundaries and the noise levels.  
The whole brain data on the other hand is dominated by uniform brain 
background noise, with only a small component coming from the striatum-
background boundary regions.  The minimum NMSE score is found at slightly 
higher cut-off frequencies in the line profile data than in the whole brain data. 
The NMSE score for entire image combines the information from the two line 
profiles with many other profiles of similar form.  However, the whole brain 
NMSE behaviour will be heavily weighted towards the cerebellum line.   
3.7.7 Varying Radius of Acquisition - results 
The contrast results were compared for a single phantom run, repeated at 
different acquisition radii of rotation.  The results are shown in Figure 3-19.  
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Figure 3-19 FBP contrast as a function of acquisition radius of rotation 
The graph shows that as the radius of rotation is increased, the image contrast 
goes down.   
3.7.8 Varying Radius of Acquisition - discussion 
The radius of rotation seen clinically is typically 13-15cm.  For patients with 
mobility/flexibility issues this must sometimes be increased to 16 or 17cm.  The 
results show that a similar contrast is seen for the 13-16cm acquisitions.  
However, when the ROR is increased to 20cm or greater then there is a 
significant loss in contrast (30% drop for the fco =2.0cycle/cm).   
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Looking at the scatter free line source resolution measurements described in 
section 2.3 for the collimator source distances of 13,16 and 20cm, the planar 
resolution (as FWHM) is 9.25mm, 10.57mm and 12.34mm respectively.  This 
equates to an increase in blurring width of 14% and 33% when moving from 13 
cm up to 16cm and 20cm.  When the ROR is extended to 25cm, the blurring 
increase is over 57%.   
3.7.9 Conclusions on Filtered back projection images 
Although the results of the various measurements performed on the filtered back 
projection images show a wide range of results in terms of the exact filter that is 
ideal for each test, a broad consensus between these measurements is seen and 
so some conclusions can be drawn.   
The sharpest images, those with the highest cut-off frequencies for the filter, give 
the highest contrast.  These images show the smallest differences in recovery 
coefficient between acquisitions.  These two properties would suggest that it 
could be the best for VOI based analysis programs.  However, these images show 
very high levels of noise, and are visually very hard to interpret.  Automatic 
image registration does not work very well with excessively noisy images, so 
alignment of VOIs may be problematic unless a surrogate image is used for the 
alignment.   
At the other extreme, the very smooth images show low levels of noise, but lack 
the detail in the striatal activity.   
The images preferred for visual reporting are near the centre of the filter ranges 
at 1.2-1.3 cycles /cm.  These images are slightly sharper than those with the 
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highest SNR as defined using the larger VOIs.  They are very close to those with 
the highest SNR as measured using the line profiles.   
Comparing these results with settings used in published data, a wide range of 
settings have been used.  To date no work has been published optimising the 
settings for FBP in DAT imaging, however a number of settings have been used. 
In their work showing the usefulness of a large VOI based analysis package, 
Tossici-bolt et al. 110 used a relatively smooth filter (0.6 cycle/cm order 10).  The 
argument for their specific analysis package was to create a resolution 
independent system, which incorporates large VOIs.  A similar filter was used by 
Badiavas et al. 77 for their implementation of the same uptake measurement.  
Work utilising more tightly defined VOIs have used a range of filters (0.5 
cycles/cm up to 2.2 cycles/cm) 49,111-115.  The use of smoother filters would allow 
visual reporting, but at the expense of some contrast.  Dickson et al. 115 noted that 
although they had suggested the use of very sharply reconstructed images, that 
smoothed options might be required for visual reporting.  A note of caution 
should be taken when comparing the filter settings from different published data 
due to the variation in the definition of the filter (see section 3.1).   
3.8 Results:  Phantom experiments with OSEM 
3.8.1 Contrast and noise for three iterative reconstruction 
models 
The contrast and noise were measured using method described in section 3.6.3.1 
using VOIs defined on the CT image and transferred to the SPECT data as per the 
FBP data in section 3.7.1.  No attenuation or scatter compensation techniques 
112 
 
were included in these reconstructions and no post reconstruction smoothing 
was applied.   
 
Figure 3-20 Contrast as a function of image refreshes for different OSEM based 
reconstructions 
Figure 3-20 shows the results from phantom Run 2, using a radius of rotation of 
14cm.  The Gaussian blurring function is extended to +/- 2 pixels in the x-axis 
and +/-1 pixel in the Z-axis.  The FBP data is also shown for comparison, as a 
function of cut-off frequency.  The cut-off frequency (fco) was scaled to allow 
visualisation on the same chart by multiplying by 100.   
Figure 3-20 shows the data from three iterative models, two of which include 
resolution recovery.  The Depth Dependent Resolution Recovery (DDRR-OSEM) 
and Fixed Resolution Recovery (FRR-OSEM) give almost identical results - as 
shown by the overlapping data on the graph.  The basic OSEM model shows 
faster convergence, but lower contrast.  The inherent filtering in the resolution 
recovery based models means they converge more slowly, but result in higher 
image contrast.  This trend is seen in all datasets: the resolution recovery models 
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give increased contrast when compared to OSEM.  The FBP reconstructions are 
seen to give higher contrast in these measurements than those achievable by 
OSEM.   
The noise in this same set of reconstructions was measured using the same 
region as per section 3.7.1.  This noise data was combined with the contrast data 
shown in Figure 3-20 to give Figure 3-21.  The two curves for iterative 
reconstruction are produced by varying the number of iterations/image 
refreshes in the reconstruction.  This variable produces changes in both the noise 
and contrast in the images.   
 
Figure 3-21 Signal as a function of Noise for different Iterative reconstructions 
These signal-noise graphs show that at any specific noise level, the DDRR-OSEM 
will give better contrast than OSEM.  The filtering inherent in the DDRR-OSEM 
and FRR-OSEM mean the noise levels are controlled better.   
Some researchers (e.g. Hutton et al. 116) have suggested that a post-
reconstruction filter can improve noise characteristics.  Due to the inherent 
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smoothing in the resolution recovery models, their improvement with post 
filtering was reported to be smaller.   
 
Figure 3-22 Contrast as a function of noise for different OSEM based reconstructions with 
post-reconstruction filter 
Figure 3-22 shows the effect on noise and contrast when a post-reconstruction 
smoothing filter is applied to the data in Figure 3-21.  Two representative 
reconstructions are shown with post-reconstruction smoothing.  The data from 
an OSEM reconstruction with 20 image refreshes (5 iterations of 4 subsets) was 
smoothed using a range of Butterworth filters.  The same series of Butterworth 
filters was applied to the Depth-Dependent resolution recovery image 
reconstructed using 12 iterations of 8 subsets (96 image refreshes).   
A dramatic reduction in noise is seen in the OSEM data, with contrast loss only 
when very smooth Butterworth filters are applied.  The reduction in noise for the 
DD-RR OSEM data is less pronounced, but higher contrast is still seen for almost 
all noise levels.   
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The shoulder in these graphs, where the smoother filter starts to have a dramatic 
effect on the contrast is seen at filters around 1.4 cycles/cm.   
The ratio of signal to noise (SNR) can also be used to describe this trade off as is 
seen in Figure 3-23.   
 
Figure 3-23 SNR as a function of image refreshes 
The curves for SNR for OSEM, FRR-OSEM and DDRR-OSEM show peaks at 4 and 
16 refreshes.  The SNR curves from FRR-OSEM and DDRR-OSEM are 
superimposed.   
Different levels of post-reconstruction filtering are shown as the vertical lines 
coming up from the SNR curves.  Filtering was applied to specific reconstruction 
data sets:  
 The data that gave Peak SNR in non-filtered data,  
 At a level where 95% of maximum contrast is seen, i.e. at 16 or 20 image 
refreshes for OSEM, and 96 image refreshes for DDRR-OSEM.  
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The peak SNR occurs when relatively smooth post-reconstruction filters are 
applied.  For both sets of OSEM models the peak SNR is at post reconstruction 
filters of 0.8 cycles/cm.   
3.8.2 Contrast and noise for three iterative reconstruction 
models – discussion 
The contrast and noise results for the iterative reconstruction processes show 
complicated dependence on the number of image refreshes and the use of post 
reconstruction smoothing.   
When resolution modelling is included, the images will converge at a slower rate 
than for the basic OSEM reconstruction.  However, if sufficient image refreshes 
are performed, and the post-reconstruction filter is chosen appropriately, the 
DDRR-OSEM can always produce an image data that is either higher contrast for 
the same noise, or lower noise for the same contrast.   
No discernable differences are seen between DDRR and FRR.  The depth-
dependent model calculates the blurring function for the distance between the 
object and the detector.  However, for the contrast measurements here, the range 
of depths of interest is very small, only 6.5 to 10.5 cm.  At these distances the 
calculated blurring function will give a FWHM of 7 to 9.25 mm, which is very 
similar to the fixed filter model of 9mm.   
In two papers investigating the use of OSEM models in DAT SPECT imaging, 
115,117 a depth independent PSF was used with a value of 4.0mm (equating to 
9.4mm FWHM).  This figure was adopted as a compromise setting for data from a 
number of different cameras and collimator types.   
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A post-reconstruction smoothing filter can improve the noise properties of OSEM 
data.  A filter can reduce the noise levels in the image, but if the filter is too 
smooth, the contrast will decrease.  For a range of filters, only very small 
decreases in contrast are seen.  For both OSEM and the resolution recovery 
OSEM models filter cut-off frequencies below 1.4 cycles/cm have an adverse 
effect on image contrast.  However, the peak SNR as measured using this system 
occurs at much smoother filters of 0.8 cycles/cm.   
In a very recent work, Warwick et al. 118 compared resolution recovery with fixed 
or depth dependent resolution model to reconstructions without resolution 
modelling.  They found that post reconstruction smoothing was required when 
no resolution recovery was included.  They also found a small improvement with 
depth dependent resolution model, over fixed blurring.   
3.8.3 Direct comparison of FBP and DDRR-OSEM 
This section compares SUV uptake data for the FBP and DDRR-OSEM 
reconstructions.  Using a specific ROR (13cm), and the four different phantom 
contrasts, data was reconstructed using FBP and DDRR-OSEM using a range of 
filters and iteration numbers respectively.  No post-reconstruction filtering was 
used in these measurements.   
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Figure 3-24 contrast for different phantom runs using FBP and OSEM 
Filter cut-off (in FBP) and number of iterations (in OSEM) affect the contrast and 
noise levels of the resulting images, however they are of course completely 
separate variables so they should not be compared directly.  That is, the contrast 
for a particular filter should not be compared with the contrast from that 
number of iterations.  However, with this proviso, the data from the two groups 
of reconstruction can be shown on the same graph.  The x-axis shows both filter 
cut-off frequency (cycles/cm) and iterations (measured in hundreds of 
iterations).   
This data shows clear dependencies on number of iterations, and filter levels for 
the two groups of reconstructions.   
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When the data is normalised to the actual phantom concentration ratios, i.e. 
measured as recovery coefficients, the variation for low contrast data is more 
clearly seen (Figure 3-25).   
 
Figure 3-25 recovery coefficient as a function of image refreshes or cut-off frequency 
This chart shows mainly smooth variation of contrast with number of iterations 
used.  Only very small changes in image contrast are seen at over 100 iterations.   
The FBP shows abrupt changes in measured contrast for small changes in filter 
settings.  However, these variations are only seen when very smooth filters are 
used.   
The peak contrasts are seen when large numbers of iterations are used, or very 
sharp filters are applied.  For both reconstruction types there is a marked 
dependency on phantom contrast.   
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Using just the highest contrast data available, the DDRR-OSEM results are on 
average marginally lower than the FBP data.  This result is in fitting with the 
results published by Koch et al. 117.  They used similar software, but fixed the 
iterative reconstruction to 3 iterations of 8 subsets and had a fixed resolution 
function of 4mm.  The extent of the model was not quoted.  Their FBP 
reconstruction used only a ramp filter coupled with a specific post-
reconstruction filter.  They measured an average 5% lower binding ratio with 
OSEM compared to FBP.   
3.8.4 Size of Blurring Function 
In section 3.8.2 the speed at which the contrast in the images converges on the 
final value was found to be dependent on the use of resolution recovery.  The 
extent of this resolution was investigated next.   
The extent of the resolution model is measured in the number of voxels in the x 
and z directions (respectively, across the transverse slice and between slices).   
The software manual suggests a starting point of only a small number of pixels 
(x1,z0,) but does not suggest or put any limits on how far this can be extended.  
Routine clinical practice has been to employ 2x-z1.   
The influence of these settings was investigated using data from Acquisition 1, at 
13cm radius of rotation, with a range of iterations and extent of resolution model 
(x’s and z’s).  The contrast was measured using an ROI based on CT data as per 
section 3.6.3.1.  Results are shown in Figure 3-26.   
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Figure 3-26 Contrast as a function of image refreshes for varying extent of resolution 
model 
The results show that as the Gaussian profile is modelled to a larger size, the 
slower the reconstruction.  The x3,z2 data converges at over 700 image 
refreshes.  An increase in the x-width appears to increase the contrast, whereas 
for this measure of contrast at least, the widening of the z-model slows the 
convergence.   
The dark and light blue lines relate to the normal OSEM (x=z=0) and DDRR-
OSEM (with x=2,z=1) used elsewhere in this work.   
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These contrast curves would appear to recommend the use of wider modelling 
with more and more iterations, however, the visual appearance of these images 
show an unwanted side effect.  Figure 3-27 shows a central transverse slice from 
a reconstruction using a broad collimator model and lots of iterations (x3,z2, 75 
iterations of 8 subsets).  The figure on the right is the same data as the left, but 
with a post-reconstruction Butterworth filter (fco = 1.5cycle/cm, order 10).  
There are obvious non-uniformities in the background regions.  These are 
reduced in the smoothed data, but are still present.  There are also two very low 
count regions in the arch of the two striata – appearing as two black circles 
medial to the putamen and posterior to the caudate heads.  On the non-smoothed 
imaged there are distinct detail along the putamen that is artefactual – they 
appear as two separate sections – although this is removed when filtering is 
applied.  It would appear the images have been over corrected.  A similar affect 
could be achieved using an edge enhancement filter, or a non-uniform smoothing 
filter.   
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Figure 3-27 Central transverse slice from DDRR-OSEM reconstructed volume using wide 
Gaussian modelling (x3z2).  The image on the right has been smoothed post-
reconstruction Butterworth filter 
3.8.5 Size of Blurring function line profile NMSE - results 
To investigate the formation of this structured background, the line profile 
techniques described in section 3.6.3.3 and used in section 3.7.5 were employed.  
Some post reconstruction filtering was also performed to investigate the 
differences between structured and random noise in the images.  A post 
reconstruction filter of 1.5cycls/cm was applied to the reconstructed data.  This 
filter was chosen to be sharper than the point at which contrast is lost, as based 
on the curves in section 3.8.2.   
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Figure 3-28 Line Profile NMSE minimums for a range of iterative reconstructions and FBP 
with and without post-reconstruction filtering (F /NF)  
Figure 3-28 shows the minimum NMSE score for the putamen and background 
regions for a range of OSEM reconstructions using different Gaussian blurring 
widths, with and without filtering.  
The minimum NMSE scores are generally seen for data with a post 
reconstruction filter.  The FBP has the lowest background NMSE score, while the 
wide (x3z2) DDRR-OSEM reconstruction has the lowest putamen region score.  
The wide-Gaussian data is capable of giving both the minimum putamen score, 
and a low cerebellum score.  However, these two minimum values are produced 
from different reconstructions.  Figure 3-29 shows the trends in the x3z2 data 
along with the FBP data for comparison.  The minimum NMSE scores for the 
putamen and background regions occur at 64 and 400 iterations respectively.   
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Figure 3-29 Line profile NMSE scores for OSEM and FBP reconstructions 
In Figure 3-30 the NMSE score as a function of image refreshes is shown for the 
putamen line profile for the various levels of resolution modelling.  The lower 
chart is based on the same reconstructions but utilising a 3D post-reconstruction 
smoothing filter (Butterworth 1.5cycles/cm, order 10).  Using different widths of 
Gaussian resolution model will change the number of iterations needed to make 
NMSE reach a minimum.  Once this minimum is reached, adding further 
iterations will generally increase the NMSE score as more noise is added to the 
image.  Adding a post reconstruction filter removes this extra noise and so the 
NMSE score does not rise with further iterations.   
The curves for the background region are shown in the two charts in Figure 3-31.   
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Figure 3-30 Line NMSE score for the Putamen region for iterative reconstructions using 
different sizes of resolution model.  The lower chart includes a post-reconstruction 
smoothing filter 
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Figure 3-31 Line NMSE score for the background region for iterative reconstructions using 
different sizes of resolution model.  The lower chart includes a post-reconstruction filter 
The background region charts (Figure 3-31) appear to show quite variable 
results.  There is an obvious trend for the data from the larger blurring model to 
give better results at high numbers of iterations.  When a post reconstruction 
filter is added the curves follow the same trend, but are more closely matched.   
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3.8.6 Size of blurring function – discussions 
For both the filtered back-projection and the OSEM NMSE line profile results, 
there are opposing trends going on.  For the putamen region line profile, the best 
results are occurring when higher frequency data is included in the image: That 
is, when either high cut-off frequency filters are used in the FBP reconstruction, 
or large numbers of iterations and wide Gaussian modelling are used within the 
OSEM reconstruction.  The opposite is true for the background regions, where 
the best results are seen with smoother reconstructions.  For all of the images a 
post-reconstruction smoothing filter improves this image quality metric.   
Relating these NMSE scores to the image quality in terms of classification is not 
straightforward.  For the particular imaging task being investigated here, where 
the importance is in the size and intensity of uptake of a particular organ/sub-
organ, the ability of a reconstruction system to give smooth background regions 
is less important than its ability to clearly define the extent of an active region.  
As such, the line NMSE score for the putamen region may be a useful indicator of 
reconstruction performance, whereas the cerebellum region is less important.   
3.8.7 Varying Radius of acquisition – iterative results 
The depth-dependent resolution recovery model is described as using a different 
blurring function depending on the radius of rotation for the acquisition.  It is 
possible that the DDRR-OSEM will outperform FBP when patient positioning 
requires a larger ROR.   
The same projection data used in section 3.7.7 was reconstructed using DDRR-
OSEM using the known Radius of rotation.  Figure 3-32 shows the contrast 
measured for phantom run1 using different acquisition ROR.  The left figure 
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shows the FBP results, and the right DDRR-OSEM model.  Using the variation in 
contrast at the highest contrast setting used, the DDRR-OSEM model shows a 
smaller variation in the measured contrast across the ROR used compared with 
FBP (7% vs. 10%).  However, when just the 13-16cm data is used, the FBP has a 
smaller spread of results (2.4% vs. 3.8%).   
 
 
Figure 3-32 Contrast measurements using different acquisition radii, as a function of cut-
off filter used for FBP (top) and image refreshes for DDRR-OSEM (bottom) 
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3.8.8 Varying Radius of acquisition – discussion 
The depth dependent resolution model appears to make significant 
improvements when the phantoms are imaged over a wide range of ROR.  
However, such wide variations are rarely seen in clinical brain imaging.  When 
the more clinically relevant ROR range is used, the FBP data shows a smaller 
variation.  As such, the results suggest the depth dependent model does not 
reduce the negative effects of increased ROR over the typical range of brain 
imaging distances.  Such a result may be important for SPECT imaging of the 
body.   
3.8.9 The effect of errors in ROR measurement - results 
The use of depth dependent Resolution recovery requires that the ROR be input 
into the reconstruction program.  On the scanners used in this work, this data is 
not stored within the image information file (the header file).  The Radius of 
Rotation (ROR) has to be recorded manually.  If the radius were not recorded 
properly, then an estimate would have to be made.   
A test was performed using the 13cm ROR data, with a range of incorrect radii 
input into the reconstruction program.  The input range was 175mm-205mm 
Centre of rotation-crystal distances, relating to 13-16cm ROR.  The contrast was 
measured using the CT derived ROIs.   
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Figure 3-33 Contrast as a function of image refreshes when different ROR distances are 
used 
Figure 3-33 shows the contrast measured for Run1 data acquired at 13cm, using 
different ROR input data.  The coefficient of variation for the contrast 
measurements at maximum contrast is 0.2%.  The contrast in the reconstructed 
images is not dependent on the ROR used in the program over the range of 
distances that are likely to be used.   
3.8.10 The effect of errors in ROR measurement – discussion 
The collimator blurring function used in this program is a function of distance as 
given by the experiments in chapter 2.  The blurring function sizes are shown in 
Table 3-3.  For this range of radii, there are only minimal differences between the 
blurring function used, and the correct blurring function.   
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Table 3-3 Calculated blurring function at different distances from collimator 
Collimator source 
distance (mm) 
FWHM (mm) 
Percentage change 
from 130mm ROR 
130 9.25 0% 
140 9.69 4.77% 
150 10.13 9.53% 
160 10.57 14.3% 
 
3.9 Compensation methods for attenuation 
The effect of attenuation is to reduce the apparent levels of activity within the 
reconstructed image.  In particular, regions central to the body, i.e. surrounded 
by attenuating material will be affected the most.  The counts in a central region 
of the brain will be reduced by a factor of around 60%.  However, what matters is 
not the size of bias or even the error in the uptake measurements, but the 
relative differences between patients.  The composition of patient’s heads is very 
uniform between patients, regardless of body habitus.  In fact, as is shown here, 
patient head sizes do not vary considerably, and so the range of the attenuation 
effect in the very centre of the brain will typically vary from 58% to 64%.   
Patients with larger than average heads will exhibit increased attenuation effects 
and hence reduced apparent uptake within the brain.  There are however a 
number of factors that will change the absolute level of uptake within the brain, 
and these are accommodated for by scaling the images using a background or 
non-specific binding region (see chapters 5 and 6).  When the attenuation effect 
is combined with this scaling effect, some of the attenuation effects are cancelled 
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out.  What remain are the differences in relative attenuation effect to the target 
and background regions due to the head size.  Depending on the background 
region being used, it is possible for the target region and background region to 
be at the same effective depth and in this specific case the size of the patients 
head will have no bearing on the measured up take in the image.   
This effect can be calculated theoretically for specific regions of the brain and for 
pre-determined head sizes.  This calculation will not give accurate attenuation 
measurements for specific patients, but will give a good estimate of the likely 
magnitude of differences between patients, and hence a good indication of the 
likely variation in uptake measurements due to patient head size.   
Following Chang’s description of an attenuation correction technique 98, and 
using a simple ellipse as the head outline, the attenuation effect at different 
positions can be calculated.   
3.9.1 Attenuation compensation calculations - Methods 
A series of 21 patients attending for PET-CT brain investigations were chosen at 
random.  After appropriate manual realignment to correct for head position, a 
central slice covering the striatum was selected on the CT image volume.  The 
width (left-right) and depth (ant-post) distances were measured manually using 
clinical CT reporting software.   
Various head sizes were modelled using a simple spreadsheet program as an 
ellipse following Equation 3-10.  The ellipse is centred on the coordinate origin, 
and the half lengths (or radii) are ‘a’ and ‘b’.  The coordinates xɵ  and yɵ  are the 
points on the ellipse that are found at angle  from the point of interest X0, Y0.   
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Equation 3-10 
The thickness of tissue (l ) from the point of interest (X0, Y0) for a particular 
projection angle  is given by Equation 3-11.   
 
Equation 3-11 
The attenuation effect at that point is then calculated by averaging the 
attenuation effects over all projection angles (M) (Equation 3-12) (adapted from 
98).   
 
Equation 3-12 
To measure the effect of head size on DAT SPECT imaging, the attenuation effect 
at a series of specific points of interest was calculated.  These points of interest 
are shown in Figure 3-34 and relate to the striatum and two series of 
background non-specific binding areas.  The attenuation effect was calculated for 
each point and averaged for each of five head sizes.   
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Figure 3-34 The position of points of interest within a brain outline used for attenuation 
effect calculations a string of points are shown in the left striatum along with two separate 
regions used for non-specific binding estimates 
3.9.2 Attenuation compensation calculations - Results 
A summary of the head sizes measured for the 21 subjects is shown in Table 3-4.  
The minimum and maximum head depths were not seen on the same patients as 
the minimum and maximum head widths i.e. the ratio of width to depth was not 
constant.  The data in Table 3-4 was used to model the range of head sizes to be 
seen in clinical imaging.  The mean depth and mean width were used to create 
the “average” head size.   
Table 3-4 Head sizes for a test population 
 Depth  
(ant-post) 
Width  
(left-right) 
Ratio 
Depth/Width 
Minimum 17.8cm 14.0cm 0.745 
Mean 
(Standard deviation) 
19.0cm 
(0.8) 
15.3cm 
(0.7) 
0.801 
(0.044) 
Maximum 20.6cm 16.7cm 0.908 
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The maximum and minimum head sizes were calculated using the maximum 
depths and widths recorded.  These do not relate to specific patients and are 
likely to show a larger range than is present in the population.  The 
measurements for the patients with the maximum and minimum depth-width 
ratios were used directly and labelled “maximum ratio” and “minimum ratio”.  
These five head sizes are shown in Figure 3-35.   
 
Figure 3-35 Elliptical outlines based on head size measurements 
In Figure 3-36 a series of three points of interest are evaluated.  The points 
marked on the perimeter of the head show the position of the points for which 
the attenuation depth is measured for a specific point of interest – marked with a 
green triangle.   
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Figure 3-36 Calculation of the attenuation effect at three points 
 
Table 3-5 Calculated attenuation affects in different positions within different sized heads 
 
Mean 
Brain 
size 
Minimu
m brain 
size 
Maximu
m head 
size 
Maximu
m ratio 
Minimu
m ratio 
Min ratio 
from 
mean 
Max ratio 
from 
mean 
Target 
average 
0.410 0.440 0.377 0.396 0.399 -8.0% 7.4% 
Background 
average 1 
0.482 0.522 0.440 0.476 0.462 -8.8% 8.1% 
Background 
average 2 
0.444 0.479 0.407 0.433 0.425 -8.4% 7.8% 
Target –
background 
ratio 1 
1.177 1.185 1.167 1.203 1.157 -1.7% 2.1% 
Target to 
Background 
ratio 2 
1.084 1.087 1.079 1.094 1.065 -1.8% 0.9% 
 
The calculated attenuation effect for the various head sizes and shapes are 
shown in Table 3-5.  The ratios of the attenuation effects between the two 
background regions and the target region is also shown.  The range of 
attenuation effects was calculated using the minimum and maximum values of 
the head size assessed.  This was expressed as a fraction of the mean head size.  
The maximum differences in attenuation effects are seen for background region 
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1, and ranges from -9% + 8%.  However, the ranges for the two ratio calculations 
is much lower at -2% to +2% of the mean value. 
3.9.3 Attenuation compensation calculations – Discussion 
While the bias in absolute activity due to attenuation is a large factor, the effect is 
relatively uniform between different head sizes with less than 10% deviation 
from the average.  When the scaling effects of a non-specific binding region are 
included the differences come down to only +/- 2%.  These results suggest that 
while the inclusion of attenuation correction may have a significant effect on the 
absolute quantitation, it is unlikely to have a large impact on classification 
systems.  This error can be compared with the test-retest variability for this 
pharmaceutical published by Booij et al. 48.  They scanned 6 healthy volunteers, 
and 10 patients with Parkinson’s disease twice each, with repeat scans occurring 
at 3-6 weeks after the first.  With an identical scanner, and acquisition, 
processing and analysis techniques, they showed a test-retest variability of 
7.47% (+/- 6.36%) and 7.36 (+/- 6.16) for the health volunteers and PD groups 
respectively.   
3.10 Compensation methods for scatter - discussion 
In section 2.2 Triple Energy Window scatter corrections were investigated with 
respect to the collimator sensitivity with distance.  In that section in was found 
the TEW could compensate for these septal penetration effects thus creating a 
more stable sensitivity value.  In section 2.3 this same TEW was found to make 
improvements to the FWHM and FWTM resolution measurements.  The former 
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effect is likely to improve quantitation in SPECT calculations, and the second 
effect may improve the reproduction of fine detail in SPECT images.   
For the first of these effects, the improvement is likely to be head size dependent 
scaling factor, which, like the attenuation effects in the last section may not have 
a large effect on quantitation.  The second effect - improvement in resolution - 
may allow improved contrast.   
The main use for TEW corrections is to compensate for scattered photons being 
included within the photopeak window.  The amount of scatter depends in part 
to the size of the head and distribution of activity within it.  The distribution of 
activity in other parts of the body may also be important.  For many patients 
there is significant uptake in the salivary and thyroid glands.  These tend to be on 
the edge of the field of view, or just outside it.  There is also uptake in other 
organs outside the field of view that will be variable between patients.   
Because of these out of field effects, and the variable glandular uptake, modelling 
with phantoms may not provide results representative of real patient data.   
The downside of this form of scatter correction is in the increases in image noise.  
Again, representative measurements of this cannot be made using phantom data 
as it does not truly represent the noise properties of clinical data, so it can only 
really be assessed using clinical patient images.   
Published work 119 has shown that these corrections can improve the accuracy of 
absolute uptake measurements in patients.  No studies have shown 
improvements in diagnostic accuracy when these corrections are included.   
In their work with cross-site camera comparisons using phantom data Dickson et 
al. 115 found problems with OSEM reconstructions in data with low pixel counts.  
They related this to the non-negativity constraint in OSEM.  Such a constraint 
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could be a problem when using TEW corrected projection data due to the low 
background count levels and increased noise.  A related issue when dealing with 
low count statistics is the use of integer values in image formats.  For data with 
low counts the rounding off to the nearest integer value could affect the resultant 
images.   
3.11 Overview of reconstruction results 
Looking at the general results seen across the range of parameters for the noise 
and contrast measurements the OSEM models that include resolution modelling 
perform better than the basic OSEM model.  However, there are no significant 
differences between the fixed and depth dependent methods for the SUR 
measurements used here.   
The DD-RR and fixed-RR OSEM models cannot be separated using the measured 
described here, and it may be that the full advantage of a depth dependent model 
only becomes noticeable over larger distances.  Since there were no drawbacks 
from using the more complex model this system was used.   
The FBP and DDRR-OSEM models can be optimised to give very similar 
performance for the large VOI based uptake measurements.  The size of the VOIs 
used to measure the contrast using striatal uptake ratios are quite large – they 
cover the entire striatum on one side.  It is conceivable that the DDRR-OSEM 
outperforms the FRR-OSEM model and FBP for smaller details.  To measure such 
changes a large range of different sized ROIs and VOIs would have to be 
employed.  The exact choice of these VOIs would affect the outcome of such a 
test, and without a clear anatomical reason for choosing the VOIs such a choice 
may introduce bias.   
141 
 
Another way of measuring these fine details is to use the line profile NMSE tests.  
There will of course be some variability in these results based on where exactly 
the line profile is drawn, but there are differences seen between the FBP and 
resolution recovery based OSEM results.  The DDRR-OSEM model can give 
superior results in this measure of fine detail.  The improved score for this 
measure suggests an ability to separate out the edges of the striatum.  This 
difference correlates with the preference of the expert observers based on visual 
assessment.   
The extent of the collimator blurring function was shown to have some 
unpredictable effects on the resultant images.  Although giving better results in 
both the VOI uptake measures and the line-profile NMSE score, the very wide 
models gave significant artefacts within the images.  The middling results of 
(x1z1) and (x2z1) gave a boost in both these metrics without obvious artefacts.   
The number of iterations used in the reconstruction must be sufficient to ensure 
adequate convergence of the images.  After 96 equivalent iterations (12i 
8subsets) 95% of the maximum contrast (as measured at 200 equivalent 
iterations) has been recovered.  This figure agrees well with the phantom work 
done by Dickson et al. 115 who suggested 100 iterations should be performed.   
The levels of noise and contrast are tuneable using different levels of post-
reconstruction smoothing.  For automatic or semi-automatic quantification 
systems that use VOI Ratios, it is likely that reconstruction methods that recover 
high levels of contrast in the images would be beneficial.  The optimum level of 
image smoothing may be dependent on the particular classification process 
being used.  Techniques using large VOIs are unlikely to be sensitive to filtering 
levels, whereas techniques using tightly constrained VOIs may be heavily 
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affected.  The new techniques proposed using machine learning are also likely to 
be dependent on the level of smoothing.   
As discussed in section 3.4 the ultimate test of the quality of an image is that it 
allows the correct diagnosis to be given.  To this end, a set of patient data will be 
reconstructed using a set reconstruction model and a range of post-
reconstruction filters.  Each subjects scan data will be reconstructed using the 
DDRR-OSEM iterative reconstruction algorithm with 12iterations of 8subsets.  
The resolution will be modelled to a width of +/- 2 pixels in the x axis and +/- 
1pixel in the Z axis.  The post-reconstruction filtering will be performed using a 
Butterworth filter with settings ranging from fco=0.5cycles/cm up to 
2.0cycles/cm.  A non-filtered dataset will also be used in the analysis.   
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4  
Clinical procedures for scanning and processing DAT SPECT scans within 
Imperial College Healthcare NHS Trust are as follows.   
Patient preparation involves thyroid blocking using tablets. These are taken 
twice per day for three days starting the morning of the day before the scan.  A 
total of six doses of 60mg of potassium iodide are taken.  The thyroid blocking 
procedures are in place to minimise uptake of free 123Iodine within the thyroid, 
hence minimising the radiation dose to the patient.   
Some medications can affect the way in which 123I-FP-β-CIT is taken up by the 
brain.  Within the drug safety leaflet for 123I-FP-β-CIT a number of such 
medications are listed, however the advice is that the prescribing clinician may 
or may not restrict these medications.  The recommendations are that such 
medication may affect absolute quantification methods, but are unlikely to cause 
changes in visual appearance of the tracer distribution.  In this institution no 
restrictions are placed on these medications.  This choice was made out of 
simplicity for the patients.  In a prospective study this choice may be made 
differently, but for this retrospective analysis the data collection has had to 
follow the clinical routine.  In fact, the purpose of this work is to investigate the 
use of classification methods that can be used in clinical practice and as such 
making restrictions on these drugs may bias the results.   
On the day of the scan the patients is allowed to eat and drink normally.  They 
are requested to stay well hydrated throughout the day and to void their bladder 
as often as necessary – this too reduces the patient’s dose.   
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The patient is injected intravenously with 185MBq 123I-FP-β-CIT.  A delay of 
between 3 and 5 hours is then needed for the tracer to be taken up by the 
dopaminergic system in the brain and reach a dynamic equilibrium with the non-
specific binding.  Immediately prior to the scan the patient is asked to void their 
bladder.  They are then positioned supine on the scanning couch with their head 
positioned in a headrest that extends out of the patient couch.  See figure 1.7, 1.8.  
The patients head is held still using chin and forehead straps.   
The SPECT acquisition is performed using the parameters defined in chapter 2 
using Forte gamma cameras (Forte, ADAC Laboratories, California, USA) and 
LEHR and VXGP collimators.  The acquired data is then reconstructed using the 
processing steps selected for visual reporting.   
All images are then realigned manually to compensate for patient positioning.  
The realigned studies are then reported by experienced clinicians using 
dedicated nuclear medicine reporting software.   
Following approval from the Clinical Governance Department of Charing Cross 
Hospital an anonymised patient database was created for auditing the value of 
123I-FP- -CIT SPECT imaging for the management of movement disorder 
patients.  The database includes salient clinical details and the (clinical) reported 
results of 123I-FP- -CIT SPECT imaging.  Where possible, a definitive diagnosis 
was given for each patient by a consultant neurologist who was responsible for 
his or her care.  This diagnosis was given at a later date using clinical history, 
scan results and long term follow up of the patients.  No specific minimum follow 
up time was used for this definitive diagnosis.   
The audit database included only anonymised data, and all image data was 
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anonymised before being copied into the study database.  The audit database 
only contained data from a single referrer and his registrars.  They referred 
patients from their movement disorders clinic and hence the vast majority of the 
patients in this database have movement based disorders, as opposed to 
dementia type disorders.   
Image data from patients within this database were reconstructed with the range 
of test reconstructions defined in chapter 3 to allow development and testing of 
automatic classification systems.   
Over the course of this work, the details of 299 patients were included onto this 
database.  Two entries were duplicates and were removed from the database.  
Six patients were lost from follow up, did not have a scan or requested to be 
removed from the database, leaving 291 records.   
Patients for whom a definitive diagnosis could not be given were excluded from 
this study. These included patients for whom the clinical symptoms, disease 
progression and scan results were inconclusive at the time of this study.  This 
resulted in 74 patients being excluded from this study.   
Patients whose diagnosis involved both small vessel cerebrovascular disease 
(SVCD) and a non-PS disease were excluded from this study.  SVCD can produce 
localised reduction in DAT that may interfere with the normal presentation of 
these scans.  Patients with a mixture of SVCD and a Parkinsonian syndrome were 
kept within the database.   
Following these exclusions, 194 patients remained in the database including 135 
with a definitive diagnosis of a Parkinsonian Syndrome (PS), and 59 with a non-
Parkinson’s syndrome (Non-PS).  Of the 194, a group of 116 patients were 
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scanned before changes in the acquisition techniques (as described in chapter 2) 
were implemented.  The demographics of these patients are shown in Table 4-1.  
A further 78 were included while the newer acquisition protocols were being 
used.  The demographics for this second group are shown in Table 4-2.  A 
number of patients reported their “handedness” as mixed, or variable.  These 
were included as “other” in the table of demographics.  Statistical analysis of 
these demographics was performed using SPSS software (SPSS statistics, v19.0, 
IBM, USA) using a significance value of P=0.05.   
Table 4-1 Demographics of patients scanned using original parameters 
Diagnosis 
Number 
of 
patients 
Sex 
(M/F) 
Age (years)  
Mean (range) 
Handedness 
(R, L 
mix/other) 
Length of 
follow up 
mean 
(range) 
PS 79 52 /31 
60.2 
(29-85) 
51/28/7 
32.28  
(0-108) 
Non-PS 37 22 / 24 
64.7 
(38-81) 
31/3/3 
24.28 
(0-60) 
 
Table 4-2 Demographics of patients scanned using optimised parameters 
Diagnosis 
Number 
of 
patients 
Sex 
(M/F) 
Age (years)  
Mean (range) 
Handedness 
(R, L 
mix/other) 
Length of 
follow up 
mean 
(range) 
PS 56 43 / 21 
62.89 
(33-84) 
61/2/1 
 
6.63 /13 
(0-60) 
Non-PS 22 15 / 15 
62.73 
(34-83) 
29/1/0 
 
5.1 / 9.3 
(0-36) 
 
These divisions were not significantly different for the two groups.  Ages 
compared using Mann-Whitney U test. Sex and handedness compared using χ2 
test.   
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Table 4-3 Breakdown of the diagnosis subtypes for the two datasets 
 
Diagnosis* 
Using 
Original 
acquisition 
parameters 
Using 
optimised 
acquisition 
parameters 
Total 
Parkinsonian 
syndromes 
Parkinson’s 
Disease 
49 39 88 
PD & CVPS / 
SVCD 
7 3 10 
DLB 4 1 5 
PD and ET 10 4 14 
MSA 2 1 3 
PD & ET & 
SVCD 
1 1 2 
PSP 3 5 8 
PD & MS 1 0 1 
Stroke & 
secondary PD 
1 0 1 
Young onset 
PD 
1 2 3 
     
Non-
Parkinsonian 
syndromes 
ET 20 11 31 
Dystonia 9 4 13 
Drug Induced 4 3 7 
OT 2 2 4 
Psychogenic/ 
stress/ 
Malingering 
 
0 
 
2 
 
2 
FXTAS 1 0 1 
MS 1 0 1 
*For definitions of abbreviations and disease groups please see chapter 1.  
The patient data described in Table 4-1 (using the original acquisition techniques) 
was used in work comparing different automatic classification systems 1.  The 
breakdown for the various subtypes of disease is shown in Table 4-3.  The two 
groups of data were used to test various classification techniques in chapters 5 
and 6.   
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5  
5.1 Feature Extraction and machine learning 
There are a range of matrix transforms that can be used to summarize large data 
sets.  The transforms are simply ways of describing the same data using different 
measures.  One example of a simple transformation is the Fourier Transform 
(FT).  This describes an image as a collection of sine waves, with frequencies and 
amplitudes.  When in this form the data is said to be in frequency space, or ‘k’ 
space.  Examining the data in the frequency domain shows how much of the 
information in the image is coming from different frequency data.  This can be 
useful in image filtering.  FTs and inverse FTs allow the transfer of information 
between real space and frequency space and assuming a sufficient range of sine 
wave frequencies is used, the process is reversible with no loss of data.   
Other transforms can be applied that extract different sorts of information from 
the images.  The transforms take the general form of a series of components and 
weights, analogous to the sine waves and amplitudes in FT.  The different 
transforms optimise different properties of these components.   
When applied to image analysis, the input matrix will typically be multiple 
images from a time series, from repeat scans or from groups of patients.   
Some of the transformations that have been applied to medical imaging tasks are 
described below.   
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5.1.1 Principal Component Analysis and Singular Value 
Decomposition 
Principal Component Analysis (PCA) allows data to be represented by a set of 
orthogonal eigenvectors and corresponding eigenvalues or weightings.  The 
eigenvectors are common for all subjects whilst the weightings are unique to 
each subject.  With reference to FT, the eigenvectors are equivalent to the sine 
waves, and the weights equivalent to the amplitudes.  The weighting factors 
show how much a particular component needs to be scaled by to give that 
subjects image.  PCA finds the uncorrelated components that describe the input 
data in the most economical way.  That is, the variance in the components is 
maximised.  There are a number of computational processes that can be used to 
perform PCA including Singular Value Deconvolution (SVD).   
The main applications for PCA in nuclear medicine imaging have been in 
characterising regional Cerebral Blood Flow (rCBF) studies and as a starting 
point to factor analysis.   
For rCBF studies, Houston 120 defined a brain template using a set of normal 
patient scans.  The range of component weights seen in template data was used 
to limit the allowed weights for subsequent test data.  They calculated the 
residual information: the information in a test patient that could not be 
described by the principal components using weightings up to three standard 
deviations.   
Instead of looking for separate clusters of points, some groups have looked at the 
correlation between the weighting for a particular component with a clinical 
grading.  This technique was applied to the 18F-FluoroDeoxyGlucose (FDG) PET 
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studies performed on patients with idiopathic PD and age-matched controls 121.  
They found two components that correlated to motor dysfunction scores and 
executive process (such as working memory and planning tasks scores).   
Of course, the neuropsychological results can also be included in such an 
analysis.  One example of this approach 122 combined the test results with ROI 
scores from SPECT data.  Their analysis identified specific correlations between 
different groups of test results.   
5.1.2 Factor Analysis 
Factor Analysis (FA) is a group of rotations/transformations that use PCA as a 
starting point.  They will typically employ prior knowledge of the data to 
constrain the components.  One example is the non-negativity constraint that has 
been employed in FA of dynamic nuclear medicine data.  The studies of dynamic 
data have generally involved analysing the components as these can relate to bio 
kinetics of the structures being imaged 123-126. 
Another variation of FA is Non-negative factorisation, which as the name implies, 
applies a transformation that results in purely additive components.  This was 
applied to rCBF data and when coupled with a support vector machine 
classification process, successfully classified groups of AD and non-AD patients 
127.  
5.1.3 Independent component analysis 
Independent component analysis (ICA) is different from PCA in that the 
components are chosen to be independent rather than merely uncorrelated.  ICA 
has been used predominantly in blind source separation problems.  The focus of 
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ICA work is in identifying the components themselves, often as a method for 
removal of extraneous data and noise.   
5.1.4 Logistic Discriminate Analysis 
Logistic discriminate analysis (LDA) performs a transformation that maximises 
the correlation between the classification groups and the components.  When 
applied to the classification of images into two groups, a discriminator is defined 
for each voxel.  The clustering of these discriminating voxels allows a 
simplification of the process using methods related to those in SPM.  This process 
has been applied to DAT imaging with 99mTc-TRODAT1 128.  
5.1.5 Projection to Latent Structures or Partial Least Squares 
The components are chosen to maximise the separation between training groups 
using brain perfusion images to differentiate between AD and frontotemporal 
dementia 129.   
5.2 Machine learning and classification methods 
The transforms described above take groups of patient data and map them into 
some form of feature space.  The exact dimensions of the feature space being 
related to the form of the transform.  The weightings for a set of patient images 
can be plotted as vectors in this p-dimensional ‘feature’ space.  Patients of similar 
disease state should display similar tracer distributions, and hence their 
weighting vectors should cluster in feature space.  A population of patient images 
with known disease state(s) can be used as a training set to define the feature 
space.   
152 
 
The image volume from a test patient can then be mapped into this feature space.  
A measure of the proximity of this vector to either the healthy group, or to two or 
more groups representing particular patient disease groups may provide a 
powerful tool for classification of the patient.  What is needed is a way of defining 
the boundaries in this feature space that relate to specific disease groups.   
There are a number of approaches that may be used to define clusters of points 
in one or more dimensions.  To describe these systems some example data was 
created using normally distributed random numbers, defined in two dimensions.   
 
Figure 5-1  Example data for normally distributed population of 100 subjects, with mean 
of 0 and standard deviation of 1 for both axes.  The circles represent 1, 2 and 3 standard 
deviations from the mean. 
For the basic single class classification task, the standard deviation of the 
training set can be used to define the probability that a patient is from that 
group.  This is shown in Figure 5-1 for data defined using two variables.  A test 
patient is shown as a green circle.  A score can be defined in terms of the number 
of standard deviations away from the group centre, which can then be translated 
into a probability.  In this example the test patient would be given a score of 2.3 
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standard deviations, meaning that a patient from the healthy group would have a 
2.1% chance of being at least this far from the cluster centre.  To use this figure 
for binary classification a cut off would need to be defined depending on the 
preferred trade-off between sensitivity and specificity.   
5.2.1 The group prototype method 
Moving on to two-class systems, the task is to define which group the test patient 
is more likely to belong to.  One conceptually simple technique defines a Group 
Prototype (GP) as the centre of each cluster by calculating the average vector for 
each classification group.  The distance from test patient to the Group Prototypes 
can then be calculated and the relative distances compared to give the diagnosis 
3.   
 
Figure 5-2.  Two example data sets are shown along with a test patient in green.  The 
group-prototype method is used here to classify the test patient in the normal (blue) 
group.  The decision line for the Group prototype method is shown and is defined as the 
being equidistant from the two group centres.  
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Figure 5-2 shows the same “healthy” data from Figure 5-1, but with the addition 
of a cluster of non-healthy patients, shown in red.  The “group prototypes” for 
healthy and non-healthy are shown at the centre of each cluster.  The vectors 
from the test patient to the two group prototypes are shown in green. Their 
relative lengths give the classification.  The decision line, is a straight line, and is 
shown in black.  In this example the test patient would be classed as normal.   
In some approaches to transforming data into feature space, the data is rounded 
and centred.  Centring moves the data so that the mean vector is positioned at 
the origin.  The rounding is a rescaling of the axes according to the variation seen 
in that axes.  This second effect could theoretically make a significant difference 
to the above classification.   
5.2.2 The Mahalanobis Distance 
The amount of variation contained within each component may be different for 
different groups of patients.  For example, if one component were to relate to 
disease severity of progression, it would be expected that the normal data set 
would bunch closely together, whilst the diseased state would spread out in a 
continuum from near the non-diseased state through to very advanced disease.  
These differences can be included by scaling the group prototype measurement 
by the variation of that specific group in that specific direction.  This is known as 
the Mahalanobis distance.   
This effect can be described using the same data as in the previous example and 
marking on the extent of the 1st 2nd and 3rd standard deviations for the two 
groups.  See Figure 5-3.   
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Figure 5-3. Two example data sets are shown with dissimilar amount of variation in the 
two components. The concentric ellipses represent the extent of the 1st, 2nd and 3rd 
standard deviations for the two groups. 
5.2.3 The Bayes Classifiers 
These Mahalanobis distances can be used as the probability measurement for a 
Bayesian classification approach.  This is calculated by modelling the 
distributions seen in the training set and combining it with prior knowledge.  
The probability that a test patient belongs to a particular group (Y), based on 
their component weightings (W) is given by    Equation 5-1. 
   Equation 5-1 
The test patient will be assigned to the group with the highest probability.  Since 
P(W) is constant, only the prior probability P(GroupY) and the function 
P(W¦GroupY) need to be defined.  Typically the prior will be neutral or will be 
equal to the ratios of classifications in the training data set.  All patients in each 
training group are used to define the probability functions.  The distributions are 
assumed to be normal distributions (Gaussian), with means and standard 
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deviations calculated for each group and component.  Such an approach was 
used in classifying images of Alzheimer’s Disease following PCA 130. 
With no prior probability, the decision line falls where the Mahalanobis distance 
is equal for the two classification groups.  However, adding a value for the prior 
probability can tune the performance of such a classifier to improve either 
sensitivity or specificity.  Figure 5-4 shows the decision lines (in black) using a 
prior equal to 1/3, ½ (i.e. equal probability) or 2/3.  Note that the example test 
patient will be classified differently when different prior probabilities are used.   
 
Figure 5-4. The decision lines when using different prior probabilities in a Bayesian 
Classifier 
5.2.4 Support Vector Machines 
Support Vector Machines (SVMs) are supervised learning techniques that have 
recently been proposed for classification problems 131.  The aim is to define a 
multi-dimensional plane that best separates the two training groups.  In Figure 
5-5 an example is given using two groups of data in two dimensions.  All three of 
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the dividing planes shown give perfect separation between the two groups, 
however, visually it can be seen that the middle line may be the best separator.   
 
Figure 5-5 Two groups being separated by three straight decision lines 
In SVM, the optimised plane is defined by a subset of the training data, the 
support vectors.  These vectors lie along the boundary between the two classes.  
The plane is defined to maximise the distance between the plane and the support 
vectors on either side.  In Figure 5-6 the central division line from Figure 5-5 is 
shown along with the “fat margins” and the distance B, which is maximised in the 
SVM process.  The plane can then be used to automatically classify other data 
points as they are mapped into the same feature space.  It should be noted that 
the classification does not give a degree of severity, or a probability of disease. 
The result of this classification is binary.   
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Figure 5-6 The optimum decision line as picked by SVM the parallel lines either side show 
the so-called 'fat margin' the width of which is maximised in the SVM process. 
Using a linear decision plane, the computational procedure is to maximise the 
thickness of the fat margins.  The identification of this maximum is found using 
standard programming solutions.  A powerful extension of this process is to map 
the data into further dimensions using non-linear mappings.  The decision plane 
will still be defined using the solutions to the same standard solutions, but the 
affect is to apply non-linear boundaries in the original coordinate system.  This is 
known in programming parlance as the ‘kernal trick’.   
5.3 Image processing and preparation 
It is proposed that an automatic classification tool can be created using a 
combination of PCA and machine learning tools.  Before being used in such a 
system, the reconstructed data in the form of transverse slices must be put 
through a number of processing steps.   
159 
 
5.3.1 Image registration / spatial normalisation 
For meaningful comparison of images from different patients, a method of 
identifying equivalent areas on multiple images must be found.  For the manual 
ROI/VOI methods this involves the user marking specific regions of the brains by 
placing ROIs/VOIs on known areas following visual interpretation.  For the 
automatic ROI/VOI options and the methods using direct pixel comparisons, the 
image volumes are spatially aligned to each other.  For further interpretation, it 
is useful if this alignment can be in a standardised space so that assessment can 
be related to known functional areas of the brain.   
Spatial normalisation, involves realigning an image so that the voxel information 
at a particular coordinates on one image refers to the same anatomical region on 
another image.   
There are three parts to any image registration process:   
 The image transformations  
 The measurements of how well the images are aligned   
 The re-sampling of the image data   
There are many options for these three parts and the ideal combinations will 
depend heavily on the images that are to be brought into registration.  The more 
prominent options are discussed below.  Since this work is based on three 
dimensional image volumes, the discussion will be focused on 3D-3D 
registrations.  However, similar methodologies can be applied to higher or lower 
dimensional data.  
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5.3.1.1 Image spatial transformations 
The simplest transformations involve rigid body movements. These 
transformations include moving (translations) in the three dimensions and three 
rotations, thus six degrees of freedom are available.  These transformations are 
often employed when the image data is from the same subject, which has been 
imaged in the same imaging plane and with known pixel sizes.   
Problems can arise when pixel size data is missing or incorrect.  In these 
circumstances three more degrees of freedom are required – to scale along each 
dimension.  Also if the data has been acquired with a gantry tilt, as can be the 
case in CT scans of the head, this tilt must be reflected in the transformation in 
the form of image skew.  Transformations that include translation, rotation, 
scaling and skews are called affine transformations and for 3D data will include 
12 degrees of freedom.   
These transformations should allow for alignment of data from an individual 
subject being repeatedly imaged.  However, some problems arise when either 
the shape of an organ or tissue changes, or multiple patients are included.   
Non-linear warping allows many more degrees of freedom.  In more complex 
warping fields the fields can be non-stationary, with data in different areas being 
moved by different amounts and in different directions. These types of fittings 
have been found to be very useful in MRI based studies, where not only are there 
inter-patient differences which require some warping to allow alignment, but 
also MRI data itself can contain some image warping effects.   
The reason for image registration is to allow the equivalent parts of two or more 
images to be positioned at the same coordinates.   If the warping fields are left 
unconstrained then the alignment may optimise to a position where the tissues 
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occupying the same location do not correspond to the same structures in the 
various patients.   
In the case of dopamine transporter imaging, the disease progression is often 
seen as a change in shape of the activity distribution.  It is possible for this 
change in shape to be masked if image warping is used, however most of the 
published work 56,57,83,132 using the SPM package has included some degree of 
warping in the spatial normalisation stage.  Others 133 have avoided this warping 
stage.   
5.3.1.2 Image alignment metrics 
The image landmark registration is performed by identifying reference points 
that occur on both images and then applying a transform that minimises these 
distances.  Such reference points are generally not available in DAT and D2 
imaging unless x-ray CT data has also been acquired, or fiducial markers are 
used.   
Count difference (CD) is simply the sum of the absolute differences between the 
source and target images 134.  This is most appropriate when the pixel values are 
of similar magnitude and spatial distribution.   
Mutual information (MI) has been proposed 135 as an alternative to count 
differences as it can be used in applications where pixel values are likely to be 
very different, e.g. in images of different modalities or pharmaceuticals.   
Kas and co-workers 136 investigated the use of different normal templates in SPM 
for 123I-FP- -CIT studies, and found that quantification was insensitive to the 
template used for the spatial normalisation.  They used the SPM implementation 
of the MI algorithm and found minimal errors.   
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Van Laere et al. 137 used data from a range of brain SPECT tracers to investigate 
different automated spatial normalisation techniques, including CD, MI and a 
system called Uniformity index (UI).  They concluded that the addition of CT data 
allowed the best realignment especially for receptor/transporter imaging.  A 
secondary conclusion was that CD was superior to MI.   
Of the commercial image analysis packages designed for DAT SPECT imaging, 
only the BRASS system from Hermes uses automatic image alignment.  Their 
package includes a number of methodologies, but the recommended model is an 
implementation of the normalised mutual information technique.   
5.3.1.3 Re-sampling methods 
Once the alignment metric has been optimised and the best transformation 
identified, the source image must then be transformed to the target location.  The 
transform is highly unlikely to represent movement of an integer number of 
pixels – and so the voxel values in the transformed image will be formed from an 
interpolation of a group of neighbouring pixels.  Since interpolation is being 
applied, there will normally be a small level of smoothing applied to the data.   
The most common form of re-sampling used is based on tri-linear interpolation.  
Tri-linear interpolation takes a weighted average of the eight voxels closest to 
the centre of the new voxel location.   
5.3.2 Count normalisation 
There are many factors that will affect the absolute levels of tracer uptake within 
the brain that are not related to the disease process being studied.  These include 
differences in injected activity, radioactive decay between injection and scan, the 
163 
 
distribution volume, the size of the organs, kidney function, and hydration levels 
amongst others.  Hence, the absolute uptake in the regions of the brain is of little 
direct clinical use.  A more useful index is the amount of tracer that binds to the 
organ as a fraction of the amount of tracer that reaches the organ.  A full 
investigation into amount of receptor sites would involve following the tracer 
uptake dynamically over a period of many hours.  As 123I-FP-β-CIT reaches a 
prolonged level of binding equilibrium 138, a simpler definition of the binding 
potential can be employed using a measure of non-specific binding.  The regional 
distribution of dopamine uptake was measured in a post-mortem uptake study 
by De Keyser et al. 139.  They showed that a range of areas in the cerebral cortex, 
including the occipital cortex, displayed no specific dopamine binding.  It is 
therefore appropriate to use either the occipital cortex or the whole cerebellum 
to normalise the pixel intensities within DAT images.   
A volume centred on the occipital cortex was identified and used as an estimate 
of non-specific binding in counts/voxel (Cocc).  The volume was defined on the 
template image using MRIcro and then converted into a binary mask.  This 
volume was then used to scale the counts in each voxel (Cvoi) to give the binding 
potential for that voxel, BPvoi. 
   Equation 5-2 
5.3.3 Image filtering 
ROI/VOI based classifications combine the information held in a large number of 
voxels into just two or four uptake ratios.  In this way the techniques are unlikely 
to be susceptible to pixel level noise as the uptake figure sums across a large 
number of voxels - effectively averaging the data.  The pixel-pixel methods such 
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as SPM and the PCA methods proposed here use the similarities or differences 
between voxels in the scans of multiple patients.  Hence, localised noise will 
increase the patient-to-patient differences and possibly mask any true 
differences between disease states.  As such these measures are likely to be very 
susceptible to pixel noise.  Some inter-patient differences will occur due to 
differences between patients that are unrelated to the disease.  Therefore, some 
level of image smoothing will improve these techniques.  However, the level of 
smoothing applied will have to be optimised for a specific imaging task.  As the 
level of smoothing is altered the classification tool will become less sensitive, but 
more specific to real group-group differences.  The exact level of smoothing will 
be a trade-off that allows removal of the influence of trivial patient-patient 
differences, whilst retaining the salient disease features.  The exact level of 
smoothing will be a function of the inherent patient-patient differences, the 
resolution of the images being used, the size of the real differences between the 
disease states and the number of patients used within the study.   
There is a balance to be achieved for optimum smoothing of datasets prior to 
analysis with SPM.  The filter should smooth/combine data from individual 
structures, allowing for inter-patient and intra-regional variability, but should 
not be so broad as to significantly reduce contrast in real defects/activations.   
These factors are necessarily going to be dependent on the resolution of imaging 
system, the noise levels in the reconstructed images, and the size of the defects 
seen in the study.   
Van-Laere et al. 140 investigated the effect of filtering when using SPM in SPECT 
imaging.  Their phantom based study used a 99mTc based phantom with a range 
of activation foci.  The phantom consisted of a series of 4mm thick plastic sheets, 
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interspaced with paper sheet printed with activity distributions.  They showed 
the trade-off between the numbers of subjects (or study pairs) needed in the 
study design, with the size of the activation effect.  They also investigated the 
ideal levels of smoothing required using Gaussian filters.  In general they found 
that the group comparison gave highest significance when the filter was around 
2*FWHM of the system, but were relatively insensitive over the range 1.5-
2.5FWHM.  They found that the ideal level of smoothing is dependent on the size 
of the activation as well as the position/surroundings of the defect resolution of 
the imaging system.   
In other works using SPM and SPECT imaging a range of filter sizes have been 
implemented.  In perfusion imaging a Gaussian filter with a FWHM of 10mm 83 
has been quoted.  In DAT imaging, researchers from Innsbruck 56 used a 6mm 
Gaussian filter for their work with 123I- -CIT.  For 123I-FP- -CIT imaging both 
8mm 132 and 10mm 133 filters have been used.   
Transferring these ideas of noise levels to PCA based techniques, it should be 
remembered that the PCA transform finds the components that encapsulate the 
largest fraction of the variance in the training data set.  If pixel noise is a large 
component of this variance then the transform will produce components that 
describe the noise, rather than the differences between subject groups.  It is 
apparent then that the level of smoothing within the image data is likely to affect 
the usefulness of PCA as an image classification tool.   
5.3.4 Applying PCA to Groups of SPECT volumes 
The range of feature extraction processes described above (in section 5.1) either 
start with PCA or, another transform which works in an equivalent manner.  As 
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such, the initial stages of a machine-learning model will start with similar data 
processing.  To apply PCA to groups of SPECT images, the volumes of patient data 
would first need to be spatially aligned, and count normalised.   
SPECT image data describe activity distributions in a three dimensional matrix 
ax,y,z.  This can be reshaped into a one-dimensional vector: 
    Equation 5-3 
Where m equals the total number of voxels in the SPECT volume i.e. the volume 
dimensions x*y*z.  Data from a group of n patients can then be combined to form 
a 2 dimensional matrix, A; 
    Equation 5-4 
Where Ai,j is the ith voxel of the jth patient.  Using Singular Value Decomposition 
(SVD), A can be transformed to produce three matrixes U, S and V,  
    Equation 5-5 
U is the left-eigenvectors, defined as the eigenvectors of AAT matrix, S is a 
diagonal matrix, whose main diagonal is populated with the singular values of A 
in decreasing order, VT is the transpose of V and is the right-eigenvectors, 
defined as the eigenvectors of ATA.   
Since the original data was built up from reconstructed volumes, the left 
eigenvectors, U, are referred to as EigenVolumes.  The full transform would 
produce m EigenVolumes of m voxels.  As m>>n, a restricted transform is 
performed to give just n EigenVolumes each containing m data points.  The 
product SVT is the component weights, sometimes referred to as loadings, or 
component weightings W.   
   Equation 5-6 
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It is the contribution of each of the EigenVolumes needed to recreate each 
patient’s image volume.  For the full transformation, SVT is an n*m matrix. Each 
row relates to an individual patient in the original dataset.   
A characteristic of this transform is that the EigenVolumes are ordered in terms 
of their contribution to the variance in the original data.  Most of the original 
image data is contained in the first few EigenVolumes.  The first EigenVolume is 
defined so that combined with its weighting gives the best approximation of the 
original matrix.  The second EigenVolume is the optimal choice to represent the 
data not covered by the first EigenVolume.  In this way, the EigenVolumes are 
defined in order, to give the original matrix in a mathematically economical way.  
We expect only the first few EigenVolumes to have significant weightings.  The 
entire cohort of patients can be defined in terms of p-EigenVolumes (p<<n) 
common to all patients, along with defining weightings individual to each 
patient.   
The SPECT data for an individual patient j, as given by summing the weighted 
components. 
    Equation 5-7 
In Principal Component Analysis (PCA) the significant EigenVolumes are called 
the principal components.  They are the main features seen in the columns of the 
input matrix A.  Although defined here from SVD, principal components were 
originally defined using the covariance matrix of A 141,142.   
By applying this transform to the input matrix A, patterns that are common 
across the columns of A are defined, along with the spread of weightings seen 
across the columns of SVT.  
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It is common to subtract the mean patient image (sometimes referred to as 
Component 0 or PC0) from each patient image prior to performing the SVD.  PC0 
must also be subtracted from test patients prior to analysis.   
5.4 Classification models 
5.4.1 Single, dual and multi-class classification tasks and 
decision trees 
Classification tasks can be defined based on the number of groups that are 
identified.  In a simple one-class problem, a definition of a group/state is given, 
and the task is to state if a test subject belongs to that class or not.  When applied 
to the ioflupane imaging used here, a single-class task would define the 
health/normal state and its ranges, and then calculate if a test image falls within 
these ranges and is therefore normal, or not normal.   
A dual-class model is created by using definitions and ranges of both the 
diseased and non-diseased states.  Further groups or subgroups can be added if 
they can be suitably differentiated.  When three groups are defined, the 
classification tasks become a three-class problem, or it can be split into multiple 
two-class problems.  This hierarchy system is particularly useful where 
subgroups are defined.  In the classification of ioflupane images, this could mean 
first characterising the data as normal or non-normal, and then characterising 
the non-normal data into more specific disease types.  A two-stage approach was 
used by Hamilton et al. 143 to differentiate between different stages of 
Parkinson’s disease and non-Parkinson’s patients using ioflupane imaging.   
169 
 
In most of the published work using ioflupane, the classification normally takes 
the form of a single layer, a one-class problem.  A normal range is defined for 
uptake measurement (e.g. VOI uptake as striatum to background ratio or 
putamen to background ratio) and patients whose image data falls outside these 
limits are given the diagnosis of Parkinsonian syndrome.   
There is some evidence to suggest that DAT imaging can be used to distinguish 
between MSA-P and PD types 56.  A similar problem was also described 57 as a 
three-class problem, defined as two two-class problems; the first stage 
discriminating between normal and abnormal, and the second stage 
discriminating between PD and MSA-P.   
The distinction between IPD and atypical Parkinson’s (including MSA, PSP and 
CBD) was shown using visual reporting 144.  In the case of D2 receptor imaging, 
the differences in disease progression between Parkinsons and Parkinsons plus 
have been shown to allow their differentiation.  Kim et al. employed a multi-class 
system with good results 145.  A natural development of these results would be 
combining both pre- and post- synaptic imaging in the diagnostic pathway.  This 
has been investigated 146,147 but these techniques have not crossed into clinical 
routine use.   
5.4.2 The problem of unilateral disease 
For many patients, the onset and progression of PD will be unilateral, with 
symptoms and imaging studies showing clear one sided patterns.  This can make 
visual reporting easier as images that are clearly non-symmetrical are a good 
indicator of disease.  When applied to ROI based approaches, the uptake in either 
hemisphere can give an abnormal classification even if the contra-lateral 
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hemisphere shows no signs of dopaminergic loss.  This unilaterality has been 
allowed for in VOI/ROI based systems by classifying both side individually, and 
then assigning as normal (or non -PS) if both sides are normal, and abnormal (or 
PS) if one or more sides is abnormal.  This is the approach taken in published 
ROI/VOI based work 78,148.   
In SPM based approaches the whole brain is used in a single-class classification 
system.  The variation from a normal template is calculated as a function of the 
normal variance on a voxel-by-voxel basis.  Voxels that are significantly different 
to the normal template are identified and if they form a cluster larger than a pre-
determined size, then a positive diagnosis is given.  In such a method, unilateral 
disease would identify a pathological state when a particular region showed 
disease.  Normal uptake on the contra-lateral side would not affect the diagnosis.   
If a PCA approach is used, and unilateral disease has not been allowed for, the 
best fit will involve an amount of averaging of the two hemispheres.  The normal 
training set would be symmetrical, and if an abnormal training set were defined, 
this would be a combination of one-sided and dual-sided disease and hence 
would also be symmetrical.   
In previous work 1 unilateral disease was accommodated for by realigning the 
brains based on gross striatal uptake.  Image volumes were mirrored along the 
central line so that the hemispheres with the maximum striatal uptake were 
aligned.  This approach replaces the assumption that dopaminergic loss is 
symmetrical, with assumptions about the level of non-symmetry.   
Another approach would be to treat each half brain as a separate example of 
either disease or non-disease.  Both halves of the non-PS patients would give 
examples of non-PS hemispheres.  The PS data would have to be split since it 
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would only be known that at least one half of each PS brain is showing signs of 
disease.  One approach would be to include just the side with more advanced 
disease.  A second approach would be to have some classification that would 
allow one or both sides to be included providing they both show disease.  To 
identify the more diseased hemisphere of the PS patients, a single class 
classification technique will have to be performed.   
Other analysis techniques use the either a basic decision tree, (e.g. in the case of 
ROI based data, the patient is classified as abnormal if either side is below a 
particular threshold) or the classification relies on an abnormal volume of 
interest being identified (as in the SPM analysis).   
The whole brain analysis discussed so far has taken the whole brain as the input 
data, and the analysis identifies disease state by looking at the weighting factors 
for whole brain components.  As such a diseased brain with a one sided 
degeneration will be given weightings that would best approximate to the 
activity distribution i.e. it will identify an average weighting between the 
diseased and non-diseased halves.   
So, how can this be incorporated into the PCA / cluster analysis? As the 
averaging comes from the application of PCA/fitting to the weights, the data 
from the two sides of the brain has to be split before this stage.  The two 
approaches are:  
1. Split the training data, do a left-right mirror of one side and then input all 
the brain halves into the analysis,  
2. Split the data and then apply PCA to both data sets independently. Test 
patients could then be split and fitted separately to the two sets of 
component weights.   
172 
 
The first approach has the advantage of using all the available data to define the 
D-Space / feature space.  This should work well for the non-PS group of data as it 
increases the number of data sets.  However, if both sides of the PS patients are 
used to define the PS cluster, this could be contaminated with non-diseased brain 
halves.  The second approach allows the separate classification for the two 
halves of a test patient, but the training sets for the PS data will both contain a 
mix of diseased levels, and hence may restrict the sensitivity of the test.   
5.4.3 The training dataset and feature space: 
The SVD transform aims to describe the variance contained in a dataset.  If the 
training set is formed of data from a single disease group, the variance will relate 
to normal variability in that group.  If the training group contains a mixture of 
two groups of images, then the variance identified will be a combination of the 
inter- and intra-group variance.  Assuming the intra-group variance is the same 
for the two groups, the inter-group variance will be maximised if the training set 
is a 50-50 mixture of the two groups.  In such a situation the variation in the 
weightings between the two groups will be maximised.   
The clearest distinction between the two groups would be given if the two 
groups were extreme cases.  That is, a group of perfectly normal data and 
another containing only advanced stage disease.  However, such a split may not 
provide the best classification system when patients of mild disease are 
presented.  The best solution may in fact be to define the feature space using 
closely grouped extreme data, but to use data from a full spread of disease states 
to training the machine learning classification tool.   
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Such adjustments or biasing of the PCA results would represent a form of factor 
analysis.  Taking this idea further, if the classification groups are known during 
the transformation stage, the components can be adjusted to maximise the 
differences between the two groups.  This is formally done using the PLS 
approach.   
5.5 Confounding features 
A number of features have been shown to affect the uptake of ioflupane.  In 
particular, DAT uptake in healthy volunteers has been shown to reduce with age 
149.  Their large cohort study showed a linear 6.6% per decade decrease in 
striatal DAT availability.  The reduction was similar in both caudate and 
putamen.  The same study described small hemispheric asymmetries, but it was 
shown that these were not related to left- or right-handedness.   
These losses can be compared with the losses shown in Parkinson’s Disease at 
around 8% 37, 5% 56 or 6-7% 112 per year.  These rates show greater variability in 
the literature, which may be explained by the underlying disease progression 
being non-linear.   
A smaller dependence has been shown on gender in healthy patients 150. 
However, this small dependence was not confirmed in a separate study 
investigating the uptake variations due to hormonal changes during menstrual 
cycle, for which no dependency was found 151.   
These changes suggest that inclusion of the subjects’ age, and possibly gender, 
may improve disease classification.   
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5.6 Developing and Testing the PCA based classification 
technique 
In this work, we use SPECT images of patients with known disease state to define 
a feature space using SVD; we then define a number of automatic classification 
techniques. The classification models used include Group Prototype, Support 
Vector Machines and Naïve Bayes.  Other patients of known disease state are 
then mapped to this D-space and their diagnosis determined automatically given 
the classifier.  To allow comparisons with other published data, four 
commercially available classification models are tested using the same patient 
database (see chapter 6).   
A SVD based processing tool was written using the MATLAB toolkit.  After 
prototyping, bug fixing and optimising the code, the system was tested under a 
number of configurations using the clinical data described in chapter 4.   
The two datasets described in chapter 4 were used to train and test variations on 
the SVD and machine learning classification system. The first sets of 
measurements were performed using images acquired using the original clinical 
data format (dataset A).  These results have been previously published 1.  The 
descriptions below include results and some text from that publication with 
permission from the publisher.   
The second set of measurements investigates the use of SVD for the clinical data 
acquired using the optimised clinical settings as defined in chapters 2 and 3 
(clinical dataset B).   
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5.6.1 Testing the SVD/PCA based system using clinical dataset A 
- method 
For this work an image volume created from 18F-FDOPA PET data and aligned to 
the standard Talairach space was used as a template.  All the 123I-FP- -CIT SPECT 
data was spatially normalised to this template using a routine contained in the 
SPM software package (SPM 8, Welcome Trust Centre for Neurology, London, 
UK).  This automatic registration works in two stages; the first is a linear affine 
transformation and is followed by non-linear warping using basis functions.  
After automatic spatial normalisation, the images were checked visually to 
ensure correct alignment.  The following image processing and statistical 
analysis were performed using the MATLAB software package (Mathworks, 
Massachusetts, USA) using a combination of existing and in-house written 
functions.   
A volume centred on the occipital cortex was identified and used as an estimate 
of nonspecific binding in counts/ voxel (Cns).  The volume was defined on the 
template image using MRIcro 106 and was then converted into a binary mask.  
This volume was then used to scale the counts in each voxel (Ci) to give the 
binding potential for that voxel, BPi (Equation 5-8).  
 
Equation 5-8 
Using this system the data from every patient in the training set was rescaled to 
binding potential in each voxel.   
A second mask was defined on the template image marking the external 
boundary of the brain and brain stem.  This second mask, also defined using 
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MRIcro, allowed the counts in the voxels outside the brain and the brain stem to 
be set to zero in the training and test patients.  In this way, variations in the skin 
uptake and counts outside the body are removed to prevent them influencing the 
processing.   
The problem of unilateral disease was assessed in this dataset by mirroring some 
of the patient data so that the highest uptake from each patient is on the same 
side.  This was performed by using two more VOI masks drawn by eye on an MRI 
template.  These masks define the size of the left and right striatum.  The masks 
were used to identify the hemisphere containing the higher uptake (using total 
counts in that VOI).  Image volumes were then mirrored left to right where 
needed to ensure the higher uptake was seen in the right-hand side.  In total, 116 
patient images were used in this analysis.  See chapter 4 for a full description.   
The 116 patient image volumes were used in a leave-one-out cross validation 
procedure.  Each training run uses 115 patient image volumes to define the 
feature space using SVD.  Prior to the SVD transformation being applied, the 
average image volume (PC0) across all 115 patients is calculated and then 
subtracted from each image volume.  A number of automatic classifiers were 
then trained using the known disease classifications of these 115 patients.  The 
average image volume (PC0) is then subtracted from the test patient image 
volume.  This volume is then mapped into the feature space and the classification 
tools used to give a diagnosis.  The process was repeated a further 115 times 
leaving out each patient in turn.   
The number of components used in the classification step was varied between 1 
and 5.  The automatic classification tool measured included a group-prototype 
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model (SVD-GP), and two naive Bayes models (with and without the training 
group ratios as a prior, SVD-NB and SVD-NBP).   
5.6.2 SVD/PCA based system using clinical dataset A-results 
The leave-one out cross validation uses 116 separate training and testing runs to 
give the final results in terms of specificity and sensitivity.   The intermediate 
steps created during this process are described for one of these runs (using 115 
image volumes, and one test volume).    
The feature space is defined using between one and five components – these 
components are in the form of image volumes that can be combined (using 
specific weighting factors) to reproduce (to a certain level of accuracy) any of the 
patient data.  The first four of these image volumes are shown in Figure 5-7.  The 
images show six central slices from these volumes.   
 
Figure 5-7 Six example slices from the first four components 
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The weighting factors for each of the 115 training volumes for these first five 
components are described as vectors in a five dimensional feature space.  These 
vectors are plotted in Figure 5-8.  For simplicity only the first three components 
have been shown.  The 116th patient, the test patient, is also shown mapped into 
this feature space.   
 
Figure 5-8 The component weights for 115 patients for the first three components.  A test 
patient projected into this feature space is also shown.  PS is Parkinsonian syndrome and 
NPS is non-Parkinsonian 
The main result of the classification systems is a binary diagnosis.  This was 
compared with the known diagnosis to give sensitivity, specificity and overall 
accuracy results.   
The accuracy of each system in terms of the Area Under the Curve (AUC) as a 
function of the number of components is shown in Figure 5-9.  The maximum 
accuracy is reached once the first three components have been included in the 
classification.  The Naive Bayes and Group prototype classifications also give the 
relative probabilities for the two test groups, and absolute distance to GP centres 
respectively.  These two variables were used as the input to an ROC analysis 
(Figure 5-10).   
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To visualise the two groups, the average PS and non-PS component weights for 
the first three components were used to scale the component volumes.  The 
average training volume PC0 was then added to each of these image volumes.  
The two image volumes represent the group prototype images for the two 
disease states.  Six central transverse slices of these image volumes are shown in 
Figure 5-11.   
 
Figure 5-9 The Area Under Curve from ROC analysis SVD based classification 
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Figure 5-10 ROC analysis for Naive Bayes and Group prototype classifiers, using 3 
components 
 
Figure 5-11 Six Transverse slices through averaged image volumes of non-PS patients (top 
row) and PS patients (bottom row) 
5.6.3 SVD/PCA based system using clinical dataset A-discussion 
The choice of feature extraction and classification model is not unique and can be 
optimized for the clinical situation involved.  Alternative feature extraction 
systems have been proposed in other imaging investigations; these range in size 
and specificity from the raw voxel counts up to just a few VOI values. In this 
clinical situation, disease progression will generally follow a familiar pattern 
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(starting with the putamen and progressing to the caudate).  Therefore, a feature 
extraction technique was chosen that would identify patterns in uptake across 
different groups of patients.   
Although this technique identifies the most mathematically economical 
components, the first four components show obvious similarities with 
anatomical features (see Figure 5-7).  The components relate to the differences 
between patients and the mean patient image.  The first component shows 
general uptake in the caudate and putamen.  The second component shows some 
asymmetrical changes from the mean image.  This asymmetry can only be seen 
because some of the patient images were flipped left to right.  The third and 
fourth components show changes in the putamen uptake.  However, care should 
be taken when examining the components, as they are defined by the variations 
in the training set rather than by specific classification tasks.   
These results show that a SVD based classification technique can be used as an 
automatic classification tool with a high level of accuracy when compared to the 
gold standard diagnosis.  The performance was shown to be a function of both 
the number of components used and of the type of classification model used.   
5.7 Developing and optimising the SVD/PCA based system 
using clinical dataset B - methods 
Following the changes made to the clinical acquisition protocol (see chapter 2) 
and recommended reconstructions changes (chapter 3) a second clinical data set 
was produced (dataset B).  The full breakdown of this is described in chapter 4.   
This dataset was used to study the characteristics of the SVD based classification 
tool.  As with the reconstruction optimisation work in chapter 3, the 
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characteristics of the classification model rely on a number of variables that must 
all be taken into consideration.  These include: 
 Features of the image quality 
o Including image filtering 
 Pre-processing steps on the image data 
o Spatial registration 
o Count normalisation 
o Masking for extra-cerebellum count data 
o Non-symmetrical uptake effects – left/right alignment of 
maximum hemispheres/ used of half brains 
 Data extraction steps: 
o The number of components used from the transformation 
 Classification options 
o Classification model 
o Trade-off between sensitivity and specificity 
5.7.1 Pre-processing step: spatial registration- methods 
The data for the SVD analysis techniques were exported in DICOM format, and 
then converted to nifti format using imageJ 107.  The SPM spatial normalisation 
procedures were then used to fit the data to a template.  The SPM spatial 
alignment method uses a version of the “count difference” method for alignment 
scoring.  It is therefore important to use a template image of similar intensity and 
distribution.  Spatial alignment was then performed using a 123I-FP- -CIT based 
template.  This template originated in the IBZMtool kit 152.  This template was 
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used to create a new template based on the local data using non-Parkinsonian 
subjects.  The new local template could then be used for further work.   
The SPM on-line help files suggest using some smoothing for both the template 
(target) and source images, and that the smoothing levels should be similar.  By 
visual assessment the central range of filters (1.0-1.4 cycles/cm) showed similar 
smoothness to the template image.  Since no other modality image data was 
available for these images, the only ways to assess the alignment is to use the 
spatial normalisation metrics, or by visual assessment.  Through trial and error it 
was observed that most of the filtering levels within this central region gave 
visually acceptable results.   
The non-Parkinson’s patient images were first spatially aligned to the 123I-FP- -
CIT template.  This was performed using the data with a post reconstruction 
filter of 1.0 cycles/cm.  Combinations of affine and non-linear warping steps 
were included in this transformation.  The resultant transformation data was 
then applied to the other noise realisation for each patient, including the data to 
which no post-reconstruction filter had been applied.  These non-filtered data 
were then summed together and the resulting template counts divided by 21 to 
give the average non-Parkinson’s patient.   
5.7.1.1 Pre-processing Step: Spatial Registration- Results 
Central slices of this template are shown in Figure 5-12.  Visual checks were then 
made using the MRI template to check the alignment of the local template to the 
standard MNI stereotactic space. Figure 5-13 shows a central transverse slice 
from a T1 weighted MRI template and the local DAT template.   
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Figure 5-12 The central slices of the locally derived 123I-FP-β-CIT template 
 
Figure 5-13 central slice from local template and T1 MR Image 
This new locally defined template was used for further spatial normalisations.  It 
was defined without any post-reconstruction filtering or filtering at the 
combining stage to simplify the use of any further smoothing that may be 
necessary.   
The entire dataset was then spatially normalised to this local template using just 
linear transformations.  No warping effects were included in this process.  There 
is some debate over the use of non-linear warping factors in this alignment 
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process.  In this work, the decision was made to not use warping as this was 
thought to mask changes in underlying shape of uptake.   
During this process both source and target images were smoothed using a 
Gaussian filter with 8mm FWHM.  This filter was applied only for the alignment 
process.  The resulting re-aligned images had their original levels of smoothing.  
For each subject the non-post-filtered data was used to define the re-alignment 
transformation.  This transformation was then applied to all other image files for 
that patient.   
5.7.1.2 Pre-processing Step: Spatial Registration- Discussion 
The use of a local template compiled with the radiopharmaceutical being 
investigated is generally recommended.  However, visual comparisons of the 
spatial normalisation to an 18F-F-DOPA template (as used in the study with 
clinical dataset-A) show that good alignment can be made with either template.  
A full analysis of the preferred template image was not considered.  The use of 
different templates for spatial normalisation was investigated by Kas et al. 136.  
They used four different 123I-FP- -CIT templates to spatially normalise a set of 
123I-FP- -CIT data from a single site.  They found no difference in analysis results 
when the template was changed to that of another centre.  They did not 
investigate the use of template constructed from other radiopharmaceuticals.  
Colloby et al. 133 followed a procedure similar to that described here except that 
the template used to register the 123I-FP- -CIT images was a T1 weighted MR 
volume.  They reported good registration even with this image from a completely 
different image modality.   
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5.7.2 Number of Components Preliminary Investigation - 
Methods 
In the previous section (5.6.2) it was shown that the accuracy of the SVD based 
system is a function of the number of components that are used.  Dataset-B 
contains 78 patients, so the full deconvolution using the whole brains as input 
volumes will produce 78 components.  Performing SVD on the full dataset of 78 
patients (after subtraction of the average volume PC0), produces the three 
matrixes U, S and VT.  S is a diagonal matrix containing the singular values of the 
input matrix in size order.  The values show the amount of variance in the 
original matrix that is described by each component.   
5.7.2.1 Number of Components Preliminary Investigation - Results 
The variance described by each component (as a fraction of the total variance) is 
plotted as a function of component number in Figure 5-14.  The three curves 
have been created for the full dataset of 78 patients volumes following spatial 
normalisation, using the whole image volume (i.e. using both hemispheres 
without any left-right mirroring).  The first curve uses just spatially aligned data. 
The second is created after the data has been rescaled to give binding potential.  
The third is from images where the data has been masked to remove extra-
cerebral activity.  The graph is truncated to show just the results from the first 
20 components.  All three curves follow a very smooth gradual decline in 
fractional variance all the way to 77 components.  The 77th component weighting 
is 0.0035, 0.0040 and 0.0035 for curves 1, 2 and 3 respectively.  The 78th 
component <1x10-9 for all three slopes.   
187 
 
 
Figure 5-14 fraction of total variance described in each component for three types of 
image pre-processing 
5.7.2.2 Number of Components Preliminary Investigation - 
Discussion 
When assessing the variance curves the common approach is to identify a 
‘shoulder’ in the data.  The first two curves appear to show an abrupt change at 2 
components, whereas the third shows a very gradual change with the shoulder 
appearing at between 5 and 10 components.   
The curves only show the fraction of the total variation that is reproduced by 
each component, they do not show if this variance useful for the diagnosis.  The 
first curve shows data that has not been count normalised; the variance in the 
components will therefore have to include this count scaling information, and 
since this is likely to be an image-wide scaling factor, the first component will be 
strongly influenced by this information.   
These curves suggest that for the skull-stripped normalised data at least 5 
components may be necessary.  The classification procedures were repeated 
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with between 1 and 10 components for most of the classification tests.  For one 
image quality (the non-filtered data) the number of components was extended to 
cover the first 20 components.   
5.7.3 Pre-processing steps: Count normalisation and extra-
cerebral data -methods 
There are many variables that can affect the number of counts within the images 
that are not related to the underlying disease status.  The data was assessed with 
and without scaling to binding potential (following Equation 5-8) using the same 
VOI for non-specific binding that was used in section 5.6.   
This rescaled data was assessed with and without the masking of the extra-
cerebral count data.  This was performed using the same volume mask as 5.6.   
5.7.4 Pre-processing steps: Count normalisation and extra-
cerebral data -results 
The classification accuracy for the naïve Bayes classifier using different levels of 
pre-processing is shown in Figure 5-15 as a function of the number of 
components.  This data uses the whole brain data that has not had any post-
reconstruction filtering.  The accuracy is quoted for the naïve Bayes classifier 
with no prior and uses data with no left-right flipping of hemispheres.   
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Figure 5-15 NB classifier accuracy for different levels of pre-processing 
This data shows that the pre-processing steps of count normalisation and skull 
masking can improve the accuracy of this classification system.  Similar results 
are seen for the SVM and GP classifiers.  The accuracy level is 95% and is 
constant with the number of components for this system (except when only the 
first component is used).  These results are broadly similar to the previous 
results (section 5.6).  All further calculations were performed using the count 
normalised and skull masked data.   
5.7.5 Image Quality Effects - Methods 
In chapter 3, the image quality produced by different reconstructions was 
described.  It was postulated that the level of smoothing used in the 
reconstruction would influence the accuracy of any classification model.   
The clinical data was reconstructed using the depth dependent resolution 
recovery model, using a blurring model width of x2-z1 with 12 iterations of 8 
subsets.  The resulting images were saved with varying levels of post-
reconstruction filtering.  All were Butterworth filters of order 10, with a range of 
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cut-off frequencies (0.5, 0.7, 0.9, 1.0, 1.2, 1.4, 1.6, 1.8, and 2.0 cycles/cm).  A non-
filtered image set was also saved giving a total of 10 different levels of image 
noise.  The data was pre-processed by spatial registration, count normalisation 
and skull masking.   
5.7.6 Image Quality Effects - Results 
The classification accuracy for the naïve Bayes classifier is shown in Figure 5-16 
as a function of image filtering.  The results for 1 to 10 components were 
included.  This data uses the whole brain data that has been count normalised 
and been skull masked, with no left-right flipping of hemispheres.   
 
Figure 5-16 Naive Bayes classifier accuracy as a function of image filtering levels 
The accuracy is seen to be highly variable for the data that has been smoothed 
the most.  Filters with frequencies lower than 1 cycle/cm give the poorest 
results.  The results calculated using just the first component are very poor for all 
levels of image smoothing.  Using data with no post reconstruction filtering will 
give good accuracy results for this classifier.   
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5.7.7 Image Quality Effects – Discussion 
The apparent non-dependence on image filtering is perhaps surprising when 
considered against the published work on SPM analysis.  However, the approach 
here does not reply on the GLM model to give a statistical basis to the analysis.  
Looking back to the reconstruction work in chapter 3, the data considered here 
have been produced using the OSEM method including resolution modelling.  
This was shown in chapter 3 to impart a certain level of image smoothing in the 
reconstruction process.  A further smoothing factor is the poor resolution of the 
SPECT imaging system itself.  The typical resolution ranges for these images will 
be in the region of 6-10mm FWHM.  Between them all these factors will provide a 
level of image smoothing before any post reconstruction filtering is applied.   
The following tests will all be performed using data that has not had a post 
reconstruction filter applied.   
5.7.8 Testing the Feature Classification Model - Methods 
Four types of classification models were tested for the various combinations of 
data types, pre-processing steps, and feature extraction results described above.   
 The group prototype method uses the distance from the test patient to 
the mean vectors for the two disease groups and as described in section 
5.2.1.  The classification given by the group with the smallest distance.   
 For the single class method using individual hemispheres the 
Mahalanobis distance was used.   
 A support vector machine was tested using a linear decision plane.  
 Two forms of the Naïve Bayes model were used, with and without the 
prior disease split to weight the classifications (see section 5.2.3).  The 
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classification was given by the group with the highest probability.  The 
data was further investigated by using the relative probabilities as the 
input to an ROC analysis – thus allowing a maximisation of the accuracy 
by adjusting the sensitivity and specificity.   
Due to the way these classification models use the feature space vectors to give 
the classification, their dependence on the number of components may be 
variable and so all must be recorded for a range of numbers of components.  The 
image data used in this section has had no post-reconstruction filtering.  No 
allowance for unilateral disease was made at this point.   
5.7.9 Testing the Feature Classification Model - Results 
The total accuracy for each of the classification methods is shown in Figure 5-17 
as a function of the number of components.  The three classification models all 
give good diagnostic accuracy for 2 or more components.  The NB classifier gives 
consistent accuracy of 96% for 2 to 11 components.  The group prototype results 
are not as good, mainly being at 91%.  The SVM classifier gives the best 
performance (97%) but it needs a high number of components to give this 
accuracy.  Of note there is a small improvement in both the SVM and GP 
classifiers when the 13th component is included.   
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Figure 5-17 Accuracy as a function of number of components 
 
5.7.10  Testing of the Feature Classification Model – 
Discussion 
The way in which these classifiers form decisions planes within the feature space 
is quite different.  The Group prototype uses the ‘distances’ in feature space for 
the test subject vector to the average positions in the two classification groups.  
Because of the way the feature space is calculated, the components which 
contribute more of the variance in the training set will be weighted more heavily 
than the lower order components.  Assuming the required data is held in the first 
few components, it would be expected that the accuracy of this classification 
system would peak at low component numbers and then not change much as 
further components are added.  This expected performance is due to the scaling 
factors in the feature space dimension related to S.  For the data discussed here, 
and taking the scree plots in section 5.7.2.1 into consideration, the first few 
components do contain a lot of the information, but the scree slope also shows 
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that most of the other components (above 5) have almost the same contribution 
to S and hence the group prototype can still make small changes in its accuracy 
as the higher order components are added.    
The group prototype takes the entire dataset into consideration as it creates the 
decision boundary.  However it does not take into consideration the spread of 
data within the training groups.   
The Naïve Bayes classifier takes the spread of each group into consideration.  
Like the GP system the NB calculation uses all of the data in the training data to 
define the decision boundary.  An increase in spread of the data for training 
group along a specific components will have the effect of reducing the 
importance of a variation along that component for a test patient.  The NB 
system therefore weights the importance of each component by the spread of 
scores for that components within the training groups.   
Because the GP and NB training system use the entire training sets they are less 
susceptible to problems arising from individual training subjects especially when 
the training group is large.  An incorrectly classified data point within these two 
datasets would be unlikely to have a significant effect on the classifiers 
performance.   
The SVM classifier is very different from the GP and NB systems as it uses a small 
subset of the data to form the decision plane.  The variation of component 
weightings within a training group has little impact on the decision boundary.  
Because the classifier uses just the subset of training points near the decision 
boundary this system is either sensitive or completely insensitive to 
misplacement data point depending on it proximity to the boundary.  A 
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mislabelled data point is likely to have an impact on the decision plane, as it will 
be selected as one of the support vectors.   
The emphasis placed on specific components by SVM depends on the usefulness 
for classification.  Taking the weightings for the support vectors alone in the two 
training groups, if there is no correlation between the component and the 
training group then the boundary will not be dependent on that specific 
component. i.e. the boundary will run normal to that component axis.  If such a 
correlation occurs by chance for a component then the resulting decision plane 
may perform badly.  It is these random correlations skewing the SVM decision 
plane that will lead to the phenomenon known as over fitting.  With any noisy 
training set such correlations will occur and hence the ideal number of 
components is likely to be considerably less than the full range of components 
available for training.  
5.7.11 Non-symmetrical uptake effects -methods 
The simplest approach uses the whole brains for each patient as an input 
function.  This was used for the baseline calculations.   
A second approach is to split each brain into two hemispheres.  The left hand 
hemispheres were mirrored left to right.  The training set was then composed of 
156 hemispheres.  Of these 44 represented Non-PS hemispheres and 112 PS 
hemispheres.  The classification models were then trained using 154 
hemispheres, with the other 2 belonging to the test patient.  Both of the test 
hemispheres were then classified and if both hemispheres were classed as 
normal than the test patient was classed as NPS.  If one or both hemispheres 
were classed as PS then the test patient was classed as PS.   
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A third approach used all the hemispheres to define the feature space.  The NPS 
hemispheres were then used to define a normal group.  This normal group would 
then include either 42 or 44 hemispheres depending on the classification of the 
test patient. Test hemispheres were then classified using the Mahalanobis 
distance from the NPS group.  The test hemisphere with the larger distance is 
assumed to be the least normal and was hence used for the classification.  This 
single class problem was used to test if the presence of unaffected hemispheres 
in the PS group would affect the results.   
A fourth approach was used which re-aligned the brains so that the striata with 
the highest uptake was one the same side.  This was performed using the same 
striatum VOI as used in section 5.6.   
5.7.12 Non-symmetrical uptake effects -results 
The results for the data classified using just the NPS half brains was in the form 
of Mahalanobis distances.  These were used as an input into a ROC analysis to 
give accuracy figures.  The other three systems used the Naive Bayes classifier.  
The input training data was from the Non filtered images and calculations were 
performed for between 1 and 20 components.  The accuracy of each system is 
shown in Figure 5-18 as a function of number of components.   Using this NB 
classifier the base line figures are better than the various non-symmetrical 
classification approaches. The other classifications tools were also assessed with 
the non-symmetrical training sets.  The accuracies for the NB, GP and SVM 
classifiers tested with Maxmimum-hemisphere alignment system are shown in 
Figure 5-19.  A broad maximum accuracy is seen for the SVM classifier.   
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Figure 5-18 Naive Bayes analysis using Non-Symmetrical Classification 
 
 
Figure 5-19 Maximum-Hemisphere aligned data classified using SVM, NB and GP systems 
 
5.8 Overview of the SVD and machine learning systems 
The best accuracy score is given by the measurements that have come from the 
SVM classifier.  The SVM classifier gives an accuracy score of 99% using the 
training data in which the hemispheres with the maximum uptake are aligned 
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and training with between 15 and 20 components.  This relates to just one 
patient being misdiagnosed.  The broad maximum suggests a real classification 
result as opposed to noise in the classifier that can come about through random 
changes.   
The ‘maximum aligned hemisphere’ method of allowing for unilateral disease is 
shown to work better than the various systems analysing half brains 
individually.  This is perhaps surprising as this system makes certain 
assumptions about the disease progressions.  The implied assumption is that for 
similar levels of asymmetry in the PS group, or that any differences in the levels 
of asymmetry can be accounted for within the components.   
The use of confounding features was not investigated here.  It was felt that the 
improvements that might be possible when including age dependencies would 
not have a great impact on what is already an almost perfect classifier.  The use 
of these confounding features is examined further in the next chapter.   
The preferred method that has been shown to give the best results consists of 
the following steps: 
 A training dataset is acquired containing both PS and NPS subjects 
 The scan data is reconstructed and minimal filtering applied 
 The data is spatially registered to a template 
 The full training set is count normalised using a background region as an 
estimate of non-specific binding 
 Counts originating from outside the brain are masked out using a 
template 
 The average counts distribution is subtracted from the dataset 
 Singular Values Decomposition is used to define a feature space in 17 
dimensions 
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 The vectors for the training data within the feature space as used to 
define an SVM classifier 
 Data from test patients are reconstructed using the same settings 
 They are then spatially normalised to the template 
 The counts are normalised using the non-specific binding 
 The extra-cerebral counts are masked out 
 The mean training image volume is subtracted 
 The test patient is mapped into the training feature space and the 
classification given 
 
Although there are many steps in this procedure, only the image reconstruction 
and spatial alignment need any user intervention.  All the other stages can be 
automated as they were in these investigations.  Once the data is reconstructed 
and aligned to a template the entire process is automated and can take a matter 
of seconds for the entire training and classification procedure.   
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A number of VOI based methods have been suggested for quantification in 
dopamine receptor and transporter imaging.  These methods can be split into 
two subgroups depending on whether the placement of the VOIs is manual or 
automatic.  Three of the techniques using manually based VOIs have been 
combined into a software package (QuantiSPECT, Mirada solutions) 153-155.  
These will be described before moving on to describe three automatic systems, 
BRASS (Hermes medical, Stockholm) 148, Basgan (University of Genoa) and 
IBZMtool (University of Hamburg) 152.   
   
Figure 6-1 The three VOIs definition used in the QuantiSPECT software 
6.1 Manually placed ROI/VOI techniques 
A number of techniques have been developed that involve the manual placement 
of ROIs and VOIs as a measure of striatal uptake.  Three of these techniques are 
combined in software called QuantiSPECT.  Figure 6-1 shows the ROI placements 
from left to right, the two-box, three-box and crescent methods.   
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6.1.1 The 2-box Method 
The 2-box method 153 (sometimes known as the Southampton method) was 
introduced as a general technique for overcoming the partial volume effect by 
using a VOI large enough to encompass any blurring.  When applied to 123I-FP- -
CIT imaging, 13 transverse slices (fixed thickness 44mm) are summed together 
and the rest of the calculation performed in 2D.  The striatal VOIs are of fixed size 
and are positioned manually.  Their size (61*48mm) was chosen to encompass 
all counts from the striatum, allowing for inter-patient variability and blurring of 
counts.  This should reduce the dependency on equipment and processing 
choices.  The background is defined automatically using a threshold and typically 
encompasses most of the cortex.  A threshold of 50% of non-specific binding 
maximum counts is used to define the boundary on heavily smoothed images.  
This boundary is then brought inwards by 20mm to remove any partial volume 
effects near the exterior of the brain.  The same slices are used for both the 
striatum and background regions.   
In retrospective studies it was found to give good correlation with clinical 
diagnosis 110,156.  The reported sensitivity and specificities varied between these 
studies.  With processing and analysis techniques the same, the differences were 
put down to the referral base.  Comparison with visual reporting has also been 
reported 78.   
Rather than the usual specific uptake ratio, they define a metric known as the 
Specific Uptake Size Index (SUSI).  This is the specific uptake (CS) divided by the 
concentration per unit volume in the background region (mean background 
region counts C NS divided by volume of background region VS) (Equation 6-1).   
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Equation 6-1 
 
SUSI has the units of volume.  It is the volume of non-specific binding that 
contains the same activity as that in the specific biding region.  SUSI can then 
further be converted to a specific binding index (SBI) by dividing by the volume 
of a standard striatum (Vss) (Equation 6-2).   
 
Equation 6-2 
 
The value for VSS is for a standard striatal volume as the true volume of the 
patients’ striatum is generally unknown.  The figure chosen for this is based on 
the volumes of the striatum in their anthropomorphic phantom.  It acts only as a 
scaling factor.  Their simulation studies used a range of imaging resolutions to 
model a known phantom distribution.  The resulting SUSI figures were shown to 
be independent of imaging resolution and VOI size for all but the smallest VOIs 
they applied.  This large VOI approach has the advantage of consistency of 
measurements across different resolution/noise levels.  However, the measure is 
only of gross DAT receptor numbers across the whole striatum and is unlikely to 
discern small changes in DAT distribution.   
6.1.2 The 3-box Method 
Like the 2box method, this method 154,157,158 uses a “slab” of summed transverse 
slices to allow the calculation to be run in 2D.  However, the thickness of this slab 
has to be chosen by the operator.  Fixed size and shape ROIs are then positioned 
over the basal ganglia.  The background region is of variable size and is 
positioned manually.  Like the 2-Box method, the ROI are large compared to the 
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striata, to minimise the affects of image blurring, inter-subject variability and 
image quality parameters.  The result metrics are the Total Binding Potential 
Index (TBPI) for each striatum, and an asymmetry index.  The TBPI is calculated 
from the total counts in the striatum (CS), the volume of the striatum VS and the 
average counts in the background region/ non-specific binding region ( C NS) 
Equation 6-3. 
 
Equation 6-3 
6.1.3 The Crescent Method 
This model 155 uses a fixed thickness slab of 12mm centred on the slice with the 
highest counts.  Unlike the two previous methods, this uses relatively small, and 
anatomically shaped ROIs placed over the striatum and occipital cortex.  The 
regions can be moved and rotated, but not resized.  A further difference from the 
2-and 3- box methods is the splitting of the striatum into caudate and putamen 
regions.   
6.2 Automatically Placed ROI/VOI Techniques 
6.2.1 BRASS 
The Brain Registration and Analysis Software Suite (BRASS, Hermes Medical, 
Stockholm) is a selection of tools that can be used to automatically assess uptake 
in the basal ganglia.  The software includes a template made of the scans of 20 
healthy volunteers that have been spatially registered.  A series of anatomically 
shaped VOIs have been defined based on this template.  An implementation of 
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the mutual information algorithm is used to spatially normalise test patients to 
this template, which then allows the VOIs to be applied.  The uptake is measured 
for left and right caudate and putamen relative to a posterior region, positioned 
over the occipital cortex. Figure 6-2 shows the positioning of these regions on 
one of the test patients.  The figure shows the position of seven regions, four 
relating the striatum, and three non-specific binding regions.  The large posterior 
region shown in dark blue is used to calculate the uptake ratios.  The two other 
background regions (the light blue anterior region and green posterior-inferior 
region) are not used.   
 
Figure 6-2 Positioning and size of the VOIs used in the BRASS analysis package 
The software can be used with a choice of two templates, one produced from FBP 
images; the other from OSEM based images.  The software has been tested in 
comparison with visual reporting 148 and compared for images reconstructed 
with FBP or OSEM 117.   
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Another study 144 showed that for a specific classification task (PS vs. atypical 
PS), visual assessment could be better than semi-quantitative methods.  The 
given explanation was that the VOI based models are unable to identify changes 
in the patterns of uptake.   
6.2.2 BasGan 
The basal ganglia matching tools package (BasGan) 102 was developed by the 
University of Genoa.  They used a standard anatomical atlas 159 on which they 
defined volumes of interest for the caudate and putamen manually.  These 
defined VOIs were then convolved with a smoothing filter (a Gaussian function 
with 10mm FWHM) to produce a template.  Test patients are then automatically 
aligned to this template.  The main difference between this and the BRASS 
package is that once aligned, a partial volume effect correction is applied to the 
images, before caudate and putamen uptakes are given.   
6.2.3 IBZM Tool 
The IBZM tool 152 was originally designed for D2 imaging, but has been extended 
to cover DAT based investigations.  The software is in the form of an add-on set 
of functions to the popular SPM software (see section 6.5).  The overall 
methodology is similar to BRASS, in that it allows spatial normalisation to a 
template followed by VOI based measures of uptake.  The entire brain (minus the 
striata) is used as a background region, and uptake values given for left and right 
striata.   
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6.2.4 Comparison of VOI Techniques 
A comparison of some of these techniques (QuantiSPECT and BRASS) was 
published for a set of 22 patients (11 PS and 11 ET) 78.  Long term follow up for 
these patients was not available, so a visual report of the images was used to 
define the two groups.  The report focussed on the inter- and intra- operator 
variability for the techniques as well as reporting the concordance with visual 
reporting.   
6.3 Size and Shape Analysis 
The property of interest may be the size or shape of an organ.  This is often used 
for classification of CT images (e.g. RECIST criteria 160) where the size of lesion is 
measured along its longest axis.  Other applications have used the volume and/or 
ratios of lengths. Staff et al. 161 applied automatic techniques to delineate the ROI 
describing the striatal activity.  They used the ratio of the length and width of 
this shape as a measure of disease progression.  Using the data from 52 scans 
(including 20 controls and 5 non-PS patients), and long term follow up as their 
gold standard, ROC analysis showed similar performance to the putamen-
background ratio (from the crescent ROI method in QuantiSPECT) and visual 
analysis.   
6.4 Fractal Analysis 
The heterogeneity of a ROI (e.g. the variance of the counts divided by the mean 
counts for a ROI) depends on the ROI size, the object being imaged, and the 
imaging process (e.g. resolution effects, non-uniformities in the scanner).  Fractal 
models measure how image heterogeneity changes with ROI size through a 
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metric called Dispersion.  Kuikka and co-workers 162 used these processes to 
investigate 2D transverse slices from DAT imaging studies.  The phantom data 
matched known values.  One draw back of this approach is that an estimate of 
the system heterogeneity must be made, either by statistical approaches, or by 
dual isotope scanning, and the results are sensitive to this estimate.  This 
technique has yet to be applied as a diagnostic classification method.   
6.5 Voxel-by-voxel Analysis – Statistical Parametric Mapping 
Multivariate approaches have been used in some medial imaging problems.  
These are typically used to show similarities and differences between groups of 
data but have also been applied to classification.   
Statistical Parametric Mapping (SPM) 163 works on a voxel level to define the 
mean and standard deviation for one or more groups of images.  These standard 
deviations are then used to identify voxels that fall outside a particular 
probability level.  Since a brain image will typically be made of around 5x105 
voxels, special precautions must be made in relation to the problem of multiple 
comparisons.  If all the voxels in the image were uncorrelated, a Bonferroni or 
similar correction would be appropriate.  The approach developed by Friston 163 
involves some smoothing of the image data thus ensuring a level of correlation 
between neighbouring voxels.  The general linear model (GLM) can then be used 
to identify statistically relevant differences between groups by identifying 
clusters of significant voxels.  The statistical power of the GLM when two groups 
are defined means SPM is generally used as a method for identifying differences 
between groups of patients, rather than classification.  
208 
 
Scherfler et al. 57 investigated differences in 123I- -CIT uptake in patients with 
IPD and MSA-P.  They found that both had reduced uptake in the striata when 
compared with healthy controls.  The MSA-P patients were found to have 
statistically significant reductions in the midbrain compared to IPD.  In similar 
work with 123I-Beta-CIT, Nocker et al 56 found significantly lower uptake in the 
dorsal brainstem of MSA-P.  On follow up scans the MSA-P patients were found to 
have more rapid decline in caudate and putamen uptake compared to PD.   
Cuberas-Borros et al. 132 used SPM to confirm the appropriateness of a VOI based 
technique.  They found only the striatum contained significant differences 
between IPD and controls/drug induced PD.   
In a PET based study, Wang et al. 164 used 18F-FP- -CIT and found significant 
decreases in striatum, and in particular posterior putamen areas.  Their VOI 
measurements showed significant negative correlations between caudate, 
putamen and posterior putamen regions to UPDRS motor scores.   
Colloby 133 and colleagues used SPM to investigate differences between groups of 
patients with DLB, Alzheimer’s, IPD and healthy controls imaged with 123I-FP- -
CIT.  They found significant differences between AD and DLB, and between IDP 
and controls.  No significant differences were seen between DLB and IPD.  They 
used SPM as a classification tool by quantifying differences between a test 
patient, and a template formed from scans of healthy volunteers.   
Others have reported on regional cerebral blood flow differences in PS 61 and 
DLB 43 and glucose metabolism in MSA 58.   
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6.6 The BRASS package  
6.6.1 Testing Methods 
The two clinical datasets described in chapter 4 were used to test the BRASS 
system for DATSCAN quantification.  The images for the 116 patients in dataset-
A were reconstructed with the fixed settings described in chapter 4.  The data for 
the 78 patients in dataset-B were reconstructed with a range of filter settings.  
The data were then imported into the BRASS software.  There are two 123I-FP- -
CIT templates in this software one for FBP data and one for OSEM data.  The 
latter was used for this analysis.  The software runs using predefined settings, 
which cannot be altered.  Each image was analysed individually, using its own 
spatial registration, with the uptake figures being calculated after this 
registration process.  The program does not allow uptake calculations without 
this registration, or using the registration parameters of another image.  A visual 
check was performed for each image at the time of testing to confirm correct 
alignment.   
The uptake figures (for the left and right caudate and putamen) were recorded 
for each filter setting.  The uptake ratios were analysed to give the minimum 
uptake for each subject for both caudate and putamen.  This data was transferred 
into a statistics program (SPSS statistics, v19.0, IBM, USA) for further analysis.  
The uptake score for the two groups of patients were analysed using an unpaired 
t-test with a significance level of 0.05.   
The two uptake ratios were used as predictor variables in ROC analysis using the 
known classification as the outcome.  The Area Under the Curve (AUC) was 
calculated as a function of post-reconstruction filter.   
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6.6.2 Testing the Brass Package - Results 
BRASS Automatic alignment results 
For the 115 patients image volumes in dataset-A, no misalignment errors were 
noted.  Of the 78 patient volumes in dataset-B the number of patients for which 
the spatial alignment was deemed to be unsuccessful (based on visual 
assessment) was seen to be variable and possibly related to the filter settings. 
The whole brain volume as produced by the OSEM reconstruction package was 
used as the input for the BRASS program.  Each image volume was analysed 
individually.  The spatial normalisation step could therefore produce different 
transformations for the various image volumes for a single patient.  It was 
noticed during this process that a number of different spatial alignments were 
produced.  
For some of the alignments produced by the BRASS software the resulting 
positions of the uptake VOIs were obviously incorrect. A summary is shown in 
Table 6-1.  There appears to be general trend in that the smoothest images tend 
to have more misalignment errors.  One patient was badly aligned for all filter 
settings.  The alignment for this patient is shown in Figure 6-3.  A number of 
attempts to aid this realignment were attempted, including manual alignment 
prior to processing and cropping the image boundaries.  These were not 
successful.  Since the background region is outside the brain, the counts in that 
region are too low, and hence the striatal binding measures were very high.  The 
uptake scores for all the miss-aligned data were included as “not-a-number” i.e. 
incorrectly classified, so that these results could be compared with those from 
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other classification models, but would not skew the means and standard 
deviations.   
Table 6-1 Summary of alignment errors for BRASS program 
 Post reconstruction filter (cycles/cm) 
 0.5 0.7 0.9 1.0 1.2 1.4 1.6 1.8 2.0 NF 
Correctly 
aligned 
75 76 77 76 77 77 77 77 77 75 
Alignment 
error 
3 2 1 2 1 1 1 1 1 2 
 
 
Figure 6-3 Example misregistration of scan using the BRASS software 
BRASS Uptake Measurement  - Results 
The average caudate and putamen uptake ratios for the two patient groups are 
shown in Figure 6-4 and Figure 6-5 respectively.  The error bars displayed show 
+/- one standard deviation.  The non-filtered data is inserted using a dummy 
filter setting of 2.4 cycles/cm to allow it to be visualised.  
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Figure 6-4 BRASS-Caudate uptake as a function of post reconstruction filter 
 
Figure 6-5 BRASS-Putamen uptake ratio as a function of post-reconstruction filter 
For both caudate and putamen uptake ratios there was a statistically significant 
difference between the PS and Non-PS groups.  The putamen results show better 
separation between PS and Non-PS than the caudate uptake results.   
The Area Under the Curve (AUC) results for both BRASS caudate and putamen 
uptake ratios are shown in Figure 6-6.  The putamen uptake ratio is shown to be 
a better classifier than the caudate uptake ratio for all filter settings.  There is a 
drop in AUC at the two extremes of filter setting.  There is a broad maximum in 
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the AUC for the putamen uptake ratio corresponding to filter settings in the 1-
1.4cycles/cm range.   
 
Figure 6-6 BRASS ROC analysis results as function of post reconstruction filter 
6.6.3 Testing the BRASS system – discussion 
The putamen uptake ratio is shown to give very good accuracy in classifying 
between the two disease states.  This is likely to be due to the normal 
progression of disease.  This will generally start in the posterior section of the 
putamen and extend anteriorly with disease progression.  With such a 
progression the last part of the striatum to be affected is the caudate, which can 
show good uptake even at relatively advanced disease.   
The increase in uptake ratios follows the expected trend with increasing filter 
cut-off frequency.  When wider smoothing filters are applied they have the effect 
of blurring some of the counts within the striatum into the surrounding areas.  
The effect is greater for higher contrast studies, as the blurring of counts occurs 
in both directions – from the striatum in to the background and from the 
background into the striatum.   
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The drop in accuracy with the three smoothest filters can be explained by the 
realignment problems for some patients.  The drop in accuracy with sharper 
filters/no post-reconstruction filter may be in part due to the misregistered 
patients, but this does not explain this entire drop in AUC.  The increased noise 
levels in these images may have lead to changes in accuracy at these points, or 
undetected misregistrations that have altered the uptake.   
6.7 The QuantiSPECT packages  
6.7.1 Testing methods 
The two clinical datasets described in chapter 4 were analysed using the 
QuantiSPECT software.  Although this software contains a module to perform 
FBP reconstruction, it was not used.  Instead the various reconstructed data from 
the Hermes system (as described in Chapter 3) was used.  All three analysis 
packages were used to assess the uptake in the clinical datasets.   
As the uptake ROIs/VOIs were assessed visually there were no perceived errors 
in placement.  However, a number of the studies were considerably harder to 
align.  These were generally the studies where there was very low striatal 
uptake.  An example of one of these problematic image volumes is shown in 
Figure 6-7.   
215 
 
 
Figure 6-7 QuantiSPECT positioning uncertainty 
The three methods produce eleven uptake measurements.  In all but one of these 
measurements lower figures are correlated with PS and higher figures with Non-
PS diseases.  So for these readings the minimum score for each patient was used 
in the analysis.  The symmetry index is the one figure that does not follow this 
pattern as it scales from minus to plus infinity, with zero being normal.  To allow 
for analysis along with the other metrics the absolute of the asymmetry score 
was subtracted from 1000.   
6.7.2 The 2-Box Method - Results 
The mean SBI for the two groups of patients is shown in Figure 6-8 as a function 
of reconstruction post filter.  The error bars show one standard deviation for the 
two groups.  There is good separation for both groups at all filter frequencies.  
There is an obvious increase in the SBI when very smooth filters are used.   
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Figure 6-8 2-Box Striatal Binding Index as a function of the post reconstruction filter 
The results of the ROC analysis in the form of the AUC are shown in Figure 6-9 as 
a function of filter cut-off frequency.  The AUC from the original dataset is also 
shown corresponding to a post-reconstruction filter of 1.2cycels/cm for 
comparison.   
 
Figure 6-9 2-Box ROC analysis as a function of post-reconstruction filter 
6.7.3 The 2-Box Method - Discussion 
The SBI curves for the two groups of patients show very uniform response and 
are nearly independent of image filtering level.  Only at very smooth filters does 
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the SBI for the two groups change.  This uniformity of response is shown in the 
constant AUC results.  One of the goals of the authors originally proposing this 
technique was to create a resolution insensitive system and these results confirm 
this property.   
6.7.4 The 3-Box Method - Results 
The mean minimum TBPI figure for the two groups of patients as a function of 
the post reconstruction filter is shown in Figure 6-10.  The error bars reflect one 
standard deviation in the results.  The mean of the absolute asymmetry indexes 
for the two groups is shown in Figure 6-11 as a function of reconstruction filter.   
 
Figure 6-10 3-Box TBPI as a function of post reconstruction filter setting 
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Figure 6-11 3-Box Asymmetry index as a function of post reconstruction filter 
The results of the ROC analysis in terms of AUC for both the TBPI and the 
asymmetry index are shown in Figure 6-12.   
 
Figure 6-12 3-Box ROC analysis as a function of filter cut-off 
6.7.5 The 3-Box Method - Discussion 
As with the 2-box analysis, the large VOI size of the 3-box analysis gives a very 
uniform response with resolution.  However, the TBPI results show very large 
variation. There is considerable overlap between the two groups when the 
standard deviation is taken into account.  The main difference between this 
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technique and the 2-box system is the placement of the background region.  For 
the 2-box method this is automatically defined and encompasses the vast 
majority of the cerebellum.  In the 3-box system the background region is 
moveable and re-sizable, although in this work the default size was used.  With a 
fixed size and shape, the variations in this region can come from two factors.  
The first factor is blurring of counts from the striatum. The recommended 
placement of this region is posterior to the striatal regions.  In published work 
others have positioned it abutting the striatal regions 78.  Here the placement was 
centrally positioned, posterior to the striatal regions, with a gap of 4 voxels to try 
to limit the level of spill-over from the striatum.   
A second variation comes from the size, shape and position of the ventricles 
relative to the position of this VOI.  The ventricles hold cerebrospinal fluid in a 
central cavity in the middle for the brain and have zero DAT uptake.  The size 
and shape of these vary between patients and can grow in size with age.   
The asymmetry index shows very large variations in magnitude – especially 
when the uptake is low.  It gives poor results as a classifier on its own.  It may be 
possible to include this as a second step of a decision tree classifier.   
6.7.6 The Crescent method - results 
The mean of the minimum striatal uptakes is shown in Figure 6-13 as a function 
of reconstruction filter.  A sharp drop off in measured uptake is seen at the 
smoother filter settings.  The same over all patterns are seen in the putamen 
uptake ratios (Figure 6-14).  Above fco=1.0cycle/cm caudate and putamen uptake 
ratios show no dependency on filter.  Both curves show good separation between 
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the two disease states.  As with the BRASS system, the putamen uptake curves 
give better differentiation.   
 
Figure 6-13 Crescent method striatal uptake as a function of reconstruction filter 
 
Figure 6-14 Crescent method putamen uptake as function of reconstruction filter 
 
The ratio of caudate to putamen counts is shown in Figure 6-15 as a function of 
smoothing filter setting.  The ratio is constant for filters above 1.0cycles/cm.  At 
lower frequencies the ratio approaches 1 as the smoothing filter averages the 
signals from the two regions.   
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Figure 6-15 Putamen to Caudate ratio as a function of reconstruction filter 
 
The usefulness of these metrics as a classifier was tested using ROC analysis.  
Figure 6-16 shows the AUC for these results as a function of filter cut-off 
frequency.   
 
Figure 6-16 ROC results for the crescent method 
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6.7.7 The Crescent method - discussion 
The results from dataset-B show almost perfect AUC scores for the striatum and 
caudate results for all but the smoothest of filter settings.  The putamen uptake 
ratio is particularly good as a classifier.   
The results from dataset-A show lower AUC scores than dataset B.  However only 
the difference is PCR AUC score is statistically significant.   
6.8 Comparison of datasets 
The two datasets are described in chapter 4.  They were acquired with different 
matrix sizes and scan timing.   The composition of known diagnosis is slightly 
different but not statistically significant.  The AUC results were compared for the 
data from dataset-A and the data from dataset-B that had been smoothed with a 
1.2cycles/cm filter.  The comparison was made using the method outlined by 
Hanley and NcNeil 165 using a significance level of p=0.05.   
The two large VOI analysis modes (2box and 3box) both have higher AUC scores 
for the older dataset.  The two methods using the smaller VOIs achieved similar 
results for both datasets, with slightly lower values for the older data set.  
However these differences were not statistically significant.  The one pair of ROC 
curves that were found to be statistically significant were those from the PCR 
method, which had a particularly poor AUC result for dataset A.   
6.9 Reconstruction setting comparisons 
The variation in accuracy with filter setting was investigated using the better 
performing analysis techniques – the crescent and BRASS based uptake ratios 
and the 2-box model.  The AUC is plotted as a function of the smoothing filter 
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setting in Figure 6-17.  The VOI techniques described here show stable 
performance with image filtering.  These 5 methods are very stable for the range 
of filter 1.0-1.4 cycles/cm.   
 
Figure 6-17 AUC as a function of filter setting for a range of analysis techniques 
6.10 Method comparisons - sensitivity and specificity 
For all of the results described above the cut-off value for the various uptake 
metrics has been used as a variable in ROC analyses.  To use these results as a 
classifier, a specific cut-off must be chosen to give the diagnosis.  As shown in the 
ROC curves, a compromise must be made between the sensitivity and specificity 
of the tests.  Where this compromise falls depends on the use of the test, the 
severity of consequence for false negative or false positive results, and on the 
prevalence of the disease in the test population.  In this work we compare the 
maximum accuracy for the test population investigated here.  The maximum 
accuracies achievable with the different VOI classifiers are shown in  
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 for dataset B.  The maximum accuracy for each method is shown as a function of 
filter frequency in Figure 6-18.   
The results for the 2 BRASS methods include between 1 and 3 missed diagnosis 
that were a direct result of misalignment.  The uptake figures for those patients 
were not included, and a null results entered.  Each incorrectly classified subject 
means a drop in accuracy of 1.3%.  If these misaligned patients are not included 
in the analysis, the BRASS- putamen system reaches a peak accuracy of 0.97.   
From Figure 6-18 it can be seen that some of the methods are strongly 
influenced by image filtering, in particular the putamen-caudate ratio and the 
asymmetry index.  The Crescent-Putamen method gives the highest accuracy of 
all the techniques.  It also gives consistent performance across the levels of image 
filtering.  
Table 6-2 Comparison of optimised VOI methods using dataset B 
 Cut-off Sensitivity Specificity Accuracy 
Brass –Caudate 1.77 0.96 0.77 0.91 
Brass –Putamen 1.00 0.95 1.00 0.96 
2-Box 5.14 0.98 0.73 0.91 
3-Box 40 0.96 0.73 0.90 
3-Box AI 11* 0.79 0.86 0.81 
Cr Striatum 1.70 0.96 0.95 0.96 
Cr-PCR 0.84 0.95 0.95 0.95 
Cr-Putamen 1.52 0.98 1.00 0.99 
*All readings below cut-off values give positive diagnosis except for 3-Box-AI which is give 
a negative diagnosis if below the cut-off. 
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Figure 6-18 Maximum achievable accuracy for each classification model as a function of 
filter frequency 
 
The maximum accuracy achievable for the datasets A and B (using the optimum 
filter setting for dataset B) is shown in Table 6-3.  The cut-off values in this table 
are different for some of the measurements as the original dataset used 
attenuation correction.   
Table 6-3 Comparison of optimised VOI methods using both datasets 
 Cut-off 
Dataset A 
Accuracy 
Dataset A 
Cut-off 
Dataset B 
Accuracy 
Dataset B 
Brass –Caudate 1.68 0.87 1.77 0.91 
Brass –Putamen 1.19 0.93 1.00 0.96 
2-Box 4.85 0.91 5.14 0.91 
3-Box 44 0.91 40 0.90 
3-Box AI* - - 11 0.81 
Cr Striatum 1.5 0.91 1.70 0.96 
Cr-PCR 0.86 0.81 0.84 0.95 
Cr-Putamen 1.2 0.91 1.52 0.99 
*All readings below cut-off values give positive diagnosis except for 3-Box-AI which is give 
a negative diagnosis if below the cut-off. Asymmetry index not recorded for dataset A 
6.11 Variation with Age 
The uptake scores for the non-PS subjects data used above was used to test the 
use of patient age as a confounding feature.  The data used to give the best 
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classifications (used in Table6-2) was used.  The uptake scores were plotted as a 
function of patients’ age (in years, at time of scan).  A linear regression was 
performed on this data, to show the age dependence of these uptake figures.  A 
summary is shown in Table 6-4.  The average change in uptake values across the 
measurements was 6.6% per decade.   
Table 6-4 Age dependence of uptake figures 
 Slope Intercept r2 % change 
per decade 
Brass –Caudate -0.025 3.52 0.36 -7.1% 
Brass –Putamen -0.027 3.03 0.39 -8.9% 
2-Box -0.07 10.2 0.48 -6.9% 
3-Box -0.52 78.3 0.28 -6.6% 
Cr Striatum -0.017 3.31 0.22 -5.1% 
Cr-Putamen -0.017 3.22 0.24 -5.3% 
 
The data was used to calculate the 95% confidence intervals for the prediction of 
uptake measure, given age.  Due to the low number of subjects in the Non-PS 
grouping, the confidence intervals for this data are correspondingly wide.   
Figure 6-19 shows the PS and NPS data for the 2-Box analysis as a function of 
age.  A regression line has been fitted to the Non-PS data.  The classification cut-
off (defined above, Table6-2)  is shown giving a misclassification of 7 patients.  
The 95% confidence intervals from the regression are also shown.  Although 
there is clearly age dependence in the uptake score, examination of this graph 
shows that a better classification cannot be given using this extra information.   
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Figure 6-19 Age dependence of 2Box striatal binding index 
Figure 6-18 shows the same analysis performed on the crescent method 
putamen uptake ratio.  There is a single misclassified patient when using the 
non-age dependent cut-off (1.52).  Again, the age dependence is seen in the NPS 
subjects, however this extra information does not improve the classification.   
 
Figure 6-20 Age Dependence of Crescent-Putamen uptake ratio 
6.12 Variation with age – discussion 
The regression analysis on non-PS patients shows an age dependency for all 
uptake measures.  The average reduction in DAT uptake measurements of 6.6% 
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compares well with published figures of 4.1%, 150 4-6.7% 166 and 6.5% 167.  The 
caudate-to-putamen ratio does not exhibit an age related change that suggests 
that the age related changes in caudate and putamen are similar.  This age 
dependence should allow an age related cut-off to be used to give better 
classification however this has not been the case for this data.  Part of the reason 
for this is the number of subjects in the training set.  Fewer subjects in the NPS 
group mean quite widely spaced 95% confidence intervals.  The change in 
uptake with age is one of many factors that affect the uptake measurements.  
There is still a wide variation in uptake in the normal population that is not 
accounted for by age.  In the test-retest variability measurements published by 
Booij et al. 48 over 7% variability was seen in the healthy control group.  The non-
PS groups used here is, because of it origin, not a healthy control group.  They are 
patients with movement disorders that are thought to not have any of the 
Parkinsonian syndromes.  It is likely that such a group will have a normal 
variance as great if not greater than the healthy control group used in that work.  
Other factors that may contribute to the variation in uptake in the non-PS group 
could include subject medication history, and possibly scatter and attenuation 
effects.   
6.13 Commercially available methods – discussions 
In this chapter, four methodologies for assessment of DAT images were 
described and assessed under a range of conditions.   
The dependence on smoothing filter in for the crescent method uptake 
measurements is much lower than that of the BRASS methodology.  This 
difference may be down to the size of the VOIs used.  Unfortunately, it was not 
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possible to assess the sizes of the VOIs used in these two techniques.  A 
secondary factor may be in the performance of the image registration program 
used in BRASS.  Some misregistrations were found when analysing the second 
patient group, but it is possible that some other more subtle misregistration 
were not noticed during visual checking.  The large VOI methods showed very 
stable output with filter smoothing.   
The two methods that measure putamen uptake separately, the BRASS-Put and 
Crescent-Put measurements, performed the best across the two patient datasets.   
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7  
In the previous two chapters a wide range of classification techniques have been 
tested using a large dataset of clinical images from a carefully controlled clinical 
audit database.   
7.1 Overall accuracy 
The best performing commercial system was the crescent method using the 
putamen uptake index.  This gave 99% accuracy for training set B.  The novel 
SVD  based system developed in this work gave the same accuracy for the same 
data set.   
7.2 Variation with image smoothness 
Over all the various classification models here showed good stability in 
performance with image filtering levels.  This was despite the wide range of 
image qualities tested.   
There were some patterns in the performance when compared to filtering levels.  
The large VOI system showed the best performance with very smooth images.  
The 2-box method showed good uniformity of accuracy with image filtering.  The 
3-box method did not have this same uniformity most likely because of the 
variation in background VOI placement with respect the ventricles.   
A number of papers have been written discussing the measurement and use of 
cross camera calibration factors.  In them various striatal uptake measurements 
have been made on anthropomorphic phantoms 86,168 and some have been 
applied to ranges of healthy volunteers 80.  The uptake measurements used in 
those works have been included in this project, and found to be insensitive to 
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image smoothing levels.  Further more, these works have used single 
reconstruction software and parameters.  It must be surmised that differences in 
uptake seen across scanners may be linked to the scattering and collimator 
effects that are prevalent in 123-Iodine imaging.   
This could not be tested within this work as all the patients were being scanned 
on a single site and as part of clinical routine.  A further study could be 
performed in which volunteer patients are scanned on multiple scanners from 
single injections.   
7.3 Statistical and clinical significance of these results 
Most of these semi-quantitative methods are capable of providing excellent 
differentiation between the disease states.  The reason these techniques are so 
powerful is to do with the progression of the disease.  In Parkinson’s disease 
clinical symptoms only start to appear once there has been a significant loss 
(>50% change) in dopaminergic cells.  Such significant changes lead to high 
diagnostic performance.   
However, there remain some patients that do not get the correct diagnosis.  One 
group of patients who have been identified are those classed as Symptoms 
Without Evidence of Dopaminergic Deficit.  This group appear to have some form 
of Parkinsonian syndrome, but it does not follow the normal pattern of IPD or 
the other main Parkinson’s-plus syndromes.   
One reason that has been suggested for possible false negative scans when using 
123I-FP- -CIT is the non-specificity of the pharmaceutical.  The ligand is known to 
have an affinity for serotonin transporters (SERT) and well as DAT 39 169.  It has 
been suggested that the early stages of some Parkinsonian syndromes may 
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involve a compensatory up regulation of SERT in response to dopaminergic loss.  
At the time of writing no clear evidence of this effect has been published, but it 
may be a useful area for investigation in the future.   
In this study the gold standard diagnosis was given by a neurologist who was 
personally involved in the subjects care.  Whilst undoubtedly an expert, the 
complex nature of these diseases may allow a misdiagnosis to be given.  Having 
said that, the near perfect classification results given by the different 
classification methods suggests that so such errors have been made.  There are of 
course a number of patients in the original audit database for whom a correct 
diagnosis was not recorded.  By leaving out these patients the overall sensitivity 
and specificity of these tests are greatly exaggerated.  The only true gold 
standard for the measurement of accuracy of these tests is with post-mortem 
evidence and sufficient data for this is unlikely to ever be recorded.   
7.4 Overview and Conclusions 
The aims of this work as set out in chapter 1 and having reviewed the available 
results and data the following points can be made:  
The gamma camera performance characteristics for 123-iodine use were 
measured and used to optimise the clinical acquisition of SPECT imaging of the 
brain.   
The image quality for a wide range of reconstruction techniques were compared 
using a range of image quality metrics.  In the end the exact reconstruction 
settings were shown to have little effect on the ultimate image quality metric- 
their usefulness in giving clinical diagnosis.   
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Four commercially available DAT SPECT analysis programs were tested and 
compared under a range of settings.   
A collection of automatic classification techniques were developed using feature 
extraction and machine learning algorithms.  The a performance of these 
algorithms was compared directly to the commercial systems to test the original 
hypothesis for this thesis: 
 
“An automatic classification tool based on machine learning techniques 
will give better performance than currently available techniques.”   
 
The answer to this hypothesis is negative, but not because of failing in the novel 
technique developed here.  Rather, it is not proven because of the near perfect 
performance of both the novel technique, and one of the commercially available 
methods.   
7.5 Future work: 
The excellent results for the combined feature extraction and machine-learning 
system may be useful in the analysis of other imaging tasks, especially if the task 
involves two distinct image distributions.  One such group of imaging techniques 
is the measurement of amyloid plaque load in Alzheimer’s disease.   
These techniques could be applied to the database of images that are available as 
part of the PPMI project 170.  This project will include a large number of patient 
scans from a range of scanner.  The scan subjects are a mix of healthy volunteers 
and treatment naïve patients with Parkinson’s disease.  With improved statistics 
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of a much larger dataset, better distinction may be drawn between the analysis 
techniques described here.  
Although near perfect classification was reported for these datasets, a recent 
publication by Segovia et al. 171 used the results described here as a benchmark 
with which to compare a new classification procedure.  They utilised a PLS based 
transformation followed by a SVM classifier and showed an improvement over 
the techniques reported here.    
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